000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki|þp|N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1613|3114|lyfalmen|V1070|1516|00|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1613||1613|3114| 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|33944|44482|lyfsjukr|||00|2|0|24,0000|Icepharma hf|Roche|Epóetín||33944||33944|44482| 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|50993|65879|lyfsjukr|||00|2|0|36,0000|Icepharma hf|Roche|Epóetín||50993||50993|65879| 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10565|15360|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10565||10565|15360| 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31435|41810|lyfalmen|||00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||31435||31435|41810| 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|40881|53665|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||40881||40881|53665| 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|20567|28171|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20567||20567|28171| 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|5107|7371|lyfsjukr|||00|1|0|0,0400|Vistor hf|Ferring|Atosíban||5107||5107|7371| 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7725|15006|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||7725||7725|15006| 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|13679|19050|lyfsjukr|||00|5|0|0,2300|Vistor hf|Ferring|Atosíban||13679||13679|19050| 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|20574|28180|lyfalmen|||00|0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||20574||20574|28180| 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|39934|52477|lyfalmen|||00|1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||39934||39934|52477| 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5429|8334|lyfalmen|||00|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5429||5429|8334| 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||00|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657| 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||00|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139| 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3238|5337|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||||3238|5337| 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|28482|38104|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||28482||28482|38104| 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1837|3420|lyfalmen|||06|5|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||1837||1837|3420| 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4963|7697|lyfalmen|||23|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4963||4963|7697| 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|3697|5965|lyfalmen|||00|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3697||3697|5965| 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen|||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5456|8371|lyfalmen|||00|24|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5456||5456|8371| 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7230|10435|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Fitusambönd||7230||7230|10435| 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3129|5188|lyfalmen|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3129||3129|5188| 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3852|6177|lyfalmen|||23|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3852||3852|6177| 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|170264|215564|lyfsjukr|||00|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||170264||170264|215564| 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|22822|30524|lyfsjukr|||02|1|0|7,4963|Icepharma hf|Pfizer ApS|Sómatrópín||22822||22822|30524| 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|5824|8405|lyfsjukr|||02|0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5824||5824|8405| 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1486|2940|lyfalmen|||00|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1486||1486|2940| 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6492|9788|lyfalmen|||00|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6492||6492|9788| 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|21481|29318|lyfalmen|||00|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||21481||21481|29318| 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2363|4140|lyfalmen|V0091|2370|43|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2363||2363|4140| 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|0|0|ABH|0|0|0|100|XEU|10841|15737|lyfalmen|||00|98|0|98,0000|Icepharma hf|Abbott Healthcare Products B.V.|Eprosartan||10841||10841|15737| 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003|30.04.2011|R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|487995|614316|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||487995||487995|614316| 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|29119|38427|lyfsjukr|||02|2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||29119||29119|38427| 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000|31.03.2011|R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2177|lyfalmen|||00|28|0|18,6667|Actavis Group hf|Actavis hf|Simvastatín||928||928|2177| 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000|31.03.2011|R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4601|lyfalmen|||00|28|0|37,3400|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4601| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6234|9435|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||6234||6234|9435| 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4223|6684|lyfalmen|||10|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4223||4223|6684| 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2115|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2115| 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4267|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4267| 001574|C09AA0209|Enalapril Mylan|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2009||R|A||0|0|B|0|PCO|0|0|0|100|SEK|569|1686|lyfalmen|||00|50|1|12,5000|Distica|Distica - óskráð lyf|Enalapríl||569||569|1686| 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22441|30046|lyfsjukr|||00|4104|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||22441||22441|30046| 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|14788|20918|lyfalmen|V0011|20229|00|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||14788||14788|20918| 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32700|42921|lyfsjukr|||00|6160|0|6,1600|Icepharma hf|Fresenius Kabi|Blöndur||32700||32700|42921| 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAI|0|0|1|100|IKR|||lyflausa|||00|20|0|2,1600|Icepharma hf|Bayer A/S|Acetýlsalicýlsýra|||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|2474|3571|lyfsjukr|||02|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2474||2474|3571| 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|3816|6127|lyfalmen|||06|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíð||3816||3816|6127| 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|848|2067|lyfalmen|||00|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||848||848|2067| 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1946|3569|lyfalmen|V0791|3569|00|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1946||1946|3569| 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|6936|10395|lyfalmen|V0795|10395|00|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10395| 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4347|6854|lyfalmen|||00|45|0|45,0000|Icepharma hf|Bioglan AB|Capsaicin||4347||4347|6854| 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|3353|5494|lyfalmen|V0793|5494|00|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5494| 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9149|13423|lyfalmen|V0456|13208|43|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9149||9149|13423| 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4419|6952|lyfalmen|V0084|6951|00|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4419||4419|6952| 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5263|8107|lyfalmen|V0794|8107|00|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8107| 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8773|12908|lyfalmen|||0|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8773||8773|12908| 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1393|2813|lyfalmen|||00|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1393||1393|2813| 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6183|9365|lyfalmen|V0085|9017|00|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6183||6183|9365| 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5394|8286|lyfalmen|||00|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5394||5394|8286| 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5414|8313|lyfalmen|||00|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5414||5414|8313| 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26418|35037|lyfsjukr|||00|5760|0|5,7600|Icepharma hf|Fresenius Kabi|Blöndur||26418||26418|35037| 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13446|19234|lyfalmen|V0087|19233|00|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13446||13446|19234| 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|9861|14397|lyfalmen|||00|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9861||9861|14397| 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|3193|5275|lyfalmen|||02|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín aspart||3193||3193|5275| 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|17881|24800|lyfalmen|V0089|24798|00|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||17881||17881|24800| 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|5437|8345|lyfalmen|V0092|8344|00|120|0|120,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||5437||5437|8345| 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3718|5993|lyfalmen|||00|60|0|60,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||3718||3718|5993| 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|17518|24344|lyfalmen|||00|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||17518||17518|24344| 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|106247|135222|lyfsjukr|||00|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||106247||106247|135222| 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|54074|69745|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||54074||54074|69745| 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAY|0|0|0|100|SEK|27357|36216|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||27357||27357|36216| 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3244|5345|lyfalmen|||00|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||3244|5345| 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|3244|5345|lyfalmen|||00|84|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3244||3244|5345| 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1679|3204|lyfalmen|V0984|3204|00|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1679||1679|3204| 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|221245|279545|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||221245||221245|279545| 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|2922|5097|vetorma|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2922|5097| 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1289|2671|lyfalmen|||07|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||1289||1289|2671| 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|30816|40557|lyfsjukr|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||30816||30816|40557| 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|MSE|0|0|0|100|SEK|77674|99840|lyfalmen|||00|1|0|14,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||77674||77674|99840| 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14478|15618|lyfalmen|V2220|4940|00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||10754||10754|15618| 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|10702|15547|lyfalmen|||00|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10702||10702|15547| 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|251733|317807|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||251733||251733|317807| 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|18477|25548|lyfalmen|V1710|25547|00|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||18477||18477|25548| 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|35901|47415|lyfalmen|||00|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||35901||35901|47415| 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|10439|15187|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||10439||10439|15187| 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|15518|21834|lyfalmen|||00|1|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||15518||15518|21834| 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17255|23538|lyfsjukr|||00|2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||17255||17255|23538| 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|23476|31345|lyfsjukr|||00|2|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||23476||23476|31345| 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26326|34922|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||26326||26326|34922| 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1669|lyfalmen|||00|0|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Stífkrampi||557||557|1669| 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|39188|51063|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||39188||39188|51063| 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|51451|66454|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||51451||51451|66454| 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|62458|80267|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||62458||62458|80267| 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|192781|243823|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||192781||192781|243823| 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9436|13815|lyfalmen|V1300|13815|0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9436||9436|13815| 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|76657|98087|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||76657||76657|98087| 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|8747|12873|lyfalmen|||00|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8747||8747|12873| 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|105838|134709|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||105838||105838|134709| 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|DKK|60824|78694|lyfalmen|||00|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||60824||60824|78694| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|123362|156702|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||123362||123362|156702| 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|182563|230999|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||182563||182563|230999| 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003|31.05.2011|R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|96073|122454|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||96073||96073|122454| 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|4450|6995|lyfalmen|||00|28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4450||4450|6995| 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|3309|5434|lyfalmen|||00|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3309||3309|5434| 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|15377|21658|lyfalmen|||00|98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||15377||15377|21658| 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|6731|10115|lyfalmen|||00|28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6731||6731|10115| 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|SEK|22975|31193|lyfalmen|||00|98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||22975||22975|31193| 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|897|2134|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||897||897|2134| 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1017|1977|lyfalmen|V0931|1977|00|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1977| 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|604|1734|lyfalmen|||67|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||604||604|1734| 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2389|4175|lyfalmen|V0933|4175|00|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4175| 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|74775|95725|lyfsjukr|||00|60|0|7,5000|Vistor hf|Abbott Laboratories A/S|Lopinavír||74775||74775|95725| 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2188|3900|lyfalmen|V0608|2351|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2188||2188|3900| 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|22432|30035|lyfsjukr|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||22432||22432|30035| 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8143|12047|lyfalmen|||00|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8143||8143|12047| 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4021|6408|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4021||4021|6408| 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|0|0|PER|0|1|0|100|DKK|609|1740|lyfalmen|||00|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||609||609|1740| 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1090|2398|lyfalmen|||10|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1090||1090|2398| 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PER|0|1|0|100|DKK|5631|8610|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5631||5631|8610| 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|5973|9078|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||5973||5973|9078| 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|8314|12281|lyfalmen|||23|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8314||8314|12281| 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|652|1799|lyfalmen|||00|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||652||652|1799| 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|0|0|ORG|0|1|0|100|DKK|6098|9249|lyfalmen|||00|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||6098||6098|9249| 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|21673|29082|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||21673||21673|29082| 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1702|3236|lyfalmen|V1901|3234|00|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1702||1702|3236| 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6941|10402|lyfalmen|||0|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6941||6941|10402| 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4765|7426|lyfalmen|||00|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4765||4765|7426| 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4699|9195|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||4699||4699|9195| 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3341|5478|lyfalmen|||00|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3341||3341|5478| 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|650|1797|lyfalmen|||00|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||650||650|1797| 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3287|5404|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3287||3287|5404| 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4456|7003|lyfalmen|||00|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4456||4456|7003| 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6293|9516|lyfalmen|||00|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6293||6293|9516| 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8376|12365|lyfalmen|||00|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8376||8376|12365| 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1979|3615|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||1979||1979|3615| 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3550|5764|lyfalmen|||00|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríð||3550||3550|5764| 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4404|lyfalmen|V0926|4404|00|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4404| 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|36501|47691|lyfsjukr|||00|1|0|4,0000|Icepharma hf|E. Merck AB|Sómatrópín||36501||36501|47691| 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1459|2903|lyfalmen|||20|25|0|25,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||1459||1459|2903| 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2564|4415|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||2564||2564|4415| 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4910|7624|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4910||4910|7624| 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|2092|lyfalmen|V0927|2092|00|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2092| 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|7346|lyfalmen|V0930|7346|00|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7346| 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1969|lyfalmen|V0921|1969|00|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|1969| 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4605|lyfalmen|V0922|4605|00|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4605| 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|926|1850|lyfalmen|V0923|1850|00|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1850| 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1713| 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|39209|51090|lyfsjukr|||00|5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||39209||39209|51090| 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3340|lyfalmen|V0925|3340|00|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3340| 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|139671|177170|lyfsjukr|||00|19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||139671||139671|177170| 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EMA|0|0|0|100|SEK|182506|230928|lyfsjukr|||00|5|0|20,0000|Icepharma hf|E. Merck AB|Sómatrópín||182506||182506|230928| 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10532|15315|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10532||10532|15315| 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|7080|7562|lyfalmen|||0|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4865||4865|7562| 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|9148|8822|lyfalmen|V0715|5999|10|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||5786||5786|8822| 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|668|1821|lyfalmen|||41|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||668||668|1821| 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006|30.04.2011|R|A|4|0|1|0|1|NOE|0|0|0|100|DKK|57823|74450|lyfsjukr|||00|2|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||57823||57823|74450| 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|5572|8042|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5572||5572|8042| 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|384|1433|lyfalmen|||41|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||384||384|1433| 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|675|1831|lyfalmen|||41|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||675||675|1831| 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1277|2654|lyfalmen|||41|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1277||1277|2654| 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1726|3268|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1726||1726|3268| 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2386|4171|lyfalmen|||00|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2386|4171| 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|9035|7199|lyfalmen|V0437|4925|00|90|0|90,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4599||4599|7199| 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1139|2465|lyfalmen|||10|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||1139||1139|2465| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1312|2702|lyfalmen|||10|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1312||1312|2702| 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|DKK|1795|3363|lyfalmen|||10|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1795||1795|3363| 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|28308|37886|lyfalmen|V1301|37886|00|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28308||28308|37886| 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|52011|67633|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||52011||52011|67633| 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3411|5573|lyfalmen|||00|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3411||3411|5573| 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1158|2491|lyfalmen|||00|2|0|0,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1158||1158|2491| 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|62908|81309|lyfalmen|V0565|80806|00|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||62908||62908|81309| 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1529|2999|lyfalmen|||24|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1529||1529|2999| 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|30454|18713|lyfalmen|V0815|15766|00|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13031||13031|18713| 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|4170|6612|lyfalmen|||00|4|0|28,0000|Vistor hf|M.S.D.|Alendrónsýra||4170||4170|6612| 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|38733|50969|lyfalmen|||00|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||38733||38733|50969| 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1259|2630|lyfalmen|V2200|2595|23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1259||1259|2630| 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|10690|5708|lyfalmen|V0718|4909|00|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra||3509||3509|5708| 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6437|9713|lyfalmen|||00|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||6437||6437|9713| 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|6784|10188|lyfalmen|||0|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||||6784|10188| 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|3835|6153|lyfalmen|||00|0|0|0,0000|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||3835||3835|6153| 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1643|3155|lyfalmen|||00|30|0|15,0000|Icepharma hf|Servier|Glíklazíð||1643||1643|3155| 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2864|4825|lyfalmen|||00|60|0|30,0000|Icepharma hf|Servier|Glíklazíð||2864||2864|4825| 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7605|11311|lyfalmen|||00|180|0|90,0000|Icepharma hf|Servier|Glíklazíð||7605||7605|11311| 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4179|6624|lyfalmen|||00|90|0|45,0000|Icepharma hf|Servier|Glíklazíð||4179||4179|6624| 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6326|9561|lyfalmen|||00|180|0|90,0000|Icepharma hf|Servier|Estradíól||6326||6326|9561| 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|1838|3422|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1838||1838|3422| 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|74798|95754|lyfsjukr|||00|15|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||74798||74798|95754| 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6835|9238|lyfalmen|V0940|4758|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6090||6090|9238| 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|3241|4999|lyfalmen|V0939|3646|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2991||2991|4999| 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|18493|32260|vetorma|||16|5|0|0,0000|Vistor hf|Merial (MSD)|||18493||18493|32260| 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6442|9720|lyfalmen|||00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6442||6442|9720| 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|92514|117988|lyfsjukr|||00|20|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||92514||92514|117988| 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|10868|14512|lyfalmen|V0938|7599|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9945||9945|14512| 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5206|7595|lyfalmen|V0941|4163|00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4889||4889|7595| 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3078|5118|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||3078||3078|5118| 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3068|5104|lyfalmen|||59|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3068||3068|5104| 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|909|2151|lyfalmen|||00|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||909||909|2151| 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|10551|15341|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||10551||10551|15341| 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|16826|21206|lyfalmen|V0942|7599|00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15017||15017|21206| 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3671|5929|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3671||3671|5929| 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|6649|8917|lyfalmen|V0943|4545|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5855||5855|8917| 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9711|12754|lyfalmen|V2209|3902|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8660||8660|12754| 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|13028|18710|lyfalmen|||00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13028||13028|18710| 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4825|7508|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4825||4825|7508| 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|13199|18083|lyfalmen|V2210|3946|00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12529||12529|18083| 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|SEK|88531|112989|lyfsjukr|||00|2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||88531||88531|112989| 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|5946|9041|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insulín aspart||5946||5946|9041| 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|107348|136604|lyfsjukr|||00|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||107348||107348|136604| 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5768|8798|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||5768||5768|8798| 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|SEK|164860|208782|lyfsjukr|||00|3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||164860||164860|208782| 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|DKK|81981|104769|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||81981||81981|104769| 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1434|2869|lyfalmen|||00|4|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||1434||1434|2869| 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|A||0|0|0|0|REP|0|0|1|100|SEK|2609|4476|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2609||2609|4476| 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2766|4691|lyfalmen|||43|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2766||2766|4691| 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|9066|17581|vetalmen|||00|50|0|0,0000|Vistor hf|Boehringer Ingelheim|||9066||9066|17581| 006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|12676|18268|lyfalmen|||00|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12676||12676|18268| 006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7182|10732|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7182||7182|10732| 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|12724|18328|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12724||12724|18328| 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|1,6700|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AD01|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel|||||| 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|15061|21261|lyfalmen|||00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||15061||15061|21261| 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4611|7215|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4611||4611|7215| 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|714|1884|lyfalmen|||00|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||714||714|1884| 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|24888|47961|vetalmen|||27|20|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||24888||24888|47961| 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13942|19857|lyfalmen|V2208|19857|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13942||13942|19857| 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|2091|3768|lyfalmen|||00|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2091||2091|3768| 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6954|10420|lyfalmen|||00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6954||6954|10420| 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|21045|28771|lyfalmen|V0341|28771|00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21045||21045|28771| 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5311|8173|lyfalmen|||00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5311||5311|8173| 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8740|12863|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8740||8740|12863| 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|26327|35400|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||26327||26327|35400| 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|170611|215999|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||170611||170611|215999| 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|325579|410484|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter|Prótein C||325579||325579|410484| 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2064|3731|lyfalmen|||10|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2064||2064|3731| 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|3050|5080|lyfalmen|||00|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3050||3050|5080| 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|101065|128719|lyfsjukr|||00|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||101065||101065|128719| 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|288933|364493|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||288933||288933|364493| 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PER|0|0|0|100|DKK|3322|5452|lyfalmen|V0988|5449|06|2|0|0,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3322||3322|5452| 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|8764|12649|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Clintec parenteral SA|||8764||8764|12649| 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|121893|154858|lyfsjukr|||00|100|0|0,0000|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||121893||121893|154858| 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|24042|32055|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Sevóflúran||24042||24042|32055| 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2025|3533|vetorma|||16|7|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2025|3533| 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6423|9694|lyfalmen|||00|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6423||6423|9694| 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3709|5981|lyfalmen|V2215|5981|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3709||3709|5981| 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|5098|7881|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5098||5098|7881| 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|4621|6669|lyfsjukr|||00|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4621||4621|6669| 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22139|30144|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||22139||22139|30144| 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|0|0|SPL|0|0|0|100|DKK|9937|14501|lyfalmen|||00|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9937||9937|14501| 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2602|3755|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2602||2602|3755| 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|2674|4565|lyfalmen|V2211|4565|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2674||2674|4565| 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|6595|9929|lyfalmen|||00|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6595||6595|9929| 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|22388|30456|lyfalmen|||00|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||22388||22388|30456| 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3271|lyfalmen|V1075|3271|00|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3271| 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4115|6536|lyfalmen|||00|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4115||4115|6536| 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0,0000|Icepharma hf|Baxter|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 007920|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2159|3861|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|||2159||2159|3861| 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1219|2575|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Ólópatadín||1219||1219|2575| 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|185377|234531|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||185377||185377|234531| 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|21140|28413|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||21140||21140|28413| 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1905|lyfalmen|||00|30|1|10,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1905| 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|46350|60052|lyfsjukr|||00|1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjað)||46350||46350|60052| 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|SEK|617|1751|lyfalmen|||00|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||617||617|1751| 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3644|5892|lyfalmen|||00|1|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3644||3644|5892| 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|24171|32217|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||24171||24171|32217| 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29989|39519|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||29989||29989|39519| 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|5663|8654|lyfalmen|||00|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5663||5663|8654| 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|56788|73151|lyfsjukr|||00|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||56788||56788|73151| 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|113577|144422|lyfsjukr|||00|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||113577||113577|144422| 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|90508|115470|lyfsjukr|||00|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||90508||90508|115470| 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|133890|169914|lyfsjukr|||00|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||133890||133890|169914| 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|157282|199271|lyfsjukr|||00|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||157282||157282|199271| 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1572|3058|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1572||1572|3058| 008219|D07AC0101|Betnovat|húðfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|280|1290|lyfalmen|||20|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||280||280|1290| 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|37398|48817|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||37398||37398|48817| 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|29284|38634|lyfsjukr|||00|6000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||29284||29284|38634| 008243|D07AC0101|Betnovat|húðlausn|1|mg/g|30|ml|1|plglas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|459|1535|lyfalmen|||33|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||459||459|1535| 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|34216|44824|lyfsjukr|||00|8000|0|0,0000|Icepharma hf|Baxter Medical AB|Blöndur||34216||34216|44824| 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998|30.04.2011|R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8651|12742|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8651||8651|12742| 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|919|2165|lyfalmen|V0733|2009|00|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||919||919|2165| 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3035|5059|lyfalmen|V2213|5059|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3035||3035|5059| 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1210|2563|lyfalmen|||33|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1210||1210|2563| 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8839|12999|lyfalmen|V2214|12999|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8839||8839|12999| 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|2967|4966|lyfalmen|V0734|4966|00|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2967||2967|4966| 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4918|7635|lyfalmen|V0736|7635|00|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4918||4918|7635| 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|6637|9986|lyfalmen|V0738|9862|00|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6637||6637|9986| 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|158448|200735|lyfsjukr|||02|2|0|0,0000|Vistor hf|Genzyme BV|Thýrótrópín||158448||158448|200735| 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|836|2051|lyfalmen|V0431|2051|00|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||836||836|2051| 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MKA|0|0|0|100|SEK|727|1902|lyfalmen|V0430|1902|00|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||727||727|1902| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|0|0|0|100|USD|4699|8197|vetorma|||00|1000|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||4699||4699|8197| 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|13084|25296|vetalmen|||00|50|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||13084||13084|25296| 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|4202|6655|lyfalmen|||00|100|0|100,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4202||4202|6655| 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2972|4973|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2972||2972|4973| 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|112245|142750|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||112245||112245|142750| 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|118405|150481|lyfsjukr|||00|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||118405||118405|150481| 008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3165|5237|lyfalmen|||00|15|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3165||3165|5237| 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3709|5981|lyfalmen|V2222|5981|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3709||3709|5981| 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1991|3631|lyfalmen|||20|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1991||1991|3631| 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6225|9423|lyfalmen|V1350|9423|00|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6225|9423| 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12263|17749|lyfalmen|||00|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12263|17749| 009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5339|8211|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5339||5339|8211| 009079|D11AH0201|Elidel|krem|1|%|100|g|1|túpa||D11AH02|01.11.2002|30.04.2011|R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|16228|22726|lyfalmen|||00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||16228||16228|22726| 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|9031|13034|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9031||9031|13034| 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|9031|13034|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9031||9031|13034| 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|IPI|0|0|1|100|DKK|14341|20357|lyfalmen|||03|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14341||14341|20357| 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|K||0|0|0|1|FMC|0|0|0|100|XEU|9031|13034|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||9031||9031|13034| 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|53633|69192|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer ApS|Voricónazól||53633||53633|69192| 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||1764| 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5612|8584|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5612||5612|8584| 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1173|2512|lyfalmen|||23|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1173||1173|2512| 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1294|2677|lyfalmen|||23|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1294||1294|2677| 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1497|2955|lyfalmen|||23|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1497||1497|2955| 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1874|3471|lyfalmen|||23|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1874||1874|3471| 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7471|10783|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7471||7471|10783| 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7471|10783|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7471||7471|10783| 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|7471|10783|lyfsjukr|||00|8000|0|8,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||7471||7471|10783| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|204735|258825|lyfsjukr|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||204735||204735|258825| 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|5436|8344|lyfalmen|||00|30|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||5436||5436|8344| 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|61265|78770|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||61265||61265|78770| 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6771|10170|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||6771||6771|10170| 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7709|11453|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||7709||7709|11453| 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7753|11513|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||7753||7753|11513| 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|8777|12914|lyfalmen|||00|180|0|0,0000|Vistor hf|Dentsply Limited|Prílókaín í blöndum||8777||8777|12914| 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7907|11724|lyfalmen|||17|180|0|0,0000|Vistor hf|Dentsply Limited|||7907||7907|11724| 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6083|9229|lyfalmen|||02|180|0|0,0000|Vistor hf|Dentsply Limited|Mepívakaín||6083||6083|9229| 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|2234|3963|lyfalmen|V1151|2468|00|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2234||2234|3963| 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|4253|6725|lyfalmen|V1152|2859|00|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4253||4253|6725| 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|6078|9222|lyfalmen|||00|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||6078||6078|9222| 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003|31.05.2011|R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|156851|198731|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||156851||156851|198731| 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|232932|294212|lyfsjukr|||00|60|0|30,0000|Icepharma hf|Roche Registration Limited|Valgancíklóvír||232932||232932|294212| 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004|30.04.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|422432|532035|lyfsjukr|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Pegvisómant||422432||422432|532035| 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|154229|195440|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||154229||154229|195440| 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|7470|10781|lyfsjukr|||00|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7470||7470|10781| 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|13202|18928|lyfalmen|V1153|5282|00|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||13202||13202|18928| 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|0|0|ORG|0|1|0|100|DKK|18615|25721|lyfalmen|||00|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18615||18615|25721| 010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|A||0|0|E|0|LBK|0|0|0|100|DKK|14714|20825|lyfalmen|||00|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14714|20825| 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|23853|32295|lyfalmen|||00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||23853||23853|32295| 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|3811|6121|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||3811||3811|6121| 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|7599|11302|lyfalmen|||51|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||7599||7599|11302| 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|12905|18555|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||12905||12905|18555| 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|ELA|0|0|0|100|DKK|76147|132835|vetorma|||00|1000|0|0,0000|Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||76147||76147|132835| 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|6970|10442|lyfalmen|||00|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6970||6970|10442| 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|7387|10661|lyfsjukr|||00|2500|0|0,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||7387||7387|10661| 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9476|13676|lyfsjukr|||00|1000|0|1,0000|Icepharma hf|Fresenius Kabi|Amínósýrur||9476||9476|13676| 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1224|2582|lyfalmen|||00|5|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||1224||1224|2582| 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|5630|8609|lyfalmen|V0720|2067|00|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5630||5630|8609| 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6062|8749|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Kolvetni||6062||6062|8749| 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|9322|13454|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Kolvetni||9322||9322|13454| 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4124|5952|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||4124||4124|5952| 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2364|3412|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Kolvetni||2364||2364|3412| 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8977|13187|lyfalmen|||00|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8977||8977|13187| 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|9310|13437|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||9310||9310|13437| 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6684|9647|lyfsjukr|||00|7500|0|7,5000|Icepharma hf|Baxter Medical AB|Elektrólýtar||6684||6684|9647| 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4057|5855|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||4057||4057|5855| 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|14556|5811|lyfalmen|V0719|4326|00|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3585||3585|5811| 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2184|3152|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||2184||2184|3152| 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACT|0|0|0|100|DKK|363719|458350|lyfsjukr|||00|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||363719||363719|458350| 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACT|0|0|0|100|DKK|363719|458350|lyfsjukr|||00|56|0|28,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||363719||363719|458350| 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004|30.04.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|631347|794223|lyfsjukr|||00|30|0|45,0000|Icepharma hf|Pfizer ApS|Pegvisómant||631347||631347|794223| 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004|30.04.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|840256|1056404|lyfsjukr|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Pegvisómant||840256||840256|1056404| 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2740|lyfalmen|||10|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||1340||1340|2740| 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|SKI|0|0|1|100|IKR|||lyflausa|||00|300|0|20,0000|Icepharma hf|SmithKline Beecham Ltd (I)|Klórhexidín|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4936|7230|lyfalmen|V2171|7230|10|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||4622||4622|7230| 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3182|4353|lyfalmen|V2170|4353|10|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4353| 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|49797|64378|lyfsjukr|||03|10|0|0,0000|Icepharma hf|Baxter Medical AB|Bleómýcín||49797||49797|64378| 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|3224|4653|lyfsjukr|||03|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3224||3224|4653| 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3054|5085|lyfalmen|||00|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||3054||3054|5085| 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20829|28500|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20829||20829|28500| 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20587|28196|lyfalmen|V1703|24002|00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20587||20587|28196| 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|SKI|0|0|1|100|IKR|||lyflausa|||00|50|0|16,6667|Icepharma hf|SmithKline Beecham Ltd (I)|Klórhexidín|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35465|46868|lyfalmen|V1702|46867|00|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||35465||35465|46868| 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35224|46566|lyfalmen|||00|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||35224||35224|46566| 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|19420|26732|lyfalmen|||00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníð||19420||19420|26732| 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4652|7271|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4652||4652|7271| 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|DKK|4834|7520|lyfalmen|||00|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4834||4834|7520| 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|20931|27008|lyfalmen|V2172|7599|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||19640||19640|27008| 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|1234|2595|lyfalmen|||00|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1234||1234|2595| 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|798|1999|lyfalmen|V0195|1999|00|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||798||798|1999| 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|12418|17944|lyfalmen|||02|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12418||12418|17944| 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1104|2418|lyfalmen|||00|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1104||1104|2418| 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|3045|3902|lyfalmen|V0197|3902|00|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||2189||2189|3902| 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|9463|13852|lyfalmen|||00|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9463||9463|13852| 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7305|10900|lyfalmen|||00|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7305||7305|10900| 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6865|9908|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Baxter Medical AB|Mannitól||6865||6865|9908| 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|2489|3592|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||2489||2489|3592| 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9588|14023|lyfalmen|||00|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9588||9588|14023| 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|1991|3960|vetalmen|||00|25|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals |||1991||1991|3960| 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PER|0|0|0|100|DKK|4978|7184|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Pfizer ApS|Esketamín||4978||4978|7184| 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1631|3138|lyfalmen|||00|64|0|28,8000|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1631||1631|3138| 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|91093|116204|lyfsjukr|||00|168|0|33,6000|Icepharma hf|Roche Registration Limited|Ribavirin||91093||91093|116204| 011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|10623|15439|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||10623||10623|15439| 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1486|1977|lyfalmen|V0935|1977|00|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|1977| 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4738|6605|lyfalmen|V0937|6605|00|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6605| 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4506|6503|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4506||4506|6503| 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|2607|3763|lyfsjukr|||02|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||2607||2607|3763| 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8240|12179|lyfalmen|||00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8240|12179| 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|DKK|41889|54453|lyfsjukr|||00|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||41889||41889|54453| 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11172|16190|lyfalmen|||00|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||11172||11172|16190| 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1540|3014|lyfalmen|||00|20|0|35,7143|Vistor hf|Meda AB|Azelastínum||1540||1540|3014| 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6204|9394|lyfalmen|||00|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6204||6204|9394| 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5317|9275|vetorma|||00|20|0|0,0000|Icepharma hf|Icepharma hf|||5317||5317|9275| 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|497|1587|lyfalmen|||00|30|0|15,0000|Vistor hf|Aventis Pharma |Glímepíríð||497||497|1587| 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|12216|17690|lyfalmen|||00|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||12216||12216|17690| 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|24987|43589|vetorma|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||24987||24987|43589| 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|DKK|461250|580751|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Díbótermín alfa||461250||461250|580751| 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1890|lyfalmen|||08|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1890| 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4780|7446|lyfalmen|||00|9|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4780||4780|7446| 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6918|10371|lyfalmen|||00|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6918||6918|10371| 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6363|9612|lyfalmen|||00|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6363||6363|9612| 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6978|13571|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||6978||6978|13571| 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9607|14049|lyfalmen|||00|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9607||9607|14049| 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1809|3598|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1809||1809|3598| 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1086|2393|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Lansóprazól||1086||1086|2393| 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|22910|30635|lyfsjukr|||00|2|0|0,0000|Ísaga ehf|AGA AB|Nituroxíð||22910||22910|30635| 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|7166|10342|lyfsjukr|||17|2|0|0,0000|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7166||7166|10342| 013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|30491|40149|lyfsjukr|||00|250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuþáttur IX||30491||30491|40149| 013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|51609|66652|lyfsjukr|||00|500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuþáttur IX||51609||51609|66652| 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|A||0|0|E|0|ANO|0|0|0|100|XEU|3482|4746|lyfalmen|V2120|4746|00|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2806||2806|4746| 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4583|8973|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4583||4583|8973| 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11014|21321|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||11014||11014|21321| 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1155|2297|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||1155||1155|2297| 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|192634|243638|lyfsjukr|||00|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||192634||192634|243638| 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|A||0|1|0|1|AZD|0|0|0|100|SEK|415946|523895|lyfsjukr|||00|30|0||Vistor hf|AstraZeneca A/S DK|||415946||415946|523895| 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|32416|42565|lyfsjukr|||00|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||32416||32416|42565| 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|128423|163053|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||128423||128423|163053| 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|64213|82470|lyfsjukr|||00|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||64213||64213|82470| 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|5593|8558|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Ezetimíb||5593||5593|8558| 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|DKK|19042|26257|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||19042||19042|26257| 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|156201|197915|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||156201||156201|197915| 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|1257|2627|lyfalmen|||00|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||||1257|2627| 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0,0000|Actavis Group hf|Actavis Group hf|Blöndur|||||1438| 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|A||1|0|0|0|NOP|0|0|0|100|DKK|2415|4211|lyfalmen|||00|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||||2415|4211| 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1448|2888|lyfalmen|||00|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1448||1448|2888| 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|417|1478|lyfalmen|||00|30|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||417||417|1478| 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|38595|50319|lyfsjukr|||00|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||38595||38595|50319| 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|4844|7534|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4844||4844|7534| 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|14633|20724|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||14633||14633|20724| 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|A||0|0|B|0|SPL|0|0|1|100|DKK|996|2270|lyfalmen|||00|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||996|2270| 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2569|lyfalmen|V0465|2569|00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2569| 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6401|9664|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||6401||6401|9664| 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003|30.04.2011|R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|5456|8371|lyfalmen|||51|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||5456||5456|8371| 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2666|4554|lyfalmen|||51|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2666||2666|4554| 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|4781|7448|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín (manna)||4781||4781|7448| 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|389572|490795|lyfsjukr|||00|30|0|0,0000|Vistor hf|Novartis Europharm Ltd|Imatiníb||389572||389572|490795| 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|2580|4437|lyfalmen|||71|10|0|25,0000|Vistor hf|Novo-Nordisk|Insúlín (manna)||2580||2580|4437| 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|9218|13304|lyfsjukr|||00|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9218||9218|13304| 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|0|0|0|UCB|0|0|0|100|DKK|18718|25850|lyfalmen|||00|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18718||18718|25850| 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|59109|76541|lyfalmen|||AC|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||59109||59109|76541| 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|30728|40446|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||30728||30728|40446| 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|A||0|0|0|0|AZD|0|0|0|100|SEK|28387|37985|lyfalmen|||00|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28387||28387|37985| 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1563|3045|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1563||1563|3045| 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||29|4|0|0,0000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20411|27498|lyfsjukr|||00|3944|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||20411||20411|27498| 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26719|35415|lyfsjukr|||00|5908|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||26719||26719|35415| 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|flaska||P01AB01|01.08.2009||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|4073|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Metrónídazól||||2314|4073| 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2367|4708|vetalmen|||00|45|0|0,0000|Dýraheilsa ehf|Vetcare Ltd.|||||2367|4708| 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|18809|25965|lyfalmen|||23|1|0|1825,0000|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||18809||18809|25965| 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|85354|109002|lyfsjukr|||0|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||85354|109002| 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PAL|0|0|0|100|XEU|5885|11473|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5885||5885|11473| 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|248719|314025|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíð||248719||248719|314025| 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2371|4151|lyfalmen|||10|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2371||2371|4151| 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|1365|2775|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||1365||1365|2775| 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|65007|83466|lyfsjukr|||00|2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||65007||65007|83466| 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|104009|132414|lyfsjukr|||00|2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||104009||104009|132414| 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|A||0|0|E|0|MYL|0|0|0|100|SEK|897|2134|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||||897|2134| 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|19919|27358|lyfalmen|||00|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19919||19919|27358| 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|60105|77791|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||60105||60105|77791| 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOH|0|0|0|100|DKK|40008|52569|lyfalmen|||00|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||40008||40008|52569| 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|785|1981|lyfalmen|||00|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||785||785|1981| 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72,0000|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|3265|5374|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3265||3265|5374| 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|8875|13048|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||8875||8875|13048| 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|1130|2453|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1130||1130|2453| 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4683|lyfalmen|||00|100|1|33,3333|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4683| 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1125|2446|lyfalmen|||23|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1125||1125|2446| 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3530|lyfalmen|V0832|3530|00|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3530| 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4653|lyfalmen|V0831|4653|00|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4653| 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|10574|15372|lyfalmen|||00|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín detemír||10574||10574|15372| 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|356677|449512|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||356677||356677|449512| 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|94803|120860|lyfsjukr|||00|1|0|0,0000|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||94803||94803|120860| 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5483|8408|lyfalmen|||00|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5483||5483|8408| 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13939|19853|lyfalmen|V1732|19852|00|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13939||13939|19853| 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5483|8408|lyfalmen|||00|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5483||5483|8408| 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15068|21270|lyfalmen|V1731|21268|00|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15068||15068|21270| 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|72722|93149|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||72722||72722|93149| 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|72722|93149|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||72722||72722|93149| 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|63236|81244|lyfsjukr|||43|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||63236||63236|81244| 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|5483|8408|lyfalmen|||00|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5483||5483|8408| 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13792|19668|lyfalmen|V1730|19667|00|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13792||13792|19668| 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|72722|93149|lyfsjukr|||43|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||72722||72722|93149| 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|23319|31625|lyfalmen|||00|120|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||23319||23319|31625| 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|48572|63317|lyfalmen|||00|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||48572||48572|63317| 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|SAL|0|0|0|100|USD|909|2151|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||909||909|2151| 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3289|5737|vetorma|||16|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3289||3289|5737| 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4622|8063|vetorma|||16|12|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4622||4622|8063| 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|2934|5118|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2934||2934|5118| 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3679|6418|vetorma|||16|3|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3679||3679|6418| 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4688|7320|lyfalmen|||10|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4688||4688|7320| 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|4122|7191|vetorma|||16|8|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4122||4122|7191| 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2075|3746|lyfalmen|||0|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||||2075|3746| 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|1|100|XEU|2330|4095|lyfalmen|||00|10|0|0,0000|Vistor hf|Astellas Pharma A/S|Takrólímus||2330||2330|4095| 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1523|2991|lyfalmen|||02|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1523||1523|2991| 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BAN|0|0|0|100|DKK|3289|5737|vetorma|||16|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3289||3289|5737| 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|0|0|GSK|0|1|0|100|GBP|1465|2911|lyfalmen|||00|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1465||1465|2911| 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|15120|21335|lyfalmen|V2208|20262|00|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15120||15120|21335| 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1132|2456|lyfalmen|||02|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1132||1132|2456| 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|22641|30774|lyfalmen|V0341|29358|00|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22641||22641|30774| 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1199|2548|lyfalmen|||02|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1199||1199|2548| 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|2586|4445|lyfalmen|||00|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2586||2586|4445| 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen|||||| 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|7849|11644|lyfalmen|||00|28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||7849||7849|11644| 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2744|4661|lyfalmen|||00|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2744||2744|4661| 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6907|10356|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6907||6907|10356| 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|MSE|0|0|0|100|SEK|5216|8043|lyfalmen|||00|0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5216||5216|8043| 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10475|15237|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10475||10475|15237| 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1809|3382|lyfalmen|||00|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1809||1809|3382| 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|15217|21457|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||15217||15217|21457| 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|9134|13402|lyfalmen|||10|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||9134||9134|13402| 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4166|6606|lyfalmen|||00|28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4166||4166|6606| 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PER|0|0|0|100|DKK|99394|126622|lyfsjukr|||00|70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||99394||99394|126622| 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|4401|6352|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Cýtarabín||4401||4401|6352| 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2700|4601|lyfalmen|||00|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2700||2700|4601| 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998|30.04.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|27010|35780|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Pfizer ApS|Karbóplatín||27010||27010|35780| 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998|30.04.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|226831|286555|lyfsjukr|||00|225|0|0,0000|Icepharma hf|Pfizer ApS|Karbóplatín||226831||226831|286555| 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998|30.04.2011|R|A|2|0|1|0|1|PER|0|0|0|100|DKK|79553|101722|lyfsjukr|||00|75|0|0,0000|Icepharma hf|Pfizer ApS|Karbóplatín||79553||79553|101722| 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|18155|25144|lyfalmen|||00|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18155||18155|25144| 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7285| 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|35465|46868|lyfalmen|V0106|46867|00|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||35465||35465|46868| 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2296|lyfalmen|V0466|2296|00|12|0|12,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2296| 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|191201|241840|lyfsjukr|||00|2|0|180,0000|Icepharma hf|Roche|Epóetín||191201||191201|241840| 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|143237|181645|lyfsjukr|||00|6|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||143237||143237|181645| 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8094|11980|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8094||8094|11980| 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|47746|61804|lyfsjukr|||00|2|0|0,0000|Icepharma hf|Ipsen Ltd.|Sómatrópín||47746||47746|61804| 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3168|5241|lyfalmen|V0789|5241|10|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3168||3168|5241| 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|5849|8909|lyfalmen|V0713|8909|10|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5849||5849|8909| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|63266|81758|lyfalmen|||00|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||63266||63266|81758| 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|93223|119354|lyfalmen|||00|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||93223||93223|119354| 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|30126|40168|lyfalmen|||00|28|0|0,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||30126||30126|40168| 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|59743|77337|lyfalmen|||00|2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||59743||59743|77337| 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|20731|28377|lyfalmen|||00|0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||20731||20731|28377| 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|MSE|0|0|0|100|SEK|31067|41348|lyfalmen|||00|1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||31067||31067|41348| 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2080|3753|lyfalmen|||00|14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2080||2080|3753| 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|A||0|0|0|0|PER|0|0|0|100|DKK|3677|5937|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3677|5937| 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4197|6649|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||4197||4197|6649| 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|8108|11999|lyfalmen|||00|98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||8108||8108|11999| 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|6594|9928|lyfalmen|||00|56|0|56,0000|Icepharma hf|Pfizer ApS|Lansóprazól||6594||6594|9928| 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|41193|53580|lyfsjukr|||00|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||41193||41193|53580| 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|14426|20464|lyfalmen|||00|98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||14426||14426|20464| 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3257|5363|lyfalmen|||00|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3257||3257|5363| 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PAL|0|0|0|100|DKK|19457|37533|vetalmen|||16|60|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||19457||19457|37533| 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26418|35037|lyfsjukr|||00|4824|0|0,0000|Icepharma hf|Fresenius Kabi|Blöndur||26418||26418|35037| 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|1584|3074|lyfalmen|||03|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1584||1584|3074| 017111|A09AA0201|Combizym|töflur|||100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1488|2943|lyfalmen|||10|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1488||1488|2943| 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|273538|345173|lyfsjukr|||00|5|0|0,0000|Icepharma hf|SkyPharma PLC|Cýtarabín||273538||273538|345173| 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|8189|12110|lyfalmen|||10|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||8189||8189|12110| 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|183024|231578|lyfsjukr|||00|1|0|0,0000|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||183024||183024|231578| 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|41749|54277|lyfsjukr|||00|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||41749||41749|54277| 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1413|2840|lyfalmen|V0221|2221|00|100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1413||1413|2840| 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|132800|168547|lyfsjukr|||00|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||132800||132800|168547| 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|49618|64630|lyfalmen|||00|28|0|28,0000|Icepharma hf|Roche|Íbandrónsýra||49618||49618|64630| 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|154083|195734|lyfalmen|||00|84|0|84,0000|Icepharma hf|Roche|Íbandrónsýra||154083||154083|195734| 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|5654|8642|lyfalmen|||00|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5654||5654|8642| 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|10767|15636|lyfalmen|||00|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10767||10767|15636| 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2794|4729|lyfalmen|||00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2794||2794|4729| 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|DKK|9355|13502|lyfsjukr|||00|3|0|0,0000|Vistor hf|M.S.D.|Aprepitant||9355||9355|13502| 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|911|2154|lyfalmen|||00|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||911||911|2154| 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3062|5096|lyfalmen|||00|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3062||3062|5096| 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|3773|6069|lyfalmen|||00|100|0|66,6667|Medico ehf|Solvay Duphar |Betahistín||3773||3773|6069| 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1459|2653|lyfalmen|V0465|2569|00|20|0|12,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1276||1276|2653| 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|6944|13506|vetalmen|||00|100|0|0,0000|Vistor hf|Boehringer Ingelheim|||6944||6944|13506| 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|41294|54183|lyfalmen|||00|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||41294||41294|54183| 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|13454|19244|lyfalmen|V1370|19243|00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||13454||13454|19244| 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|10809|15694|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10809||10809|15694| 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|44385|58063|lyfalmen|||00|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||44385||44385|58063| 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|9871|14410|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9871||9871|14410| 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|7305|10900|lyfalmen|||00|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||7305||7305|10900| 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2352|4125|lyfalmen|||00|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2352||2352|4125| 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|3453|5631|lyfalmen|||00|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3453||3453|5631| 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004|31.03.2011|R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|68503|74960|lyfsjukr|||00|5|0|0,0000|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||58229||58229|74960| 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|11145|16153|lyfalmen|||00|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||11145||11145|16153| 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|7757|11519|lyfalmen|||00|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7757||7757|11519| 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3951|6312|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3951||3951|6312| 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|4316|6811|lyfalmen|||02|0|0|0,0000|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||4316||4316|6811| 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|9218|13517|lyfalmen|||00|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||9218||9218|13517| 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2481|lyfalmen|V0704|2481|00|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1150||1150|2481| 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|0|0|DSH|0|0|0|100|DKK|2888|4858|lyfalmen|||00|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2888||2888|4858| 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8577|12640|lyfalmen|||00|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8577||8577|12640| 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|14182|19681|lyfsjukr|||03|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||14182||14182|19681| 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|1513|2977|lyfalmen|||00|14|0|7,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1513||1513|2977| 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|21029|28751|lyfalmen|||00|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||21029||21029|28751| 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3028|5050|lyfalmen|||00|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3028||3028|5050| 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MKA|0|0|1|100|SEK|989|2260|lyfalmen|V2400|1888|00|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||989||989|2260| 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6074|9216|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6074||6074|9216| 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|17122|23848|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17122||17122|23848| 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|35678|47135|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||35678||35678|47135| 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|123434|156792|lyfsjukr|||00|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||123434||123434|156792| 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3018|5036|lyfalmen|||00|30|0|60,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3018||3018|5036| 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|9750|14245|lyfalmen|||00|100|0|200,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||9750||9750|14245| 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|58322|75077|lyfsjukr|||43|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||58322||58322|75077| 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|618|1753|lyfalmen|||00|100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||618||618|1753| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1320|2626|vetalmen|||27|100|0|0,0000|Icepharma hf|Kela Laboratoria NV|||1320||1320|2626| 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|10445|15196|lyfalmen|V1052|11592|00|5|0|62,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10445||10445|15196| 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15238|21483|lyfalmen|||00|56|0|37,3300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15238||15238|21483| 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|21481|28841|lyfsjukr|||02|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21481||21481|28841| 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15238|21483|lyfalmen|||00|56|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15238||15238|21483| 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14365|20387|lyfalmen|V1372|20387|00|56|0|18,6700|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14365||14365|20387| 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|7466|11120|lyfalmen|V1051|9145|00|5|0|41,6667|Vistor hf|Janssen-Cilag AB|Fentanýl||7466||7466|11120| 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|24244|32309|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||24244||24244|32309| 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|7619|11330|lyfalmen|V1373|8019|00|28|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7619||7619|11330| 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4139|6569|lyfalmen|V1050|5692|00|5|0|20,8333|Vistor hf|Janssen-Cilag AB|Fentanýl||4139||4139|6569| 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|33658|44123|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||33658||33658|44123| 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|34511|45194|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||34511||34511|45194| 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|42169|54805|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||42169||42169|54805| 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9717|14200|lyfalmen|V1053|13358|00|5|0|83,3333|Vistor hf|Janssen-Cilag AB|Fentanýl||9717||9717|14200| 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|14396|20426|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14396||14396|20426| 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|4937|7661|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4937||4937|7661| 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|53792|69391|lyfsjukr|||00|1|0|0,0000|Gróco ehf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||53792||53792|69391| 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|THE|0|0|0|100|XEU|770211|968497|lyfsjukr|||00|10|0|0,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||770211||770211|968497| 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|A||0|0|0|0|VET|0|0|0|100|DKK|21900|42224|vetalmen|||00|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21900|42224| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7084|10598|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7084||7084|10598| 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|54216|69924|lyfsjukr|||AC|4|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||54216||54216|69924| 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7084|10598|lyfalmen|||00|56|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||7084||7084|10598| 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|17432|24237|lyfalmen|||00|140|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||17432||17432|24237| 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|620|1755|lyfalmen|||00|100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||620||620|1755| 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|3879|5598|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3879||3879|5598| 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|648|1794|lyfalmen|||00|250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||648||648|1794| 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|17040|23268|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||17040||17040|23268| 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|201330|254552|lyfsjukr|||AC|16|0|0,0000|Icepharma hf|Roche Registration Limited|Bevacizúmab||201330||201330|254552| 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1138|2464|lyfalmen|V0454|2460|10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1138||1138|2464| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|205409|259671|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||205409||205409|259671| 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13357|19122|lyfalmen|||00|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13357||13357|19122| 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13357|19122|lyfalmen|||00|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13357||13357|19122| 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|57615|74666|lyfalmen|||00|1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||57615||57615|74666| 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13357|19122|lyfalmen|||00|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13357||13357|19122| 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13357|19122|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13357||13357|19122| 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13357|19122|lyfalmen|||00|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13357||13357|19122| 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|813311|1022588|lyfsjukr|||02|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||813311||813311|1022588| 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|385|1434|lyfalmen|||00|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||385||385|1434| 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|66090|84825|lyfsjukr|||00|30|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||66090||66090|84825| 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1704|3184|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1664||1664|3184| 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||43|100|0|50,0000|Vistor hf|GlaxoSmithKline CH AB|Ferrósúlfat|||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|3021|5040|lyfalmen|||00|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3021||3021|5040| 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|25769|34699|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||25769||25769|34699| 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2807|4747|lyfalmen|||04|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2807||2807|4747| 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|598|1725|lyfalmen|V0953|1546|00|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||598||598|1725| 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|7052|10554|lyfalmen|||00|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||7052||7052|10554| 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|55047|71443|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||55047||55047|71443| 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4054|6453|lyfalmen|||00|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4054||4054|6453| 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11719|16938|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||11719||11719|16938| 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|24841|33535|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||24841||24841|33535| 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|625|1762|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||625||625|1762| 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|5890|8965|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5890||5890|8965| 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1905|3513|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1905||1905|3513| 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|17155|23889|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||17155||17155|23889| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20,0000|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín|||||| 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2302|4016|vetorma|||16|8|0|0,0000|Vistor hf|Merial SAS|||2302||2302|4016| 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|161551|204629|lyfsjukr|||00|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||161551||161551|204629| 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2088|3764|lyfalmen|V0429|3764|00|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2088||2088|3764| 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|DKK|5831|8884|lyfalmen|||63|28|0|28,0000|Vistor hf|M.S.D.|Montelúkast||5831||5831|8884| 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2540|4382|lyfalmen|||00|60|0|60,0000|Icepharma hf|Galderma Nordic AB|Adapalen||2540||2540|4382| 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|827|1884|lyfalmen|||00|12|0|7,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1884| 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.04.2010||R|K||0|0|*|0|DAC|0|0|0|100|DKK|3320|5449|lyfalmen|V0988|5449|06|2|0|0,0000|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||||3320|5449| 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2296|lyfalmen|V0466|2296|00|12|0|12,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1015||1015|2296| 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1494|lyfalmen|V0609|1494|00|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||429||429|1494| 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1053|2348|lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Dexpantenól||1053||1053|2348| 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2531|lyfalmen|V0610|2531|00|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2531| 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|17677|24544|lyfalmen|||02|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17677||17677|24544| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|DKK|17722|24601|lyfalmen|||63|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17722||17722|24601| 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||| 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A||0|0|E|0|DAC|0|0|1|100|XEU|1790|3356|lyfalmen|V0965|3195|24|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1790||1790|3356| 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||| 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|DKK|18004|24954|lyfalmen|||63|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||18004||18004|24954| 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|1635|2360|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||1635||1635|2360| 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4543|7122|lyfalmen|||00|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4543||4543|7122| 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|13905|19810|lyfalmen|||00|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13905||13905|19810| 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|14783|20912|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14783||14783|20912| 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|7348|10959|lyfalmen|||00|30|0|9,0000|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||7348||7348|10959| 021625|A07EC0203|Pentasa Sachets|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|A||0|0|B|0|FER|0|0|0|100|DKK|15614|21955|lyfalmen|||00|60|0|40,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15614||15614|21955| 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|16346|22397|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||16346||16346|22397| 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|23407|31735|lyfalmen|||00|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||23407||23407|31735| 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|16346|22397|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||16346||16346|22397| 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25161|33936|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||25161||25161|33936| 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4608|7211|lyfalmen|||00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4608||4608|7211| 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9399|13565|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Própófól||9399||9399|13565| 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PER|0|0|0|100|DKK|4744|6847|lyfsjukr|||02|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4744||4744|6847| 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||20143||20143|27639| 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|3967|6334|lyfalmen|||00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3967||3967|6334| 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.01.2010||R|A||0|0|0|0|DAC|0|0|0|100|SEK|6085|9017|lyfalmen|V0085|9017|00|28|0|37,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5928||5928|9017| 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|22313|29885|lyfsjukr|||00|2500|0|2,5000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||22313||22313|29885| 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|5482|8406|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5482||5482|8406| 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|0|0|ELD|0|1|0|100|XEU|18892|26069|lyfalmen|||00|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18892||18892|26069| 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||20143||20143|27639| 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|86739|110740|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||86739||86739|110740| 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|A||0|0|0|1|BAM|0|0|0|100|SEK|126403|160518|lyfsjukr|||00|1200|0|1,2000|Icepharma hf|Baxter Medical AB|Albúmín||126403||126403|160518| 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríð|||||| 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|7444|11090|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||7444||7444|11090| 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|8724|12841|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8724||8724|12841| 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|26752|35933|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||26752||26752|35933| 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|K||0|0|*|0|SAA|0|0|0|100|NOK|5478|8401|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5478||5478|8401| 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|A||0|0|0|0|MSD|0|0|0|100|DKK|9303|13633|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||9303||9303|13633| 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|303553|382842|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||303553||303553|382842| 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|334995|422301|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Roche Registration Limited|Erlótiníb||334995||334995|422301| 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1256|lyfalmen|V0917|1256|00|20|0|20,0000|Actavis Group hf|Actavis hf|Paroxetín||255||255|1256| 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10615|18517|vetorma|||00|24|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||10615||10615|18517| 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|25188|33970|lyfalmen|||02|1|0|0,0000|Vistor hf|Allergan|Clostridium botulinum toxín-A||25188||25188|33970| 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2347|4094|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2347||2347|4094| 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|1342|2743|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1342||1342|2743| 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1429|2493|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1429|2493| 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|3965|2701|lyfalmen|V0308|2532|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1311||1311|2701| 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PER|0|0|0|100|DKK|6970|3753|lyfalmen|V0310|3480|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2080||2080|3753| 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2223|3878|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||2223||2223|3878| 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|652|1799|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||652||652|1799| 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|1954|3580|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1954||1954|3580| 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|1439|2510|vetorma|||00|1|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||1439||1439|2510| 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4843|7532|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4843||4843|7532| 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A||0|0|B|0|ACA|0|1|0|100|IKR|2129|2921|lyfalmen|V0919|2921|00|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2921| 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|1974|lyfalmen|V0918|1974|00|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|1974| 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|1218|2520|lyfalmen|||00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Metótrexat||1179||1179|2520| 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|14046|19987|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||14046||14046|19987| 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|231492|292405|lyfsjukr|||00|3|0|0,0000|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||231492||231492|292405| 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2872| 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2755|lyfalmen|V0409|2755|67|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2755| 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4125|lyfalmen|V0410|4125|67|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4125| 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25161|33936|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||25161||25161|33936| 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20143||20143|27639| 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5856|8918|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5856||5856|8918| 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|86732|110731|lyfsjukr|||00|30|0|0,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||86732||86732|110731| 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|26628|35778|lyfalmen|||00|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||26628||26628|35778| 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|41574|54535|lyfalmen|||00|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||41574||41574|54535| 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21053|28781|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21053||21053|28781| 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5914|8997|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5914||5914|8997| 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21267|29049|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||21267||21267|29049| 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989|31.03.2011|R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|20869|28073|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Roche|Flúmazeníl||20869||20869|28073| 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|4971|7512|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2920||4828|7512|31.05.2011 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|3722|5999|lyfalmen|V0715|5999|00|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3722||3722|5999| 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|17797|24695|lyfalmen|||00|34|0|0,0000|Vistor hf|Dentsply DeTrey GmbH|Blöndur||17797||17797|24695| 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|7661|11057|lyfsjukr|||00|0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7661||7661|11057| 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|29459|38854|lyfsjukr|||00|0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||29459||29459|38854| 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|22308|29879|lyfsjukr|||00|0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||22308||22308|29879| 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|53128|68558|lyfsjukr|||00|0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||53128||53128|68558| 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|35900|46937|lyfsjukr|||00|0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||35900||35900|46937| 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8683|12532|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||8683||8683|12532| 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|107003|136171|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||107003||107003|136171| 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|21708|29126|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||21708||21708|29126| 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|15399|21208|lyfsjukr|||00|0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||15399||15399|21208| 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|37752|49261|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||37752||37752|49261| 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|75505|96641|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||75505||75505|96641| 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|8874|13047|lyfalmen|||00|3|0|14,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||8874||8874|13047| 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|186476|235910|lyfsjukr|||00|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||186476||186476|235910| 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|151011|191401|lyfsjukr|||00|200|0|0,0000|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||151011||151011|191401| 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|17747|24632|lyfalmen|||00|6|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||17747||17747|24632| 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13310|19063|lyfalmen|||00|4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13310||13310|19063| 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|139885|177438|lyfsjukr|||00|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||139885||139885|177438| 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|26970|31189|lyfalmen|V0090|14012|00|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||22972||22972|31189| 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006|31.03.2011|R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4343|6848|lyfalmen|||00|4|0|7,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4343||4343|6848| 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3738|6021|lyfalmen|||00|12|0|60,0000|Icepharma hf|Santen Oy|Tímólól||3738||3738|6021| 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|58656|75496|lyfsjukr|||00|120|0|100,0000|Icepharma hf|Roche|Saquínavír||58656||58656|75496| 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|IPI|0|0|0|100|DKK|79413|101546|lyfsjukr|||00|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||79413||79413|101546| 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|DKK|3036|5060|lyfalmen|||00|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3036||3036|5060| 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|DKK|80201|102535|lyfsjukr|||00|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||80201||80201|102535| 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005|31.05.2011|R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|5984|8636|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5984||5984|8636| 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|2635|4512|lyfalmen|V0102|4512|00|5|0|9,9900|Vistor hf|Janssen-Cilag AB|Fentanýl||2635||2635|4512| 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|20064|27540|lyfalmen|||00|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||20064||20064|27540| 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|1860|2684|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter Medical AB|Elektrólýtar||1860||1860|2684| 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|23472|31340|lyfsjukr|||00|3944|0|3,9400|Icepharma hf|Fresenius Kabi|Blöndur||23472||23472|31340| 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|66176|85410|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||66176||66176|85410| 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25161|33936|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||25161||25161|33936| 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7921|11743|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7921||7921|11743| 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|445|1516|lyfalmen|||00|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||445||445|1516| 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7921|11743|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7921||7921|11743| 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13346|19109|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13346||13346|19109| 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13346|19109|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13346||13346|19109| 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13368|19136|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13368||13368|19136| 024532|V04CL0007|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13346|19109|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13346||13346|19109| 024559|V04CL0008|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13346|19109|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13346||13346|19109| 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13505|19308|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13505||13505|19308| 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13346|19109|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13346||13346|19109| 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5711|8720|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5711||5711|8720| 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13346|19109|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13346||13346|19109| 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|72561|93423|lyfalmen|||00|100|0|360,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||72561||72561|93423| 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13505|19308|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13505||13505|19308| 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1626|3132|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1626||1626|3132| 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|5711|8720|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5711||5711|8720| 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7921|11743|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7921||7921|11743| 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7921|11743|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7921||7921|11743| 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1626|3132|lyfalmen|||02|2|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1626||1626|3132| 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|660|1810|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||660||660|1810| 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20143||20143|27639| 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2011|3658|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2011||2011|3658| 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2223|3948|lyfalmen|||0|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2223||2223|3948| 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009|31.05.2011|R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4175|6619|lyfalmen|||0|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4175||4175|6619| 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20143||20143|27639| 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|989|2260|lyfalmen|||08|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||989||989|2260| 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|0|0|MSD|0|0|0|100|DKK|14303|20310|lyfalmen|||00|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||14303||14303|20310| 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|PAD|0|0|1|100|IKR|794|1994|lyfalmen|||00|14|0|3,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||794||794|1994| 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|87090|111180|lyfsjukr|||00|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||87090||87090|111180| 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|81345|103970|lyfsjukr|||00|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||81345||81345|103970| 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|1|0|0|100|DKK|9982|19339|vetalmen|||00|20|0|0,0000|Vistor hf|Boehringer Ingelheim|||9982||9982|19339| 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|17278|24043|lyfalmen|||00|30|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||17278||17278|24043| 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|20508|28097|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||20508||20508|28097| 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|6560|9881|lyfalmen|||00|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6560||6560|9881| 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|35669|47124|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||35669||35669|47124| 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|A||0|0|*|0|DAC|0|0|0|100|XEU|1991|3631|lyfalmen|V1090|3597|06|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||1991||1991|3631| 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|5466|8385|lyfalmen|||00|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5466||5466|8385| 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|14256|20251|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14256||14256|20251| 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998|30.04.2011|R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|45091|lyfsjukr|||00|50|1|0,0000|Distica|Distica - óskráð lyf|Tenípósíð||34429||34429|45091| 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|19043|26258|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||19043||19043|26258| 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|27542|36925|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||27542||27542|36925| 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|55501|72013|lyfalmen|||00|100|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||55501||55501|72013| 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|7581|10941|lyfsjukr|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7581||7581|10941| 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25161|33936|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||25161||25161|33936| 025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|1032|2319|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1032||1032|2319| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|4907|8560|vetorma|||16|1|0|0,0000|Vistor hf|Merial (MSD)|||4907||4907|8560| 025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|A||0|0|E|0|MYL|0|0|1|100|SEK|536|1641|lyfalmen|||00|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||536||536|1641| 025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MYL|0|0|1|100|SEK|2742|3505|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1899||1899|3505| 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.05.2011||L|A||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||10|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíð|||||| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|9668|16865|vetorma|||16|2|0|0,0000|Vistor hf|Merial (MSD)|||9668||9668|16865| 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20143||20143|27639| 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|44429|57641|lyfsjukr|||00|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||44429||44429|57641| 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|K||0|1|0|1|PFM|0|0|0|100|DKK|222172|280708|lyfsjukr|||00|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||222172||222172|280708| 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|1893|3497|lyfalmen|||00|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1893|3497| 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|7172|10718|lyfalmen|||00|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||7172|10718| 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|3739|6022|lyfalmen|||00|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3739|6022| 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|14811|20947|lyfalmen|||00|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||14811|20947| 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|22194|30213|lyfalmen|||00|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||22194|30213| 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|A||0|0|E|0|UCB|0|0|0|100|DKK|29579|39481|lyfalmen|||00|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||29579|39481| 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1490|2946|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1490||1490|2946| 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.03.2011||R|A||0|0|0|0|DAC|0|0|1|100|NOK|1642|3154|lyfalmen|||10|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1642||1642|3154|31.05.2011 026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|A||0|0|0|0|DAC|0|0|1|100|NOK|1145|2460|lyfalmen|V0454|2460|10|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1135||1135|2460| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|443|1513|lyfalmen|||00|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||443||443|1513| 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2813|4755|lyfalmen|||10|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2813||2813|4755| 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|A||0|0|*|0|ALA|0|0|0|100|USD|2290|4040|lyfalmen|||00|5|0|0,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2290||2290|4040| 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|7286|10874|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7286||7286|10874| 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|30819|35975|lyfalmen|V0375|35975|00|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||26785||26785|35975| 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|34587|38875|lyfalmen|V0376|38875|00|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||29096||29096|38875| 027328|N03AX1205|Neurontin (Lyfjaver)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.10.2009||R|A||0|0|E|0|LVR|0|0|0|100|DKK|17803|13402|lyfalmen|V2160|13250|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Gabapentín||9134||9134|13402| 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1805|3377|lyfalmen|||00|14|0|1,7500|Vistor hf|Eisai Ltd|Zonisamíð||1805||1805|3377| 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7526|11203|lyfalmen|||00|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||7526||7526|11203| 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|9918|14475|lyfalmen|||00|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||9918||9918|14475| 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|12894|18541|lyfalmen|||00|56|0|28,0000|Vistor hf|Eisai Ltd|Zonisamíð||12894||12894|18541| 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|875|2104|lyfalmen|V0431|2051|00|100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||875||875|2104| 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|875|2104|lyfalmen|V0430|1902|00|100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||875||875|2104| 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SPE|0|0|0|100|DKK|104691|133270|lyfsjukr|||00|105|0|0,7500|Vistor hf|SP Europe|Posacónazól||104691||104691|133270| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|21361|29167|lyfalmen|||00|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21361||21361|29167| 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|33309|44162|lyfalmen|||00|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||33309|44162| 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|24689|33344|lyfalmen|||00|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24689||24689|33344| 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|47861|62425|lyfalmen|||00|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||47861|62425| 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|A||0|0|*|0|ELD|0|1|0|100|XEU|61828|79954|lyfalmen|||00|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||61828|79954| 028045|G03AB0001|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB|01.11.2009||R|A||0|0|0|0|BAP|0|0|0|100|SEK|5196|8015|lyfalmen|||00|84|0||Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5196||5196|8015| 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|A|2|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|25284|34091|lyfalmen|||00|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||25284||25284|34091| 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3715|5491|lyfalmen|V1911|5491|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3351||3351|5491| 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4096|6510|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4096|6510| 028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|19563|26911|lyfalmen|||00|196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiður-Nikótínsýra í blöndum||||19563|26911| 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|14238|20228|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||14238|20228| 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4096|6510|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4096|6510| 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|14238|20228|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||14238|20228| 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4721|7365|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4721|7365| 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|16422|22969|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||16422|22969| 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4721|7365|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||4721|7365| 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|16422|22969|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og þvagræsilyf||||16422|22969| 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|A||0|1|0|1|NOE|0|0|0|100|DKK|59055|75997|lyfsjukr|||00|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||59055||59055|75997| 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2637|4515|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2637||2637|4515| 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22139|30144|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||22139||22139|30144| 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8471|12495|lyfalmen|||02|1|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||8471||8471|12495| 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|1944|3567|lyfalmen|V0712|3567|00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1944||1944|3567| 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2179|3888|lyfalmen|||10|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2179||2179|3888| 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|5478|8401|lyfalmen|||10|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5478||5478|8401| 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2656|lyfalmen|||00|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2656| 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8158|lyfalmen|V0705|8158|00|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5300||5300|8158| 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|15077|lyfalmen|||00|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|15077| 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|831|1537|lyfalmen|V2010|1489|00|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||460||460|1537| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|1|0|0|100|DKK|8284|16079|vetalmen|||27|10|0|0,0000|Icepharma hf|Orion Corporation (I)|||8284||8284|16079| 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|5408|5099|lyfalmen|V2020|4805|00|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||3064||3064|5099| 028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|19497|17741|lyfalmen|V2030|16663|00|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||12256||12256|17741| 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|917|2162|lyfalmen|||02|24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||917||917|2162| 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|1362|2771|lyfalmen|V0551|2771|10|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2771| 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|4998|7744|lyfalmen|V0552|7744|10|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7744| 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|577|1697|lyfalmen|V0554|1697|10|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1697| 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|563|1678|lyfalmen|V0555|1678|10|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1678| 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|2031|3686|lyfalmen|V0556|3686|10|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3686| 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1073|2375|lyfalmen|||24|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1073|2375| 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|7572|11265|lyfalmen|||00|28|0|28,0000|Icepharma hf|Servier|Agómelatín||7572||7572|11265| 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|A||0|0|0|0|SEV|0|1|0|100|DKK|22556|30667|lyfalmen|||00|84|0|84,0000|Icepharma hf|Servier|Agómelatín||22556||22556|30667| 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|620|1755|lyfalmen|||00|40|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||620||620|1755| 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|251|1251|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||||251|1251| 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki|samsett pk|A07EA06|01.01.2007||R|A||0|0|B|0|DAC|0|0|0|100|XEU|7938|11766|lyfalmen|V0291|11612|56|7|0|7,0000|D.A.C. ehf|D.A.C. ehf|Búdesóníð||7938||7938|11766| 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7895|9536|lyfalmen|V0362|2229|00|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6308||6308|9536| 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|23523|31404|lyfsjukr|||00|50|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||23523||23523|31404| 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|6082|8778|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||6082||6082|8778| 029574|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|4672|6743|lyfsjukr|||00|5|0|0,0000|Actavis Group hf|Actavis Group hf|Írinótekan||4672||4672|6743| 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5279|8129|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5279|8129| 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16579|23166|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||16579|23166| 029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|5279|8129|lyfalmen|||00|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||5279|8129| 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|16579|23166|lyfalmen|||00|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||16579|23166| 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|104599|133154|lyfsjukr|||00|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||104599||104599|133154| 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|A||0|1|0|1|AEU|0|0|0|100|DKK|209196|264423|lyfsjukr|||00|1|0|16,6600|Vistor hf|Amgen Europe B.V.|||209196||209196|264423| 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 030313|G04CA0206|Tamsulosin Portfarma|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|SEK|4996|4951|lyfalmen|V0437|4925|00|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2956||2956|4951| 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|23570|31940|lyfalmen|||00|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||23570||23570|31940| 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||00|60|0|25,0000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9628|14078|lyfalmen|V1400|14077|00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9628||9628|14078| 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3071|5108|lyfalmen|V1401|5107|00|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||3071||3071|5108| 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|16837|29371|vetorma|||00|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16837|29371| 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1021|2304|lyfalmen|V2005|2304|00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1021||1021|2304| 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MYL|0|0|0|100|SEK|1489|2944|lyfalmen|||00|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||1489||1489|2944| 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|0|0|NHE|0|0|1|100|DKK|869|2096|lyfalmen|||23|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||869||869|2096| 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3293|5412|lyfalmen|||17|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3293||3293|5412| 031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|68377|87696|lyfsjukr|||00|20|0||Vistor hf|Schering-Plough|Temozolomid||68377||68377|87696| 031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|83307|106433|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||83307||83307|106433| 031348|L01AX0301|Temodal|hylki|140|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|115815|147230|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||115815||115815|147230| 031371|L01AX0301|Temodal|hylki|180|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|147981|187599|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||147981||147981|187599| 031394|L01AX0301|Temodal|hylki|250|mg|5|skpokar|1|pakki||L01AX03|01.01.2010||R|A||0|1|0|1|SCP|0|0|0|100|DKK|183666|232383|lyfsjukr|||00|5|0||Vistor hf|Schering-Plough|Temozolomid||183666||183666|232383| 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2186|3898|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||2186||2186|3898| 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6196|9383|lyfalmen|||02|15|0|37,5000|Vistor hf|Novo-Nordisk|Insúlín aspart||6196||6196|9383| 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|24265|32335|lyfsjukr|||00|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||24265||24265|32335| 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|2085|3760|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2085||2085|3760| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10050|14495|lyfsjukr|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||10050|14495| 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|14690|20318|lyfsjukr|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||14690|20318| 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|50828|65672|lyfsjukr|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||50828|65672| 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0,0000|Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|22025|30001|lyfalmen|||00|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22025||22025|30001| 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|3971|6927|vetorma|||27|50|0|0,0000|Vistor hf|Merial (MSD)|||3971||3971|6927| 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|15497|27034|vetorma|||27|200|0|0,0000|Vistor hf|Merial (MSD)|||15497||15497|27034| 032723|N06AX1609|Venlafaxin Ranbaxy|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2009||R|A||0|0|B|0|RAN|0|1|0|100|XEU|9379|6171|lyfalmen|||00|100|0|75,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||3848||3848|6171|30.04.2011 032756|N06AX1609|Venlafaxin Ranbaxy|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.01.2010||R|A||0|0|B|0|RAN|0|1|0|100|XEU|7354|6283|lyfalmen|V0956|6283|00|100|0|150,0000|Gróco ehf|Ranbaxy (UK) Ltd|Venlafaxín||3930||3930|6283| 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|22323|29898|lyfsjukr|||00|1|0|29,6300|Vistor hf|Ferring|Degarelix||||22323|29898| 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|A||0|1|0|1|FER|0|0|0|100|DKK|44523|57759|lyfsjukr|||00|2|0|44,4400|Vistor hf|Ferring|Degarelix||||44523|57759| 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|A||0|0|0|0|LHS|0|0|0|100|XEU|9582|18571|vetalmen|||27|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||9582|18571| 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1178|2519|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Dexametasón||1178||1178|2519| 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|A||0|0|*|0|WIH|0|0|0|100|DKK|48699|63477|lyfalmen|V0563|63477|00|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||48699||48699|63477| 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|83867|107136|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|Darunavír||83867||83867|107136| 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|A||0|1|0|1|JCI|0|0|0|100|SEK|109391|139168|lyfsjukr|||43|60|0||Vistor hf|Janssen-Cilag International N.V.|Darunavír||109391||109391|139168| 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|ml|1|hgl||L04AC05|01.06.2009|31.03.2011|R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|622568|783205|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||622568||622568|783205| 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2590|5146|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||2590|5146| 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|781|1976|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||781||781|1976| 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|24130|32166|lyfsjukr|||00|25|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||24130||24130|32166| 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8505|12542|lyfalmen|||0|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8505|12542| 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|A||0|0|E|0|ELD|0|0|0|100|XEU|8505|12542|lyfalmen|||0|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8505|12542| 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|CHE|0|0|1|100|SEK|2438|4242|lyfalmen|||00|300|0|10,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||2438||2438|4242| 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1914|3526|lyfalmen|||00|6|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1914||1914|3526| 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3282|5397|lyfalmen|||00|12|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3282||3282|5397| 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|180499|228409|lyfsjukr|||00|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||180499||180499|228409| 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|7797|11253|lyfsjukr|||02|25|0|0,0000|Vistor hf|LEO Pharma A/S|Prótamín||7797||7797|11253| 035099|C02CA0404|Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009|30.04.2011|R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|2635|4467|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Doxazósín||2602||2602|4467| 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|2368|3418|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||2368||2368|3418| 035177|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6044|7341|lyfalmen|||10|100|0|16,6800|D.A.C. ehf|D.A.C. ehf|Gabapentín||4703||4703|7341|31.03.2011 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|16713|23334|lyfalmen|||10|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16713||16713|23334| 035222|N06DA0403|Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|13453|19243|lyfalmen|V1370|19243|00|28|0|14,0000|D.A.C. ehf|D.A.C. ehf|Galantamín||13453||13453|19243| 035234|M01AB5502|Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5052|7818|lyfalmen|V2130|6274|0|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Díklófenaknatríum í blöndum||5052||5052|7818| 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3709|5981|lyfalmen|V2215|5981|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3709|5981| 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005|31.05.2011|R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2870|lyfalmen|||00|56|0|4,6700|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2870| 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3253|lyfalmen|V0703|3253|00|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1715||1715|3253| 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005|31.05.2011|R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|4835|lyfalmen|||00|56|0|18,6700|Actavis Group hf|Actavis hf|Lamótrigín||2871||2871|4835| 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PER|0|0|0|100|DKK|125770|159724|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Pegaptaníb||125770||125770|159724| 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|10636|15457|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10636||10636|15457| 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|A||0|0|0|0|GZE|0|0|0|100|XEU|31987|38639|lyfalmen|||00|180|0||Vistor hf|Genzyme Europe B.V.|Sevelamer||28908||28908|38639| 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|K||0|1|0|1|MSE|0|0|0|100|SEK|147998|187620|lyfsjukr|||00|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||147998||147998|187620| 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|6184|9367|lyfalmen|||00|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6184||6184|9367| 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3035|5059|lyfalmen|V2213|5059|00|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3035|5059| 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8839|12999|lyfalmen|V2214|12999|00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8839||8839|12999| 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|A||0|1|0|1|ABL|0|0|0|100|DKK|6345|9157|lyfsjukr|||00|30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6345||6345|9157| 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|205811|260175|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||205811||205811|260175| 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|410509|517071|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||410509||410509|517071| 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|IPI|0|0|0|100|DKK|819292|1030094|lyfsjukr|||00|30|0|0,0000|Icepharma hf|Pfizer Limited|Sunitíníb||819292||819292|1030094| 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|846|2065|lyfalmen|||00|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||846||846|2065| 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1487|2942|lyfalmen|||08|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1487||1487|2942| 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|GCO|0|0|0|100|IKR|||lyflausa|||00|30|0|6,0000|Vistor hf|GlaxoSmithKline CH AB|Silíkonsambönd|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2935|4922|lyfalmen|||08|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2935||2935|4922| 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|890|2125|lyfalmen|||00|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||890||890|2125| 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11936|17235|lyfalmen|||00|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||11936||11936|17235| 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|21913|29860|lyfalmen|||00|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||21913||21913|29860| 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|42854|56141|lyfalmen|||00|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||42854||42854|56141| 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2629|4504|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2629||2629|4504| 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1168|2505|lyfalmen|||0|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1168||1168|2505| 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2238| 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3698| 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|8709|12821|lyfalmen|||00|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8709|12821| 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1427|lyfalmen|V0917|1256|00|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1427| 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2303|lyfalmen|V0918|1974|00|60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2303| 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3084|lyfalmen|V0919|2921|00|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3084| 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1088|2396|lyfalmen|||00|50|0|50,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1088||1088|2396| 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|2674|4565|lyfalmen|V2211|4565|00|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2674||2674|4565| 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|182583|231024|lyfsjukr|||00|1|0|0,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||182583||182583|231024| 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|K||0|1|0|1|WTE|0|0|0|100|DKK|78916|100922|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||78916||78916|100922| 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|2503|4331|lyfalmen|||00|100|0|33,3333|Medico ehf|Solvay Duphar |Betahistín||2503||2503|4331| 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|41898|54464|lyfsjukr|||00|10|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||41898||41898|54464| 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|70039|89781|lyfsjukr|||00|20|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||70039||70039|89781| 039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín|||||| 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|þpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|4661|7283|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4661|7283| 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|A||0|0|0|0|SAA|0|0|0|100|NOK|22836|31019|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||22836|31019| 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|3434|5605|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3434||3434|5605| 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|594|1720|lyfalmen|||00|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||594||594|1720| 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|668|1821|lyfalmen|||00|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||668||668|1821| 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1349|2753|lyfalmen|||00|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1349||1349|2753| 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1944|3567|lyfalmen|||00|22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1944||1944|3567| 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|494|713|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||494||494|713| 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1630|2977|lyfalmen|V0367|2959|00|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1513||1513|2977| 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|8352|9967|lyfalmen|V0508|9967|00|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6623||6623|9967| 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|675|974|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||675||675|974| 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|A||0|0|E|0|AGP|0|0|1|100|GBP|1809|2556|lyfalmen|V0507|2556|00|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1205||1205|2556| 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1374|1983|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1374||1374|1983| 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og aðrar óvirkar samsetningar|||||1652| 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3434|5605|lyfalmen|||00|63|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3434||3434|5605| 041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|K||0|0|0|0|IPF|1|0|0|100|DKK|29218|50969|vetorma|||00|240|0||Icepharma hf|Pfizer Limited|GnRF hliðstæða samtengd próteini||||29218|50969| 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4576|7983|vetorma|||AA|100|0|0,0000|Icepharma hf|Intervet International B.V.|||4576||4576|7983| 041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,0000|D.A.C. ehf|D.A.C. ehf|Díklófenak|||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|TMC|0|0|0|100|SEK|210864|266994|lyfalmen|||02|100|0|0,0000|TMC Pharma Services Ltd|TMC Pharma Services Ltd|Gadófosveset||210864||210864|266994| 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MYL|0|1|0|100|SEK|1228|2587|lyfalmen|||00|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1228|2587| 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1579|3067|lyfalmen|||02|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1579||1579|3067| 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|13292|18564|lyfsjukr|||00|500|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||13292||13292|18564| 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2642|3813|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2642||2642|3813| 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3194|4610|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3194||3194|4610| 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4521|6525|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4521||4521|6525| 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4634|6688|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||4634||4634|6688| 042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5903|8520|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5903||5903|8520| 042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2238|3969|lyfalmen|||00|500|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2238|3969| 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7285|10514|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Kolvetni||7285||7285|10514| 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BA03|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3948|5698|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3948||3948|5698| 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3022|4362|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3022||3022|4362| 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2309|3332|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2309||2309|3332| 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2891|4172|lyfsjukr|||02|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2891||2891|4172| 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5695|8219|lyfsjukr|||00|2000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5695||5695|8219| 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúðir|B05BB01|01.03.2010||R|A||0|0|0|1|FRP|0|0|0|100|DKK|3793|5474|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3793||3793|5474| 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2591|3739|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2591||2591|3739| 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|1867|2695|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||1867||1867|2695| 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6335|9143|lyfsjukr|||00|4000|0|4,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||6335||6335|9143| 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2114|3051|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2114||2114|3051| 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|806|2010|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||806||806|2010| 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2993|4320|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2993||2993|4320| 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15401|21688|lyfalmen|||02|10|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||15401||15401|21688| 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|1396|2777|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1396||1396|2777| 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2082|4141|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2082||2082|4141| 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|2791|5532|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2791||2791|5532| 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|5583|10893|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5583||5583|10893| 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|A||0|0|0|0|IPF|0|0|0|100|DKK|6419|12498|vetalmen|||00|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6419||6419|12498| 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2520|3637|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2520||2520|3637| 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|390|1441|lyfalmen|||00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||390||390|1441| 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3292|4751|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3292||3292|4751| 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3743|5801|lyfalmen|||24|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3577||3577|5801| 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6087|8785|lyfsjukr|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Rópívakaín||6087||6087|8785| 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|587|1710|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||587||587|1710| 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1255|2624|lyfalmen|||10|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1255||1255|2624| 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|100,0000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|14524|20229|lyfalmen|V0011|20229|00|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||14239||14239|20229| 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|24084|32585|lyfalmen|||00|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||24084||24084|32585| 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|91993|117811|lyfalmen|||00|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||91993||91993|117811| 044763|N04BC0502|Sifrol|forðatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|2787|4720|lyfalmen|||00|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2787||2787|4720| 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999|30.04.2011|R|A|3|0|1|0|1|PER|0|0|0|100|DKK|38599|50324|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Pfizer ApS|Írinótekan||38599||38599|50324| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7699|11439|lyfalmen|||02|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||7699||7699|11439| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2229|lyfalmen|V0362|2229|00|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||966||966|2229| 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2024|lyfalmen|V0361|2024|00|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||816||816|2024| 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|2933|4233|lyfsjukr|||00|10|0|0,2500|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2933||2933|4233| 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A||0|0|0|1|VIL|0|0|0|100|NOK|5865|8465|lyfsjukr|||00|10|0|0,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5865||5865|8465| 045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|A||0|0|0|0|AGT|0|0|1|100|XEU|392|1444|lyfalmen|||04|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||392||392|1444| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|22010|42435|vetalmen|||27|10|0|0,0000|Icepharma hf|Pfizer vet.|||22010||22010|42435| 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1078|2382|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1078||1078|2382| 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|4092|6505|lyfalmen|V1088|6505|02|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||4092||4092|6505| 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|711|1880|lyfalmen|V0001|1880|00|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||711||711|1880| 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1168|2505|lyfalmen|V0002|2505|00|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||1168||1168|2505| 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1469|2917|lyfalmen|V0003|2917|00|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||1469||1469|2917| 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|DKK|6815|10230|lyfalmen|V1089|10230|02|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6815||6815|10230| 047042|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|76498|97887|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||76498||76498|97887| 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1053|2348|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1053||1053|2348| 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992|31.05.2011|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|39|961|lyfalmen|||23|14|0|7,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||39||39|961| 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||00|10|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18684| 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||00|50|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61564| 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|DKK|152976|193867|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||152976||152976|193867| 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|13141|14739|lyfalmen|V0560|14324|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíð||10111||10111|14739| 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|A||0|0|*|0|POF|0|0|0|100|XEU|24886|29275|lyfalmen|V0562|28737|00|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíð||21447||21447|29275| 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|5471|7896|lyfsjukr|||02|250|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||5471||5471|7896| 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8636|12464|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Albúmín||8636||8636|12464| 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|2815|4758|lyfalmen|V0940|4758|00|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2815||2815|4758| 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|2615|3646|lyfalmen|V0939|3646|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2002||2002|3646| 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|8115|7599|lyfalmen|V0938|7599|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4892||4892|7599| 048133|N06AB1004|Esopram|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|3085|4163|lyfalmen|V0941|4163|00|28|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2380||2380|4163| 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|7972|7599|lyfalmen|V0942|7599|00|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4892||4892|7599| 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|A||0|0|0|0|APC|0|1|0|100|XEU|4089|4545|lyfalmen|V0943|4545|00|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2659||2659|4545| 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|A||0|0|B|0|APC|0|1|0|100|XEU|15943|7599|lyfalmen|V2172|7599|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||4892||4892|7599| 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|1219|2575|lyfalmen|||00|100|0|0,0000|Vistor hf|Meda AB|Klídín og geðlyf||1219||1219|2575| 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|14478|20529|lyfalmen|||00|98|0|196,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||14478||14478|20529| 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4267|6744|lyfalmen|||00|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||4267||4267|6744| 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1868|3463|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1868||1868|3463| 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|64199|79400|lyfalmen|V2230|77428|00|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||61387||61387|79400| 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|A||0|1|0|1|GZE|0|0|0|100|XEU|1029102|1293406|lyfsjukr|||00|1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1029102||1029102|1293406| 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|502|1594|lyfalmen|V0772|1494|00|100|0|16,6667|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||502||502|1594| 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2522|4357|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2522||2522|4357| 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|17633|24489|lyfalmen|||00|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17633||17633|24489| 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2496|4322|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2496||2496|4322| 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3318|5446|lyfalmen|||00|2|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3318||3318|5446| 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|9765|14265|lyfalmen|||00|8|0|0,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||9765||9765|14265| 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|6583|9913|lyfalmen|||23|5|0|5,0000|Icepharma hf|Galderma Nordic AB|Amorolfín||6583||6583|9913| 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2024|lyfalmen|V0361|2024|00|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||816||816|2024| 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2229|lyfalmen|V0362|2229|00|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||966||966|2229| 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1827|3019|lyfalmen|V0367|3019|00|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1544||1544|3019| 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4928|lyfalmen|V0343|4526|00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4928| 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1254|2623|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1254||1254|2623| 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|1640|3151|lyfalmen|||00|30|0|30,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||1640||1640|3151| 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2584|3981|lyfalmen|||00|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||2247||2247|3981| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|64199|82929|lyfalmen|||00|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||64199||64199|82929| 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8304|11985|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||8304||8304|11985| 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BAP|0|0|0|100|SEK|585814|737079|lyfsjukr|||00|112|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||585814||585814|737079| 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||00|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|3448|5624|lyfalmen|||00|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3448||3448|5624| 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|13506|19309|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13506||13506|19309| 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5733|5259|lyfalmen|V2120|4746|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3181||3181|5259| 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4937|7629|lyfalmen|V2206|7629|00|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4914||4914|7629| 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|A||0|0|E|0|AGT|0|0|0|100|IKR|4744|7230|lyfalmen|V2171|7230|00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4622||4622|7230| 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|A||0|0|E|0|AGT|0|0|0|100|IKR|11336|8438|lyfalmen|||00|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||5505||5505|8438| 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1775|3335|lyfalmen|||10|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1775||1775|3335| 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0,0000|D.A.C. ehf|D.A.C. ehf|Ketóprófen|||||| 051083|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2500 a.e. anti-Xa/ml/sprautu|B01AB04|01.06.2010|31.05.2011|R|A||0|0|0|0|PER|0|0|1|100|DKK|5322|8188|lyfalmen|||02|2|0|10,0000|Icepharma hf|Pfizer ApS|Dalteparín||5322||5322|8188| 051107|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5000 a.e. anti-Xa/ml/sprautu|B01AB04|01.06.2010|31.05.2011|R|A||0|0|0|0|PER|0|0|1|100|DKK|10640|15462|lyfalmen|||02|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||10640||10640|15462| 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1834|3416|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1834||1834|3416| 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1474|2924|lyfalmen|V1912|2924|00|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1474||1474|2924| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4009|6391|lyfalmen|V1913|6391|00|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4009||4009|6391| 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|0|0|1|UCB|0|0|0|100|DKK|31598|41538|lyfsjukr|||00|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||31598||31598|41538| 051686|N05AE0402|Zeldox (DAC)|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2011||R|A|4|0|0|*|0|DAC|0|1|0|100|XEU|28228|37786|lyfalmen|V0722|37786|00|56|0|56,0000|D.A.C. ehf|D.A.C. ehf|Ziprasidon||28228||28228|37786| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1642|2532|lyfalmen|V0308|2532|00|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||1188||1188|2532| 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|2779|3480|lyfalmen|V0310|3480|00|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1881||1881|3480| 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|221|1210|lyfalmen|V0858|1210|00|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||221||221|1210| 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|521|1620|lyfalmen|V0859|1620|00|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||521||521|1620| 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|357573|450637|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||357573||357573|450637| 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|MYL|0|0|1|100|SEK|369|1412|lyfalmen|V0856|1412|00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||369|1412| 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|1184|2527|lyfalmen|||00|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1184||1184|2527| 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|A||0|0|0|0|MYL|0|0|0|100|SEK|759|1946|lyfalmen|V0855|1946|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||759||759|1946| 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|746971|939331|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||746971||746971|939331| 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|662052|832758|lyfsjukr|||00|60|0|0,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||662052||662052|832758| 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|3901|6244|lyfalmen|||00|3|0||Vistor hf|Allergan|Tímólól í blöndum||3901||3901|6244| 052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.01.2010||R|A||0|0|*|0|ALL|0|0|0|100|SEK|11301|16367|lyfalmen|||00|9|0||Vistor hf|Allergan|Tímólól í blöndum||11301||11301|16367| 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38672|50416|lyfsjukr|||00|8212|0|8,2000|Icepharma hf|Fresenius Kabi|Blöndur||38672||38672|50416| 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31438|41337|lyfsjukr|||00|7698|0|7,7100|Icepharma hf|Fresenius Kabi|Blöndur||31438||31438|41337| 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|46139|59787|lyfsjukr|||63|10|0|8,3333|Actavis Group hf|Pharmachemie|Kalsíumfólínat||46139||46139|59787| 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33188|43533|lyfsjukr|||00|7680|0|7,6800|Icepharma hf|Fresenius Kabi|Blöndur||33188||33188|43533| 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27767|36730|lyfsjukr|||00|7200|0|7,2000|Icepharma hf|Fresenius Kabi|Blöndur||27767||27767|36730| 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37342|48747|lyfsjukr|||00|7880|0|7,9000|Icepharma hf|Fresenius Kabi|Blöndur||37342||37342|48747| 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34674|45398|lyfsjukr|||00|7616|0|7,6000|Icepharma hf|Fresenius Kabi|Blöndur||34674||34674|45398| 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2463|4277|lyfalmen|V0903|4277|00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2463||2463|4277| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2316|4076|lyfalmen|||23|63|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2316||2316|4076| 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|65021|83484|lyfsjukr|||00|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||65021||65021|83484| 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5636|8617|lyfalmen|||10|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||5636||5636|8617| 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6030|9156|lyfalmen|||02|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6030||6030|9156| 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|39768|52268|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||39768||39768|52268| 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|33381|44253|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||33381||33381|44253| 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|656|1805|lyfalmen|V0902|1805|00|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||656||656|1805| 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|15407|21695|lyfalmen|||00|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15407||15407|21695| 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|A||0|0|0|0|OTS|0|1|0|100|DKK|1617|3119|lyfalmen|||00|1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1617||1617|3119| 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PER|0|0|0|100|DKK|1206|2557|lyfalmen|||20|30|0|30,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1206||1206|2557| 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2729|4641|lyfalmen|||02|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2729||2729|4641| 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|1,2500|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|67501|86596|lyfsjukr|||00|56|0|22,4000|Icepharma hf|Roche Registration Limited|Ribavirin||67501||67501|86596| 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|2,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1131|2455|lyfalmen|||00|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1131||1131|2455| 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|0|0|ACA|0|1|0|100|XEU|1779|3341|lyfalmen|V0914|3341|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1779||1779|3341| 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|A||1|0|0|0|REB|0|0|0|100|DKK|5015|9802|vetalmen|||27|10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríð||||5015|9802| 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8122|14168|vetorma|||16|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||8122||8122|14168| 055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|A||0|0|0|0|ALA|0|0|1|100|USD|1629|3136|lyfalmen|||00|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríð||||1629|3136| 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|808|2013|lyfalmen|||10|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||808||808|2013| 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|9730|14218|lyfalmen|||10|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9730||9730|14218| 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4350|6858|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|Pýrazínamíð||4350||4350|6858| 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|2208|3928|lyfalmen|V2185|3928|00|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2208||2208|3928| 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|4539|2456|lyfalmen|V2205|2456|00|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2456| 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6185|3174|lyfalmen|V2207|3174|00|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3174| 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|5976|lyfalmen|V0339|5976|00|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|5976| 056183|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|31839|42317|lyfalmen|||0|168|0||Vistor hf|AstraZeneca AB|Ticagrelor||31839||31839|42317| 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|A|5|0|0|0|0|CES|1|0|0|100|XEU|28509|49733|vetorma|||00|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28509||28509|49733| 056514|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.11.2009||R|K||0|1|0|1|SOI|0|0|0|100|SEK|91166|116296|lyfsjukr|||00|3|0||Swedish Orphan International AB|Swedish Orphan International AB|||91166||91166|116296| 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1314|2705|lyfalmen|||10|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1314||1314|2705| 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|245895|310481|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||245895||245895|310481| 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|61265|78770|lyfsjukr|||00|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||61265||61265|78770| 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|3709|5981|lyfalmen|V2222|5981|00|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||3709|5981| 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|A||0|0|0|0|AZD|0|0|0|100|SEK|11799|17048|lyfalmen|||00|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11799|17048| 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|12405|17451|lyfsjukr|||02|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||12405||12405|17451| 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|7133|10295|lyfsjukr|||02|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||7133||7133|10295| 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5161|7449|lyfsjukr|||00|200|0|0,2000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||5161||5161|7449| 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|3933|5676|lyfsjukr|||02|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||3933||3933|5676| 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|26147|34697|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||26147||26147|34697| 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|21284|29071|lyfalmen|||0|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||21284|29071| 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|450|1523|lyfalmen|||02|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||450||450|1523| 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|A||0|1|0|1|GGL|0|0|0|100|GBP|127116|161413|lyfsjukr|||00|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||127116||127116|161413| 058283|QI01AD040|Avipro Thymovac|frþlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|171281|298791|vetorma|||00|5000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||171281|298791| 058294|QI01AD040|Avipro Thymovac|frþlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|260192|453892|vetorma|||00|10000|0|0,0000|Icepharma hf|Lohmann Animal Health|||||260192|453892| 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|18392|25441|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||18392||18392|25441| 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1063|2361|lyfalmen|||00|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1063||1063|2361| 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|105847|134720|lyfsjukr|||00|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||105847||105847|134720| 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1273|2649|lyfalmen|||43|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1273||1273|2649| 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2373|4154|lyfalmen|||43|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2373||2373|4154| 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4266|6743|lyfalmen|||51|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4266||4266|6743| 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|A||0|0|E|0|AGT|0|0|0|100|IKR|2540|4382|lyfalmen|||0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2540||2540|4382| 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1565|3048|lyfalmen|||00|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíð dínítrat||1565||1565|3048| 059353|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.02.2010|31.05.2011|R|K||0|1|0|1|CEO|0|0|0|100|DKK|171246|216796|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||171246||171246|216796| 059364|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.02.2010|31.05.2011|R|K||0|1|0|1|CEO|0|0|0|100|DKK|171246|216796|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||171246||171246|216796| 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|104824|133914|lyfalmen|||02|2|0|0,0000|Vistor hf|Astellas Pharma A/S|Leuprórelín||104824||104824|133914| 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|32567|43231|lyfalmen|||51|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||32567||32567|43231| 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|95589|121847|lyfsjukr|||00|30|0|0,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||95589||95589|121847| 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|A||0|0|E|0|BPC|0|0|0|100|SEK|42143|48350|lyfalmen|||00|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||36646||36646|48350| 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|RBP|0|0|0|100|DKK|4950|7144|lyfsjukr|||00|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4950||4950|7144| 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|RBP|0|0|0|100|DKK|14733|20372|lyfsjukr|||00|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14733||14733|20372| 059870|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.11.2010||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|58133|75316|lyfalmen|||00|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||58133||58133|75316| 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|397558|501295|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||397558||397558|501295| 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|198795|251847|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||198795||198795|251847| 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|99403|127110|lyfalmen|||00|84|0|0,0000|Vistor hf|Novartis Europharm Ltd|Deferasírox||99403||99403|127110| 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|5948|9044|lyfalmen|||10|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5948||5948|9044| 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2003| 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2003| 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2899|5739|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||2899|5739| 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1519|3022|vetalmen|||0|4|0|0,0000|Icepharma hf|Pfizer Animal Health|||||1519|3022| 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|8972|17400|vetalmen|||00|20|0|0,0000|Icepharma hf|Pfizer Animal Health|||||8972|17400| 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|A||0|0|E|0|DAC|0|0|0|100|DKK|7369|10988|lyfalmen|V1030|10988|00|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7369||7369|10988| 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|50|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam|||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7370|10989|lyfalmen|V1030|10988|00|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7370||7370|10989| 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|1472|2568|vetorma|||16|26|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||1472|2568| 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|DKK|164599|208454|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Wyeth Europe|Temsirolímus||164599||164599|208454| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|4683|6759|lyfsjukr|||00|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4683||4683|6759| 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|16722|22869|lyfsjukr|||00|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16722||16722|22869| 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|23543|31429|lyfsjukr|||00|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||23543||23543|31429| 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|484|1569|lyfalmen|||10|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||484||484|1569| 062265|M01AB0505|Voltaren|eþ-stíll|50|mg|10|stk|1|pakki||M01AB05|01.11.2010||R|A||0|0|E|0|NOH|0|0|1|100|DKK|377|1423|lyfalmen|||04|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||377||377|1423| 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|A||0|1|*|0|AGP|0|0|0|100|XEU|62963|77428|lyfalmen|V2230|77428|00|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||59816||59816|77428| 062387|N04BC0502|Sifrol|forðatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|A||0|0|E|0|BII|0|0|0|100|DKK|1740|3288|lyfalmen|||00|10|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||1740||1740|3288| 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|7019|10130|lyfsjukr|||02|20|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||7019||7019|10130| 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|479|691|lyfsjukr|||02|1|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||479||479|691| 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|A||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0||Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|977|2244|lyfalmen|||10|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||977||977|2244| 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|1952|3578|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1952||1952|3578| 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|18989|33125|vetorma|||16|1000|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||18989||18989|33125| 062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|41623|54119|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||41623||41623|54119| 062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|50819|65660|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50819||50819|65660| 062935|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1826|3405|lyfalmen|||23|63|0|63,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1826||1826|3405| 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|16145|22621|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||16145||16145|22621| 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|4440|6981|lyfalmen|||00|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4440||4440|6981| 063340|D05AX0202|Daivonex (D.A.C.)|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.12.2009||R|A||0|0|B|0|DAC|0|0|0|100|DKK|5436|8344|lyfalmen|V0092|8344|00|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Kalcípótríól||5436||5436|8344| 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992|31.05.2011|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2161|3864|lyfalmen|||23|14|0|10,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||2161||2161|3864| 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2983| 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4526|lyfalmen|V0343|4526|00|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2645||2645|4526| 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|1703|3234|lyfalmen|V1901|3234|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1701||1701|3234| 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|8206|11843|lyfsjukr|||17|2|0|0,0000|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||8206||8206|11843| 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2676|4668|vetorma|||16|12|0|0,0000|Vistor hf|Fort Dodge Veterinär GmbH|||2676||2676|4668| 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|1026|2311|lyfalmen|||10|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1026||1026|2311| 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2149|3847|lyfalmen|||10|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2149||2149|3847| 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|1145349|1439295|lyfsjukr|||00|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1145349|1439295| 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|458139|576847|lyfsjukr|||00|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||458139|576847| 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|2257|3995|lyfalmen|||10|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2257||2257|3995| 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|4581397|5751536|lyfsjukr|||00|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4581397|5751536| 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2,5|0|1|0|1|UTE|0|0|0|100|XEU|2290700|2876711|lyfsjukr|||00|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2290700|2876711| 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|869|2096|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||869||869|2096| 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2059|3724|lyfalmen|||38|25|0|0,0000|Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2059||2059|3724| 065314|G01AF0201|Canesten|sk-stíll|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||25|6|0|6,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 065332|G01AF0201|Canesten|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|15633|21502|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15633||15633|21502| 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|2640|3803|lyfalmen|V1989|2379|06|2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2117||2117|3803| 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dæla|L02AE03|01.06.2011||R|A||0|1|*|0|LVR|0|0|0|100|SEK|62507|80806|lyfalmen|V0565|80806|00|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||62507||62507|80806| 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|K|3|0|0|*|0|PER|0|0|0|100|DKK|7912|11257|lyfalmen|V1989|7138|06|8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7566||7566|11257| 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|101|IKR|||lyflausa|||23|14|0|17,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065778|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.12.2009||R|K||0|1|0|1|WTE|0|0|0|100|DKK|152976|193867|lyfsjukr|||00|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||152976||152976|193867| 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|4848|6997|lyfsjukr|||02|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4848||4848|6997| 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|1964|3594|lyfalmen|V0195|1999|00|28|0|7,0000|Vistor hf|M.S.D.|Lósartan||1964||1964|3594| 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|0|0|BII|0|0|0|100|DKK|7046|10546|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||7046||7046|10546| 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|34710|45444|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||34710||34710|45444| 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|A||0|0|0|0|GOG|0|0|1|100|DKK|893|2129|lyfalmen|||23|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||893||893|2129| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||02|120|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603| 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|1546|3022|lyfalmen|V0144|3022|70|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1546||1546|3022| 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|A||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||| 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|A||0|1|0|1|AGP|0|0|0|100|XEU|16142|22141|lyfsjukr|||00|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||16142||16142|22141| 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992|31.05.2011|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|655|1803|lyfalmen|||23|20|0|2,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||655||655|1803| 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7493|11157|lyfalmen|||00|84|0|56,0000|Medico ehf|Solvay Duphar |Betahistín||7493||7493|11157| 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1508|2970|lyfalmen|||00|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1508||1508|2970| 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A||0|0|0|0|DAC|0|0|1|100|DKK|798|1999|lyfalmen|V0901|1516|00|50|0|50,0000|D.A.C. ehf|D.A.C. ehf|Nítrazepam||798||798|1999| 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|K||0|0|*|0|APC|0|0|0|100|DKK|1955|2909|lyfalmen|V1989|2379|06|2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1463||1463|2909| 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1567|2771|lyfalmen|V0551|2771|10|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2771| 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|5748|7744|lyfalmen|V0552|7744|10|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7744| 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|664|1697|lyfalmen|V0554|1697|10|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1697| 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|612|1678|lyfalmen|V0555|1678|10|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1678| 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2031|3686|lyfalmen|V0556|3686|10|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3686| 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|14199|17855|lyfalmen|V0558|17855|10|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||12347||12347|17855| 068043|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|2|glas|sk-úðari|R01AA07|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6440|12538|vetalmen|||27|50|0|0,0000|Icepharma hf|Vétoquinol AG|||6440||6440|12538| 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|þpakki||B02BX05|01.04.2011||R|A||0|1|0|1|GTS|0|0|0|100|GBP|77543|99199|lyfsjukr|||00|14|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||77543||77543|99199| 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|1847|3434|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||1847||1847|3434| 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|6116|9274|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||6116||6116|9274| 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|2653|3829|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Natríumklóríð||2653||2653|3829| 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|3302|4766|lyfsjukr|||00|400|0|0,4000|Actavis Group hf|Braun|Kalíumklóríð||3302||3302|4766| 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15,0000|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3297|lyfalmen|||00|14|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3297| 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|17190|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|17190| 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007|30.04.2011|R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|3222|5315|lyfalmen|||00|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3222||3222|5315| 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|PAD|0|0|1|100|DKK|1657|3174|lyfalmen|||00|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1657||1657|3174| 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|glas||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|453|1527|lyfalmen|V0167|1527|00|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||453||453|1527| 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|19043|26258|lyfalmen|||00|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||19043|26258| 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|27542|36925|lyfalmen|||00|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||27542|36925| 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|K||0|0|*|0|JAS|0|1|0|100|SEK|35669|47124|lyfalmen|||00|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||35669|47124| 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|47367|61328|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||47367||47367|61328| 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|29990|39520|lyfsjukr|||00|10|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||29990||29990|39520| 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5689|8211|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5689||5689|8211| 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5308|7661|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||5308||5308|7661| 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9322|13454|lyfsjukr|||00|7500|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||9322||9322|13454| 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5933|8563|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Fresenius Kabi|Kolvetni||5933||5933|8563| 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|DKK|8734|16943|vetalmen|||27|100|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||8734||8734|16943| 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|12943|18603|lyfalmen|||00|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12943||12943|18603| 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|6504|12661|vetalmen|||16|1250|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||6504||6504|12661| 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1903|lyfalmen|||00|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||728||728|1903| 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|68674|88068|lyfsjukr|||00|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||68674||68674|88068| 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|343372|432814|lyfsjukr|||00|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||343372||343372|432814| 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|15488|12930|lyfalmen|V0100|12930|00|12|0|24,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||8789||8789|12930| 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|A||0|0|E|0|PSA|0|0|0|100|XEU|3326|4922|lyfalmen|V1091|4922|00|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||2935||2935|4922| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|6551|12751|vetalmen|||27|5|0|0,0000|Vistor hf|Orion-Farmos|||6551||6551|12751| 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|300|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|A||0|0|E|0|PSA|0|0|0|100|XEU|10458|14338|lyfalmen|V0090|14012|00|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||9818||9818|14338| 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|dýr||20143||20143|27639| 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|673|971|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Súfentaníl||673||673|971| 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|156201|197915|lyfsjukr|||00|2|0|27,5900|Vistor hf|Abbott|Adalimumab||156201||156201|197915| 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|15708|22073|lyfalmen|||00|1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||15708||15708|22073| 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|15708|22073|lyfalmen|||00|2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíð||15708||15708|22073| 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1098|2409|lyfalmen|||00|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1098||1098|2409| 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|3317|5445|lyfalmen|V0295|5445|10|100|0|100,0000|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3317||3317|5445| 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|A||0|0|E|0|GSK|0|0|0|100|GBP|3724|6002|lyfalmen|||00|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð og tamsúlósínhýdroklóríð||3724||3724|6002| 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1701|3234|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1701||1701|3234| 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|755|1940|lyfalmen|V0168|1940|0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||755||755|1940| 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|321|1346|lyfalmen|V0858|1210|00|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||321||321|1346| 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|791|1989|lyfalmen|V0859|1620|00|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||791||791|1989| 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1010|2289|lyfalmen|V0855|1946|00|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||1010||1010|2289| 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|544|1652|lyfalmen|V0856|1412|00|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||544||544|1652| 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|1477|2928|lyfalmen|||00|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1477||1477|2928| 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|1324|2719|lyfalmen|||10|50|0|8,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||1324||1324|2719| 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|þpakki||G04BE03|01.12.2009||R|A||0|0|0|0|DAC|0|0|0|100|DKK|4891|7598|lyfalmen|V0096|7598|00|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4891||4891|7598| 074038|N02AB0304|Durogesic (D.A.C.)|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2009||R|A||1|0|E|0|DAC|0|0|0|100|SEK|3539|5749|lyfalmen|V0102|4512|00|5|0|9,9900|D.A.C. ehf|D.A.C. ehf|Fentanýl||3539||3539|5749| 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|3782|6081|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3782||3782|6081| 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|11014|15974|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||11014||11014|15974| 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4826|7509|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4826||4826|7509| 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|14204|20185|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||14204||14204|20185| 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|4826|7509|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4826||4826|7509| 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.03.2011||R|A||0|0|E|0|DAC|0|0|1|100|GBP|398|1452|lyfalmen|V0012|1452|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||398||398|1452| 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|0|0|NOE|0|0|0|100|DKK|15943|22368|lyfalmen|||00|98|0|0,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15943||15943|22368| 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|17898|24344|lyfsjukr|||00|50|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||17898||17898|24344| 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|242|1238|lyfalmen|||00|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||242||242|1238| 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|490|1578|lyfalmen|||00|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||490||490|1578| 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|21810|38046|vetorma|||58|25|0|0,0000|Vistor hf|Scan Vet Animal Health AS|||21810||21810|38046| 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|408|1465|lyfalmen|||00|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||408||408|1465| 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|A||0|0|B|0|AUK|0|1|0|100|GBP|745|1926|lyfalmen|||00|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||745||745|1926| 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|A|3|0|0|B|0|AEG|0|0|0|100|GBP|943|2197|lyfalmen|||00|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||943||943|2197| 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|A|5|0|0|B|0|AEG|0|0|0|100|GBP|503|1595|lyfalmen|||00|100|0|100,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||503||503|1595| 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1592|2431|lyfalmen|||00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1114||1114|2431| 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5150|7952|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||5150||5150|7952| 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15449|21748|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||15449||15449|21748| 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1831|3412|lyfalmen|||69|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1831||1831|3412| 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|5150|7952|lyfalmen|||00|30|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||5150||5150|7952| 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1999|3342|lyfalmen|V1912|2924|00|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1780||1780|3342| 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|A||0|0|0|0|NOE|0|0|1|100|DKK|15449|21748|lyfalmen|||00|90|0||Vistor hf|Novartis Europharm Ltd|Indacaterol||15449||15449|21748| 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1950|3575|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1950||1950|3575| 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|3137|5199|lyfalmen|||00|300|0|300,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||3137||3137|5199| 075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|DKK|35464|46867|lyfalmen|V0106|46867|00|56|0|18,6670|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||35464||35464|46867| 075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|7259|10837|lyfalmen|V2142|10837|00|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||7259||7259|10837| 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007|31.03.2011|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|3009|lyfalmen|||10|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|3009| 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2009||R|A|3|0|0|E|0|LVR|0|0|1|100|DKK|13988|19914|lyfalmen|V2140|19914|00|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13988||13988|19914| 075382|V04CL0030|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|21099|28839|lyfalmen|V0105|26680|00|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||21099|28839| 075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.12.2009||R|A||0|0|*|0|LVR|0|1|0|100|NOK|7607|11313|lyfalmen|V0104|9720|00|90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríð||||7607|11313| 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075440|V04CL0026|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|A||0|0|E|0|POF|0|0|0|100|XEU|4327|5628|lyfalmen|V0004|5628|00|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríð||3451||3451|5628| 075465|V04CL0024|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075470|L01CD0201|Taxotere|irþ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|31672|41631|lyfsjukr|||00|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||31672||31672|41631| 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075482|L01CD0201|Taxotere|irþ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|A||0|1|0|1|AVS|0|0|0|100|NOK|118874|151069|lyfsjukr|||00|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||118874||118874|151069| 075507|V04CL0018|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075689|V04CL0027|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|DKK|103069|131234|lyfsjukr|||00|1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuþáttur IX||103069||103069|131234| 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|A|5|0|0|0|0|DEC|0|0|0|100|DKK|735|1462|vetalmen|||16|20|0||Vistor hf|Dechra Veterinary Products A/S|||735||735|1462| 075787|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|DEC|0|0|0|100|DKK|2191|4358|vetalmen|||13|25|0|0,0000|Vistor hf|Dechra Veterinary Products A/S|||2191||2191|4358| 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6157|8886|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6157||6157|8886| 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6157|8886|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6157||6157|8886| 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|K||0|0|0|1|FMC|0|0|0|100|XEU|6177|8915|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|||6177||6177|8915| 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|A||0|0|0|0|AUK|0|0|0|100|GBP|437|1505|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||437||437|1505| 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|A||0|0|0|0|AEA|0|0|1|100|XEU|474|1556|lyfalmen|||00|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||474||474|1556| 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.06.2011||R|A||0|0|B|0|LYF|0|0|0|100|XEU|941|2195|lyfalmen|V0169|2195|00|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||941||941|2195| 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|A||0|0|*|0|MSD|0|0|0|100|DKK|6902|10349|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6902||6902|10349| 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|DKK|23506|31859|lyfalmen|||00|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||23506||23506|31859| 076181|L04AA0603|Cellcept (D.A.C.)|töflur|500|mg|50|stk|1|þpakki||L04AA06|01.12.2009||R|A||0|1|*|0|DAC|0|0|0|100|DKK|21399|22565|lyfalmen|V2231|22565|00|50|0|12,5000|D.A.C. ehf|D.A.C. ehf|Mýcófenólsýra||16100||16100|22565| 076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2LIV|V03AN01|01.12.2009||L|A||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|445|1516|lyfalmen|V1070|1516|00|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1516| 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1986|3271|lyfalmen|V1075|3271|00|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1728||1728|3271| 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|1946|3569|lyfalmen|V0791|3569|00|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1946||1946|3569| 076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|928|2177|lyfalmen|||00|100|0|6,6667|Vistor hf|Schering-Plough|Perfenazín||928||928|2177| 076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1299|2684|lyfalmen|||00|100|0|13,3333|Vistor hf|Schering-Plough|Perfenazín||||1299|2684| 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1851|3439|lyfalmen|||00|100|0|26,6667|Vistor hf|Schering-Plough|Perfenazín||||1851|3439| 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7517|13113|vetorma|||27|100|0|0,0000|Vistor hf|Merial (MSD)|||7517||7517|13113| 076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|K||0|0|0|0|GLB|0|0|0|100|GBP|6961|10323|lyfalmen|||00|0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||6883||6883|10323| 076871|G01AF0202|Canesten (D.A.C.)|sk-stíll|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||25|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009|31.05.2011|R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|5838|8893|lyfalmen|||0|1|0|2,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||5838||5838|8893| 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|240|1236|lyfalmen|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||240||240|1236| 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|707|1875|lyfalmen|||00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||707||707|1875| 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|10458|14421|lyfalmen|V0090|14012|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||9879||9879|14421| 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|701|1866|lyfalmen|||02|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||701||701|1866| 078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Ekónazól|||||| 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||| 078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|A||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||29|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||| 078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|A||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||| 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|A||0|0|0|0|POF|0|0|1|100|IKR|11524|16672|lyfalmen|V0558|16665|10|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||11524||11524|16672| 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|548|1657|lyfalmen|||00|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||548||548|1657| 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|835|2050|lyfalmen|||00|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||835||835|2050| 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|127474|161862|lyfsjukr|||00|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||127474||127474|161862| 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9359|6275|lyfalmen|V0197|3902|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3924||3924|6275| 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2729|3939|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||2729||2729|3939| 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|4849|6998|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||4849||4849|6998| 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|8160|11777|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Baxter Medical AB|Ífosfamíð||8160||8160|11777| 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3520|5723|lyfalmen|||00|10|0|4,6700|Icepharma hf|Roche Registration Limited|Oseltamivír||3520||3520|5723| 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|19375|26675|lyfalmen|||02|10|0|154,5714|Vistor hf|Schering-Plough|Perfenazín||19375||19375|26675| 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|A||0|0|B|0|ACA|0|1|0|100|XEU|3601|5833|lyfalmen|V0915|5833|00|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3601||3601|5833| 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2175|3139|lyfsjukr|||03|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2175||2175|3139| 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1445|lyfalmen|V0514|1445|00|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1445| 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1780|lyfalmen|V0518|1780|00|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1780| 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1792|lyfalmen|V0522|1792|00|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1792| 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2505|lyfalmen|V0526|2505|00|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2505| 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|A||0|0|0|0|ANI|1|0|0|100|XEU|4216|8268|vetalmen|||27|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4216|8268| 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||05|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2360|4136|lyfalmen|||00|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2360||2360|4136| 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|5854|8915|lyfalmen|||00|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||5854||5854|8915| 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2788|4509|lyfalmen|V0097|4400|00|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2633||2633|4509| 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|0|0|GSK|0|1|1|100|GBP|3040|5066|lyfalmen|||00|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3040||3040|5066| 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|35878|62587|vetorma|||27|500|0|0,0000|Vistor hf|Merial (MSD)|||35878||35878|62587| 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|7880|11088|lyfalmen|V0098|10783|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||7442||7442|11088| 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|3078|4885|lyfalmen|V0099|4766|00|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2908||2908|4885| 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|15704|21591|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||15704||15704|21591| 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|AGP|0|0|0|100|XEU|11471|13304|lyfalmen|V0100|12930|00|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||9062||9062|13304| 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|30959|40736|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Pfizer ApS|Ídarúbicín||30959||30959|40736| 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|NDR|0|0|0|100|SEK|38627|50836|lyfalmen|||02|12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||38627||38627|50836| 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|NOK|6372|9624|lyfalmen|V1350|9423|00|4|0|8,0000|D.A.C. ehf|D.A.C. ehf|Tadalafíl||6372||6372|9624| 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|A||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|4838|7526|lyfalmen|||00|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4838||4838|7526| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1917|2767|lyfsjukr|||02|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1917||1917|2767| 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.04.2010||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|20137|27631|lyfalmen|||00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||||20137|27631|30.04.2011 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5955|9054|lyfalmen|||02|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5955||5955|9054| 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8946|13145|lyfalmen|||00|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8946||8946|13145| 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|A||0|0|*|0|AGP|0|0|0|100|XEU|39877|52405|lyfalmen|V0566|52405|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||39877||39877|52405| 082040|D07XC0101|Diprosalic|áburður|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2354|4128|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2354||2354|4128| 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3132|4724|lyfalmen|||23|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2790||2790|4724| 082701|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998|31.03.2011|R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|710|1879|lyfalmen|||00|60|0|3,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||710||710|1879| 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5124|7917|lyfalmen|||23|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5124||5124|7917| 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|957|2216|lyfalmen|||00|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||957||957|2216| 082842|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998|31.03.2011|R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|1774|3334|lyfalmen|||00|200|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1774||1774|3334| 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4873|7573|lyfalmen|||00|20|0|6,2500|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4873||4873|7573| 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|5761|8788|lyfalmen|||00|20|0|12,5000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5761||5761|8788| 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13755|19622|lyfalmen|||00|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13755||13755|19622| 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|19506|26839|lyfalmen|||00|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19506||19506|26839| 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14366|20389|lyfalmen|V1372|20387|00|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14366||14366|20389| 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|7613|11322|lyfalmen|||00|20|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7613||7613|11322| 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|80279|102633|lyfsjukr|||00|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||80279||80279|102633| 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|31173|41482|lyfalmen|V1375|33677|00|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||31173||31173|41482| 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8524|12302|lyfsjukr|||02|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8524||8524|12302| 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|281|1292|lyfalmen|||02|10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||281||281|1292| 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|542|1649|lyfalmen|||02|20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||542||542|1649| 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|63993|82194|lyfsjukr|||00|0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||63993||63993|82194| 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|83424|106580|lyfsjukr|||00|0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||83424||83424|106580| 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|103207|131407|lyfsjukr|||00|0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||103207||103207|131407| 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|21331|28653|lyfsjukr|||00|0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||21331||21331|28653| 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|33316|43694|lyfsjukr|||00|0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||33316||33316|43694| 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|42662|55423|lyfsjukr|||00|0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||42662||42662|55423| 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|13212|18464|lyfsjukr|||00|0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13212|18464| 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|50364|65089|lyfsjukr|||00|0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||50364|65089| 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|155116|196553|lyfsjukr|||00|1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||155116|196553| 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|972|2237|lyfalmen|||00|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||972||972|2237| 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11536|16688|lyfalmen|||00|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||11536||11536|16688| 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|37541|49473|lyfalmen|||00|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||37541||37541|49473| 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|16172|22655|lyfalmen|||10|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||16172||16172|22655| 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009|30.04.2011|R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4382|lyfalmen|||0|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4382| 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|2553|4400|lyfalmen|||0|28|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2553||2553|4400| 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|K|1|0|1|*|0|GAN|0|0|0|100|NOK|44208|57840|lyfalmen|||00|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||44208||44208|57840| 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|2744|4661|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Levófloxacín||2744||2744|4661| 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|31173|41482|lyfalmen|V1374|33677|00|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||31173||31173|41482| 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|772|1963|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||772||772|1963| 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993|30.04.2011|R|A|2|0|0|0|1|PER|0|0|0|100|DKK|13397|18696|lyfsjukr|||00|4|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||13397||13397|18696| 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|21214|28983|lyfalmen|||00|375|0|12,5000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||21214||21214|28983| 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|36779|48517|lyfalmen|||00|750|0|25,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||36779||36779|48517| 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|A||0|1|0|1|ELD|0|0|0|100|XEU|98438|125422|lyfsjukr|||00|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||98438||98438|125422| 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|K|3|0|0|0|0|AEU|0|0|0|100|DKK|41645|54624|lyfalmen|||00|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||41645||41645|54624| 085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2270|4013|lyfalmen|||00|10|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||2270||2270|4013| 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4153|5677|lyfalmen|V1911|5491|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3487||3487|5677| 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5624|7914|lyfalmen|V1913|6391|00|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5122||5122|7914| 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8118|11716|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8118||8118|11716| 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|14112|19593|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14112||14112|19593| 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|31524|41922|lyfalmen|||00|600|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||31524||31524|41922| 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|A||0|1|E|0|FEL|0|0|0|100|DKK|63048|81485|lyfalmen|||00|1200|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||63048||63048|81485| 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|55940|72087|lyfsjukr|||00|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |||55940||55940|72087| 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|A||0|0|0|1|ROA|0|0|0|100|DKK|50204|64889|lyfsjukr|||00|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||||50204|64889| 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3112|5164|lyfalmen|||00|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3112||3112|5164| 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|167957|212669|lyfsjukr|||00|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||167957||167957|212669| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|297|1314|lyfalmen|||00|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||297||297|1314| 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|261|1264|lyfalmen|V0886|1264|00|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||261||261|1264| 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2201|3918|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2201||2201|3918| 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||01|500|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||3515| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|MEC|0|0|0|100|SEK|905|2145|lyfalmen|||00|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||905||905|2145| 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.11.2010||R|A||0|0|E|0|APC|0|0|0|100|XEU|3657|4764|lyfalmen|V1091|4594|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||2819||2819|4764| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|11209|14324|lyfalmen|V0560|14324|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||9808||9808|14324| 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|A||0|0|0|0|CHP|0|0|0|100|XEU|32864|57330|vetorma|||00|104|0||Icepharma hf|Chanelle Pharmaceuticals|||32864||32864|57330| 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||| 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1319|2712|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1319||1319|2712| 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1578|3066|lyfalmen|||14|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1578||1578|3066| 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|6087|9234|lyfalmen|||14|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6087||6087|9234| 088393|A03FA0101|Primperan|eþ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|403|1459|lyfalmen|||04|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||403||403|1459| 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10212|14877|lyfalmen|||00|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10212||10212|14877| 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|165943|210141|lyfsjukr|||00|70|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|||||165943|210141| 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|23782|28737|lyfalmen|V0562|28737|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||21018||21018|28737| 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|6648|7138|lyfalmen|V1989|7138|06|8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4555||4555|7138| 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||00|120|0|0,0000|Vistor hf|Nordic Drugs AB|Algínsýra|||||5602| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|VII|0|0|0|100|DKK|167957|212669|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||167957||167957|212669| 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|þpakki||A03AA04|01.07.2010||R|A||0|0|E|0|MYD|0|0|0|100|SEK|4136|6565|lyfalmen|||00|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4136||4136|6565| 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2423|4222|lyfalmen|||00|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2423||2423|4222| 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|37276|48664|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||37276||37276|48664| 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|A||0|0|0|0|PAD|0|0|1|100|DKK|3291|5409|lyfalmen|||00|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3291||3291|5409| 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MKA|0|0|0|100|SEK|186377|235786|lyfsjukr|||00|100|0|0,0000|Icepharma hf|Merck KgaA|Cetúxímab||186377||186377|235786| 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|A||0|0|0|1|NOM|0|0|0|100|DKK||8742|lyfsjukr|||03|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||6057||6057|8742| 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1812|3386|lyfalmen|||24|16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1812||1812|3386| 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|858|2081|lyfalmen|||00|60|0|0,0000|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||858||858|2081| 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|A||1|0|0|0|NOH|0|0|0|100|DKK|3500|5695|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3500||3500|5695| 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|A||0|0|E|0|CCS|0|0|1|100|DKK|4130|6557|lyfalmen|||00|30|0||Vistor hf|CCS Clean Chemical Sweden AB|Dexametasón||4130||4130|6557| 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1283|2539|lyfalmen|V0001|1880|00|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríð||1193||1193|2539| 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|2218|3494|lyfalmen|V0002|2505|00|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríð||1891||1891|3494| 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|4023|6411|lyfalmen|||00|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4023|6411| 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7598|14762|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7598||7598|14762| 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|8066|10884|lyfalmen|V1091|4594|00|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7293||7293|10884| 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|A||0|0|E|0|NON|0|0|0|100|DKK|2362|4138|lyfalmen|||05|18|0|7,2000|Vistor hf|Novo-Nordisk|Estradíól||2362||2362|4138| 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A||0|0|*|0|DAC|0|1|0|100|DKK|9627|14077|lyfalmen|V1400|14077|00|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9627||9627|14077| 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|24923|33638|lyfalmen|||00|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||24923||24923|33638| 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|425|1489|lyfalmen|||10|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||425||425|1489| 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|A||0|0|E|0|AUK|0|0|1|100|GBP|553|1664|lyfalmen|||10|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||553||553|1664| 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3489|4944|lyfalmen|V0718|4909|00|12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||2951||2951|4944| 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5323|8189|lyfalmen|||00|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5323||5323|8189| 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|27480|47937|vetorma|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||27480||27480|47937| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|MEB|0|0|0|100|USD|15121|20859|lyfsjukr|||00|5|0|0,0000|Vistor hf|Meda AB (V)|Mítoxantrón||15121||15121|20859| 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|62906|81306|lyfalmen|V0565|80806|00|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||62906||62906|81306| 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16759|23392|lyfalmen|||10|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16759||16759|23392| 093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|A||0|1|*|0|DAC|0|0|0|100|SEK|23317|31622|lyfalmen|V0564|31622|00|1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||23317||23317|31622| 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|47294|61713|lyfalmen|||10|98|0|261,3300|Icepharma hf|Norpharma |Oxýcódon||47294||47294|61713| 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|566577|712937|lyfsjukr|||AC|0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||566577||566577|712937| 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|K||0|1|0|1|JCI|0|0|0|100|SEK|610174|767651|lyfsjukr|||AC|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||610174||610174|767651| 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|||84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2643|4523|lyfalmen|V0385|4523|23|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2643||2643|4523| 094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|5264|8108|lyfalmen|||00|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5264||5264|8108| 094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.07.2010||R|A|5|0|0|E|0|ALM|0|0|0|100|SEK|7801|11579|lyfalmen|||00|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7801||7801|11579| 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1851|3682|vetalmen|||00|15|0|0,0000|Vistor hf|Boehringer Ingelheim|||1851||1851|3682| 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13528|19337|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13528||13528|19337| 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|19377|26678|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||19377||19377|26678| 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|87192|111785|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||87192||87192|111785| 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|79138|101201|lyfsjukr|||00|60|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||79138||79138|101201| 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|A||0|0|0|0|APE|0|0|0|100|XEU|49271|64195|lyfalmen|||00|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||49271|64195| 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|K||0|0|0|0|LHS|0|0|0|100|XEU|6722|11726|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6722||6722|11726| 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009|31.05.2011|R|A|2|0|0|0|0|WTE|0|0|0|100|DKK|40826|53596|lyfalmen|||0|4|0|14,0000|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||40826||40826|53596| 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|3065|lyfalmen|||00|100|1|50,0000|Distica|Distica - óskráð lyf|||1577||1577|3065| 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6267|7147|lyfalmen|||00|8|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||4561||4561|7147| 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3436|5608|lyfalmen|||00|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||3436||3436|5608| 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18399|25450|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18399||18399|25450| 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18399|25450|lyfalmen|||00|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18399||18399|25450| 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|1994|3635|lyfalmen|||00|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1994||1994|3635| 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|A||0|0|0|0|POF|0|0|0|100|XEU|3124|5181|lyfalmen|||00|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3124||3124|5181| 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|18399|25450|lyfalmen|||00|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18399||18399|25450| 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3785|7440|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3785||3785|7440| 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4995|9764|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4995||4995|9764| 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9096|17638|vetalmen|||00|100|0|0,0000|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9096||9096|17638| 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2450|3536|lyfsjukr|||02|60|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||2450||2450|3536| 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|13281|18550|lyfsjukr|||17|10|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||13281||13281|18550| 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|103826|132184|lyfsjukr|||17|100|0|0,0000|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||103826||103826|132184| 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1425|2857|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1425||1425|2857| 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16699|23317|lyfalmen|||00|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16699||16699|23317| 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|712959|896646|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||712959||712959|896646| 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|755775|950380|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||755775||755775|950380| 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|794890|999469|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||794890||794890|999469| 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|872363|1096698|lyfsjukr|||0|21|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|||872363||872363|1096698| 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16699|23317|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16699||16699|23317| 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1363|2772|lyfalmen|||00|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1363||1363|2772| 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|33400|44276|lyfalmen|||00|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||33400||33400|44276| 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|IPI|0|0|0|100|DKK|92096|117463|lyfsjukr|||00|1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||92096||92096|117463| 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.04.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|28278|37371|lyfsjukr|||00|10000|0|10,0000|Actavis Group hf|Braun|Hýdróxyetýl sterkja||28278||28278|37371| 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|A||0|0|0|0|AUW|1|0|0|100|XEU|8399|16300|vetalmen|||27|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8399|16300| 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|2027|3680|lyfalmen|V0426|3680|00|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2027||2027|3680| 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1144|2472|lyfalmen|||00|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1144||1144|2472| 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|23026|30780|lyfsjukr|||00|20|1|0,0000|Distica|Distica - óskráð lyf|||23026||23026|30780| 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3184|4329|lyfalmen|V0003|2917|00|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríð||2501||2501|4329| 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4653|lyfalmen|V0831|4653|00|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4653| 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3530|lyfalmen|V0832|3530|00|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3530| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1141|2468|lyfalmen|V1151|2468|00|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1141||1141|2468| 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|6868|3902|lyfalmen|V2209|3902|00|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||2189||2189|3902| 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|8801|3946|lyfalmen|V2210|3946|00|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||2221||2221|3946| 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|A||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Icepharma hf|Bioglan AB|Klórhexidín|||||| 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|3295|5350|lyfalmen|V0914|3341|00|30|0|30,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||3248||3248|5350| 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|0|0|DAC|0|1|0|100|XEU|10966|12573|lyfalmen|V0915|5833|00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Flúoxetín||8528||8528|12573| 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2530|lyfalmen|||06|5|1|25,0000|Distica|Distica - óskráð lyf|||1186||1186|2530| 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|19366|26187|lyfsjukr|||02|25|0||Actavis Group hf|Braun|Flúmazeníl||19366||19366|26187| 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|18205|25207|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||18205||18205|25207| 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|100626|128168|lyfsjukr|||00|10|0||Vistor hf|AstraZeneca UK Ltd|Fulvestrant||100626||100626|128168| 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|6229|9428|lyfalmen|V0725|9428|00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||6229||6229|9428| 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|14301|20307|lyfalmen|V0726|20307|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||14301||14301|20307| 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MYL|0|1|0|100|SEK|23378|31699|lyfalmen|V0727|31699|00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||23378||23378|31699| 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|597|1326|lyfalmen|V0730|1207|10|20|0|3,3333|D.A.C. ehf|D.A.C. ehf|Tramadól||306||306|1326| 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|3047|4444|lyfalmen|V0709|4047|00|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2585||2585|4444| 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|4213|6381|lyfalmen|V0710|6199|00|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||4001||4001|6381| 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|A||0|0|E|0|AGP|0|0|0|100|XEU|8558|12549|lyfalmen|V0711|10421|00|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||8510||8510|12549| 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|689|1850|lyfalmen|V2400|1850|00|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||689||689|1850| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987|30.04.2011|R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|52907|68281|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||52907||52907|68281| 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987|30.04.2011|R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|78318|100172|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||78318||78318|100172| 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987|30.04.2011|R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|57287|73778|lyfsjukr|||02|500|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||57287||57287|73778| 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987|30.04.2011|R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|127198|161516|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||127198||127198|161516| 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13639|19476|lyfalmen|||00|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13639|19476| 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13639|19476|lyfalmen|||00|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13639|19476| 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|12998|13674|lyfalmen|V2160|13250|0|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9333||9333|13674| 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|17978|24922|lyfalmen|||0|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17978||17978|24922| 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2044|3703|lyfalmen|||00|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2044||2044|3703| 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|6598|9933|lyfalmen|||00|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6598||6598|9933| 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|0|0|AGP|0|1|0|100|XEU|1427|2859|lyfalmen|V1152|2859|00|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1427||1427|2859| 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|3198|5282|lyfalmen|V1153|5282|00|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3198||3198|5282| 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|4012|4959|lyfalmen|V2219|4950|00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||2962||2962|4959| 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|A||0|0|B|0|APC|0|0|0|100|XEU|4653|5051|lyfalmen|V2220|5041|00|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||3029||3029|5051| 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9133|8829|lyfalmen|V0736|7635|00|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5791||5791|8829| 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|SEK|17768|34290|vetalmen|||0|250|0|0,0000|Vistor hf|Boehringer Ingelheim|||||17768|34290| 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3834|6152|lyfalmen|V0139|3780|43|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3834||3834|6152| 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|1921|2772|lyfsjukr|||02|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||1921||1921|2772| 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|AZA|0|0|0|100|SEK|3123|4507|lyfsjukr|||00|50|0|0,0000|Vistor hf|AstraZeneca AB|Própófól||3123||3123|4507| 103033|N03AX1207|Gabapentin Ranbaxy|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2010||R|A||0|0|E|0|RAN|0|0|0|100|XEU|10095|13250|lyfalmen|V2160|13250|00|100|0|33,3300|Gróco ehf|Ranbaxy (UK) Ltd|Gabapentín||9023||9023|13250| 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|3604|4851|lyfalmen|V2219|4851|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||2883||2883|4851| 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|4560|4940|lyfalmen|V2220|4940|00|98|0|196,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||2948||2948|4940| 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3045|3902|lyfalmen|V0197|3902|00|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||2189||2189|3902| 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2488|2556|lyfalmen|V0507|2556|00|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||1205||1205|2556| 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|9844|9535|lyfalmen|V0508|9492|00|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||6307||6307|9535| 103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|4582|6283|lyfalmen|V0955|6283|00|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3930||3930|6283| 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|XEU|7354|6283|lyfalmen|V0956|6283|00|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3930||3930|6283| 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1872| 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||| 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|A||0|0|0|1|GEH|0|0|0|100|NOK|13805|19208|lyfsjukr|||02|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||13805||13805|19208| 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3257|5363|lyfalmen|||23|2|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3257||3257|5363| 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2240|3972|lyfalmen|||00|21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2240||2240|3972| 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8588|12655|lyfalmen|||04|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8588||8588|12655| 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|4823|7505|lyfalmen|V0300|7505|56|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4823||4823|7505| 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5458|8374|lyfalmen|||10|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5458||5458|8374| 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|133367|169258|lyfsjukr|||00|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||133367|169258| 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4418|6951|lyfalmen|V0084|6951|00|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4418||4418|6951| 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|13445|19233|lyfalmen|V0087|19233|00|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13445||13445|19233| 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A||0|0|0|0|DAC|0|0|0|100|SEK|17879|24798|lyfalmen|V0089|24798|00|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||17879||17879|24798| 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1234|2595|lyfalmen|V2200|2595|23|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1234||1234|2595| 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4096|6510|lyfalmen|||00|28|0|0,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4096||4096|6510| 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|14238|20228|lyfalmen|||00|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14238||14238|20228| 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|4721|7365|lyfalmen|||00|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4721||4721|7365| 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|A|2|0|0|0|0|NOE|0|0|0|100|DKK|16422|22969|lyfalmen|||00|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||16422||16422|22969| 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2493|4318|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2493||2493|4318| 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2947|4939|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2947||2947|4939| 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|2765|4690|lyfalmen|||63|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2765||2765|4690| 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|997|2108|lyfalmen|V0168|1940|0|100|0|100,0000|Portfarma ehf|Portfarma|Enalapríl||878||878|2108| 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|18290|24836|lyfsjukr|||00|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18290||18290|24836| 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10115|14577|lyfsjukr|||00|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10115||10115|14577| 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1630|3137|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1630||1630|3137| 107532|N02BE0106|Parasupp|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0,2000|Actavis Group hf|Actavis hf|Paracetamól|||||| 107583|N03AF0202|Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|4768|7430|lyfalmen|||00|100|0|30,0000|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||4768||4768|7430|30.04.2011 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|1601|2793|vetorma|||16|6|0|0,0000|Dýraheilsa/Icevet ehf|Icevet ehf|||||1601|2793| 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|950|2207|lyfalmen|||00|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||950||950|2207| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2916|4896|lyfalmen|||63|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2916||2916|4896| 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|3420|5586|lyfalmen|||00|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3420||3420|5586| 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|10150|14792|lyfalmen|||00|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||10150||10150|14792| 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1205|2556|lyfalmen|||24|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1205||1205|2556| 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1672|3195|lyfalmen|V0965|3195|24|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1672||1672|3195| 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|273|1273|lyfalmen|V0730|1207|00|20|0|3,3333|Actavis Group hf|Actavis hf|Tramadól||267||267|1273| 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A||0|0|E|0|ACA|0|0|1|100|IKR|1087|1907|lyfalmen|V0731|1461|00|100|0|16,6667|Actavis Group hf|Actavis hf|Tramadól||731||731|1907| 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|250|1249|lyfalmen|V0775|1249|00|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||250||250|1249| 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|957|2216|lyfalmen|V0780|2216|00|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||957||957|2216| 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25161|33936|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||25161||25161|33936| 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20143|27639|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|rykmaurar||20143||20143|27639| 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7820|11605|lyfalmen|||02|3|0|0,0000|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7820||7820|11605| 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|429|1494|lyfalmen|V0772|1494|00|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||429||429|1494| 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|413|1472|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||413||413|1472| 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|538|1643|lyfalmen|||06|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||538||538|1643| 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3LIV|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0,0000|Ísaga ehf|AGA AB|Súrefni|||||| 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1596|3091|lyfalmen|||23|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1596||1596|3091| 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4080|6489|lyfalmen|||10|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4080||4080|6489| 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|NOK|12380|17463|lyfalmen|||00|8|0|16,0000|D.A.C. ehf|D.A.C. ehf|Tadalafíl||12035||12035|17463|30.04.2011 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|777|1970|lyfalmen|||00|100|0|33,3300|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||777||777|1970| 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|22544|30652|lyfalmen|||00|1|0|1014,9254|Vistor hf|N.V. Organon|Etónógestrel||22544||22544|30652| 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|4397|6922|lyfalmen|||23|30|0|90,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||4397||4397|6922| 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8349|4861|lyfalmen|||00|12|0|84,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2890||2890|4861|30.04.2011 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|8818|12970|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8818||8818|12970| 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|26212|35255|lyfalmen|||00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||26212||26212|35255| 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|8933|13127|lyfalmen|||00|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8933||8933|13127| 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3812|6122|lyfalmen|||00|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3812||3812|6122| 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1,5|0|0|*|0|NOE|0|0|0|100|DKK|26517|35638|lyfalmen|||00|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||26517||26517|35638| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6531|9841|lyfalmen|||00|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6531||6531|9841| 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|690708|868721|lyfsjukr|||00|112|0|0,0000|Vistor hf|Novartis Europharm Ltd|Nilotiníb||690708||690708|868721| 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|737|1916|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||737||737|1916| 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|936|2188|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||936||936|2188| 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1428|2861|lyfalmen|||00|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1428||1428|2861| 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|775|1968|lyfalmen|||23|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||775||775|1968| 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|54497|70276|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||54497||54497|70276| 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|A||0|0|E|0|MSD|0|0|1|100|DKK|4282|6765|lyfalmen|||00|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4282||4282|6765| 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|2443|4249|lyfalmen|||06|5|0|0,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2443||2443|4249| 114512|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2297|4050|lyfalmen|||23|4|0|3,5000|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2297||2297|4050| 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3656|5909|lyfalmen|||0|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3656||3656|5909| 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr|||00|10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226| 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MYL|0|0|1|100|SEK|1609|3108|lyfalmen|||00|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1609||1609|3108| 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10958|15897|lyfalmen|||0|30|0|10,2300|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10958||10958|15897| 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|21919|29868|lyfalmen|||0|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||21919||21919|29868| 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3656|5909|lyfalmen|||0|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||3656||3656|5909| 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|10958|15897|lyfalmen|||0|30|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10958||10958|15897| 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|21919|29868|lyfalmen|||0|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||21919||21919|29868| 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|1966|3597|lyfalmen|V1090|3597|06|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíð||1966||1966|3597| 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3579|5803|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3579||3579|5803| 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3649|5266|lyfsjukr|||03|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3649||3649|5266| 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1907|2752|lyfsjukr|||03|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1907||1907|2752| 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10,0000|Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||| 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2693|4591|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||2693||2693|4591| 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3094|5140|lyfalmen|||0|100|0|100,0000|Vistor hf|Schering-Plough|Mómetasón||3094||3094|5140| 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|787|1984|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||787||787|1984| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|392|1444|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||392||392|1444| 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|954|2212|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||954||954|2212| 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|18355|25395|lyfalmen|||00|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18355||18355|25395| 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6255|9464|lyfalmen|||00|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6255||6255|9464| 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|6716|10095|lyfalmen|||00|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6716||6716|10095| 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|IPI|0|0|0|100|DKK|19828|27244|lyfalmen|||00|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19828||19828|27244| 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|K||0|0|0|0|WLV|0|0|0|100|DKK|8555|12610|lyfalmen|||00|0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||8555||8555|12610| 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A||0|0|*|0|LVR|0|1|0|100|DKK|35464|46867|lyfalmen|V1702|46867|00|56|0|37,3330|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||35464||35464|46867| 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|10688|20695|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||10688||10688|20695| 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|3279|5393|lyfalmen|||10|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3279||3279|5393| 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4699|7335|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4699||4699|7335| 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|15189|21422|lyfalmen|||00|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||15189|21422| 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26845|36050|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26845|36050| 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|1665|3185|lyfalmen|||10|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1665||1665|3185| 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4642|7257|lyfalmen|||00|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4642|7257| 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|46418|60614|lyfalmen|||00|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||46418|60614| 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|53690|69740|lyfalmen|||00|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||53690|69740| 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|K|1,6|0|1|0|1|JCI|0|0|0|100|SEK|68311|87613|lyfsjukr|||00|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||68311||68311|87613| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10075|17575|vetorma|||00|250|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||10075||10075|17575| 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|2381|4164|lyfalmen|||61|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2381||2381|4164| 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|5691|8692|lyfalmen|||61|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5691||5691|8692| 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BAP|0|0|0|100|SEK|8521|12564|lyfalmen|||61|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8521||8521|12564| 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7465|14506|vetalmen|||00|1200|0|0,0000|Icepharma hf|Kela Laboratoria NV|||7465||7465|14506| 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|13094|25315|vetalmen|||00|6000|0|0,0000|Icepharma hf|Kela Laboratoria NV|||13094||13094|25315| 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4147|4491|lyfalmen|V0809|4491|00|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2620||2620|4491| 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5894|5702|lyfalmen|V0810|5702|00|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3505||3505|5702| 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|22858|21604|lyfalmen|V0812|21604|00|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||15334||15334|21604| 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17462|15766|lyfalmen|V0815|15766|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||10862||10862|15766| 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1729|3273|lyfalmen|||65|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1729||1729|3273| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||00|4|0|0,0000|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13728| 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 118315|M01AB0505|Voltaren|eþ-stíll|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|390|1441|lyfalmen|||04|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||390||390|1441| 118323|M01AB0505|Voltaren|eþ-stíll|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|3566|5785|lyfalmen|||04|50|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3566||3566|5785| 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|961|2222|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||961||961|2222| 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17970|17655|lyfalmen|V0811|17655|00|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12188||12188|17655| 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|7807|11587|lyfalmen|||00|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7807||7807|11587| 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|23970|32442|lyfalmen|||00|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||23970||23970|32442| 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3070|5107|lyfalmen|V1401|5107|00|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3070||3070|5107| 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|9627|14077|lyfalmen|V1400|14077|00|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9627||9627|14077| 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|A||0|0|B|0|AEG|0|0|0|100|XEU|507|1601|lyfalmen|||00|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||507||507|1601| 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|80193|102525|lyfsjukr|||00|5|0|0,0000|Vistor hf|Amgen Europe B.V.|Panitúmúmab||80193||80193|102525| 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|435752|548751|lyfsjukr|||00|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||435752||435752|548751| 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|435752|548751|lyfsjukr|||00|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||435752||435752|548751| 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|SAL|0|0|0|100|USD|911|2154|lyfalmen|||06|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||911||911|2154| 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|49970|64595|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Lilly ICOS Limited|Pemetrexed||49970||49970|64595| 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13453|19243|lyfalmen|V1370|19243|00|28|0|14,0000|Lyfjaver ehf|Lyfjaver ehf|Galantamín||13453||13453|19243| 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A||0|0|0|0|LVR|0|0|0|100|DKK|18476|25547|lyfalmen|V1710|25547|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||18476||18476|25547| 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5778|8811|lyfalmen|||00|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5778||5778|8811| 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|8392|12112|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||8392||8392|12112| 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|353|1390|lyfalmen|||24|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||353||353|1390| 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|399|1453|lyfalmen|V0012|1452|00|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||399||399|1453| 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|1826|3405|lyfalmen|V0908|2248|00|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1826||1826|3405| 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|266|1271|lyfalmen|||00|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||266||266|1271| 121863|A07EC0204|Asacol|eþ-stíll|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3454|5632|lyfalmen|||98|30|0|10,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3454||3454|5632| 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|K||0|0|0|0|BIV|0|0|0|100|DKK|11215|19564|vetorma|||00|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||11215||11215|19564| 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|571|1688|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||571||571|1688| 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|891|2126|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||891||891|2126| 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|PCO|0|0|1|100|DKK|2206|3925|lyfalmen|||00|100|1|40,0000|Distica|Distica - óskráð lyf|Lórazepam||2206||2206|3925| 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|46343|60520|lyfalmen|||00|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||46343||46343|60520| 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|A||0|0|0|0|CHP|0|0|0|100|XEU|1891|3762|vetalmen|||00|42|0|0,0000|Icepharma hf|Chanelle Pharmaceuticals|||||1891|3762| 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|A||0|0|0|0|SBM|0|0|0|100|NOK|38680|50903|lyfalmen|||00|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||38680|50903| 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1037|2326|lyfalmen|||00|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1037||1037|2326| 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|þpakki||C09AA02|01.01.1994||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|534|1638|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||534||534|1638| 124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|1320|1905|lyfsjukr|||00|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1320||1320|1905| 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|878|2108|lyfalmen|V0168|1940|00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||878||878|2108| 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|1546|3022|lyfalmen|V0144|3022|0|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||1546||1546|3022| 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|13938|19852|lyfalmen|V1732|19852|00|100|0|11,1100|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13938||13938|19852| 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|13791|19667|lyfalmen|V1730|19667|00|100|0|22,2200|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13791||13791|19667| 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|15067|21268|lyfalmen|V1731|21268|00|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15067||15067|21268| 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||10|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|110942|141115|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||110942|141115| 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|SKB|0|0|0|100|GBP|28472|37615|lyfsjukr|||00|10|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||28472|37615| 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|26317|34910|lyfsjukr|||00|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||26317||26317|34910| 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8772|12660|lyfsjukr|||00|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8772||8772|12660| 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|48240|62424|lyfsjukr|||00|50|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||48240||48240|62424| 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|96506|122998|lyfsjukr|||00|100|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||96506||96506|122998| 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|A||0|0|0|1|CSB|0|0|0|100|SEK|192943|244026|lyfsjukr|||00|200|0|0,0000|Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||192943||192943|244026| 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|MCS|0|0|0|100|SEK|1060|2357|lyfalmen|||10|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||1060||1060|2357| 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A||0|0|0|0|DAC|0|1|0|100|XEU|3718|5993|lyfalmen|||00|28|0|14,0000|D.A.C. ehf|D.A.C. ehf|Duloxetín||3718||3718|5993|31.03.2011 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9046|6327|lyfalmen|V0810|5702|00|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3962||3962|6327| 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6285|12241|vetalmen|||0|30|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||||6285|12241| 128173|C08DA0108|Verapamil Mylan|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|903|2143|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Verapamíl||903||903|2143| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1277|2654|lyfalmen|||10|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1277||1277|2654| 128777|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4082|5891|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Baxter Medical AB|Mesna||4082||4082|5891| 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|30551|19193|lyfalmen|V0811|17655|00|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13413||13413|19193| 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|35445|23773|lyfalmen|V0812|21604|00|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||17063||17063|23773| 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|A||0|0|B|0|AUK|0|0|1|100|GBP|223|1212|lyfalmen|||00|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||223||223|1212| 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0,0000|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3196| 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4539|7116|lyfalmen|||00|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4539||4539|7116| 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|19002|23167|lyfalmen|V0726|20307|00|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16580||16580|23167| 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|30078|35302|lyfalmen|V0727|31699|00|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||26249||26249|35302| 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2389|4175|lyfalmen|||63|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2389||2389|4175| 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4143|6575|lyfalmen|||02|125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4143||4143|6575| 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|1867|3461|lyfalmen|||63|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1867||1867|3461| 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|IPI|0|0|1|100|DKK|11789|17034|lyfalmen|||0|53|0|20,6700|Icepharma hf|Pfizer Limited|Vareniclin||||11789|17034| 130772|QI10A0001|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|65428|114136|vetorma|||0|500|0|0,0000|Vistor hf|PHARMAQ AS|||||65428|114136| 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3423|5590|lyfalmen|||00|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||3423|5590| 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|483|1568|lyfalmen|||00|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||483||483|1568| 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|760|1947|lyfalmen|||00|100|0|15,0000|Vistor hf|Recip AB|||760||760|1947| 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1013|2293|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|||1013||1013|2293| 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1122|2442|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|||1122||1122|2442| 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5780|8814|lyfalmen|||23|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5780||5780|8814| 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2,5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|9206|13501|lyfalmen|||0|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||9206|13501| 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|27619|37021|lyfalmen|||0|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||27619|37021| 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BAP|0|0|0|100|SEK|92062|117897|lyfalmen|||0|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||92062|117897| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|248|1171|lyfalmen|||00|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||193||193|1171| 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|259|1262|lyfalmen|||00|28|0|9,3300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||259||259|1262| 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9615|5383|lyfalmen|||00|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3272||3272|5383| 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|7706|5341|lyfalmen|V2221|5341|00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3241||3241|5341| 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1517|2983|lyfalmen|||00|100|0|25,0000|Vistor hf|Recip AB|Kódein||1517||1517|2983| 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7940|11769|lyfalmen|||0|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7940||7940|11769| 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||23|8|0|8,0000|Icepharma hf|Norpharma a/s|Joð/pólývídón|||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|SAL|0|0|0|100|USD|1038|2327|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1038||1038|2327| 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1413|2840|lyfalmen|||23|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1413||1413|2840| 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|28882|38129|lyfsjukr|||0|0|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||28882||28882|38129| 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|38418|50097|lyfsjukr|||0|1|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||38418||38418|50097| 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|50199|64882|lyfsjukr|||0|2|0|0,0000|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||50199|64882| 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|20|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|A||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||00|50|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||| 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|8540|12590|lyfalmen|||10|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8540||8540|12590| 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|95541|121786|lyfsjukr|||00|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||95541||95541|121786| 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|1568|3052|lyfalmen|||00|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1568||1568|3052| 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|4145|6578|lyfalmen|||00|9|0||Icepharma hf|Santen Oy|Taflúprost||4145||4145|6578| 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|K||0|0|*|0|SAO|0|0|0|100|XEU|12426|17954|lyfalmen|||00|27|0||Icepharma hf|Santen Oy|Taflúprost||12426||12426|17954| 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|1634|2358|lyfsjukr|||0|5|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||1634||1634|2358| 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|3947|5697|lyfsjukr|||0|10|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||||3947|5697| 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4896|7066|lyfsjukr|||0|25|0|0,0000|Actavis Group hf|Actavis Group hf|Epírúbicín||4896||4896|7066| 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|A||0|1|0|1|BRS|0|0|0|100|DKK|72722|93149|lyfsjukr|||43|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||72722||72722|93149| 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|134742|170984|lyfsjukr|||00|30|0|0,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||134742||134742|170984| 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PER|0|0|0|100|DKK|54773|70623|lyfsjukr|||00|1|0|17,9910|Icepharma hf|Pfizer ApS|Sómatrópín||54773||54773|70623| 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|1032|2319|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1032||1032|2319| 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|0|0|GSK|0|0|0|100|GBP|2196|3911|lyfalmen|||23|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2196||2196|3911| 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|1701|3234|lyfalmen|||23|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1701||1701|3234| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|7085|10599|lyfalmen|||00|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||7085||7085|10599| 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993|30.04.2011|R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|122757|155943|lyfsjukr|||02|150|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||122757||122757|155943| 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997|30.04.2011|R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|90900|115962|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||90900||90900|115962| 136964|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|2318|3345|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||2318||2318|3345| 136975|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|7260|10478|lyfsjukr|||00|17|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||7260||7260|10478| 136987|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|5351|7723|lyfsjukr|||00|25|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||5351||5351|7723| 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|HUK|0|0|0|100|SEK|8341|12038|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Hospira UK Ltd|Paklítaxel||8341||8341|12038| 137110|L01XA0302|Oxaliplatin Hospira|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|||lyfsjukr|||00|20|0||Icepharma hf|Hospira Nordic AB|Oxalíplatín|||||| 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar samsetningar|||||1628| 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar samsetningar|||||2020| 137679|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4516|7085|lyfalmen|V0295|5445|10|100|0|100,0000|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4516||4516|7085| 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|21339|28663|lyfsjukr|||00|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21339||21339|28663| 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|2214|3195|lyfsjukr|||00|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||2214||2214|3195| 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|5511|7954|lyfsjukr|||00|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||5511||5511|7954| 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|6124|8838|lyfsjukr|||00|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6124||6124|8838| 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|546|788|lyfsjukr|||00|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||546||546|788| 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|1562|2254|lyfsjukr|||00|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1562||1562|2254| 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1753|3305|lyfalmen|||00|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1753||1753|3305| 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3089|5133|lyfalmen|||00|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3089||3089|5133| 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|141468|179425|lyfsjukr|||00|20|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||141468||141468|179425| 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|353555|445594|lyfsjukr|||00|50|0|0,0000|Vistor hf|N.V. Organon|Sugammadex||353555||353555|445594| 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1498|2957|lyfalmen|V2010|1489|00|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1498||1498|2957| 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|12120|17093|lyfsjukr|||02|10|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12120||12120|17093| 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|DES|0|0|0|100|DKK|657|948|lyfsjukr|||02|5|0|3,3333|Swedish Orphan A/S|Defiante Farmaceutica S.A.|Oxýtócín||657||657|948| 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1280|2658|lyfalmen|||03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1280||1280|2658| 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa||N01BB20|01.11.2008||R|A||0|0|0|0|DAC|0|0|1|100|SEK|3732|6013|lyfalmen|V2002|5569|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Blöndur||3732||3732|6013| 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|4563|6586|lyfsjukr|||00|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4563||4563|6586| 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|21672|29081|lyfsjukr|||00|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||21672||21672|29081| 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|2832|4781|lyfalmen|||00|30|0|1,0400|Vistor hf|Boehringer Ingelheim International |Pramipexól||2832||2832|4781| 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4834|6182|lyfalmen|||0|84|0|0,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3856||3856|6182| 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|8876|13049|lyfalmen|V2020|4805|00|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8876||8876|13049| 142059|C07AA0511|Propranolol Mylan|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|634|1775|lyfalmen|||00|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Própranólól||634||634|1775| 142190|C07AA0511|Propranolol Mylan|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MYL|0|0|0|100|SEK|729|1905|lyfalmen|||00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||729||729|1905| 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3321|4793|lyfsjukr|||02|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3321||3321|4793| 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1088|2396|lyfalmen|||70|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1088||1088|2396| 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2942|4932|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2942||2942|4932| 142596|C07AA0511|Propranolol Mylan|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1570|3055|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Própranólól||1570||1570|3055| 142928|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.09.2010||R|K||0|0|*|0|DAC|0|0|0|100|NOK|7475|7650|lyfalmen|V1989|7138|06|8|0|75,0000|D.A.C. ehf|D.A.C. ehf|Latanóprost||4929||4929|7650| 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1489|2944|lyfalmen|||03|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1489||1489|2944| 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2339|3376|lyfsjukr|||03|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2339||2339|3376| 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|ANS|0|0|1|100|XEU|1290|2672|lyfalmen|||07|5|0|0,0000|Vistor hf|Anstalt zur gewerblichen Produktion|Prednisólón||1290||1290|2672| 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3390|5545|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3390||3390|5545| 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|SAL|0|0|0|100|USD|858|2081|lyfalmen|||06|15|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíð||858||858|2081| 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|1519|2985|lyfalmen|||00|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1519||1519|2985| 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|1369|2780|lyfalmen|||00|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1369||1369|2780| 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|8689|12793|lyfalmen|||0|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8689||8689|12793| 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|625|1762|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||625||625|1762| 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1241|2605|lyfalmen|||10|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1241||1241|2605| 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|2089|3765|lyfalmen|V0429|3764|00|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2089||2089|3765| 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998|30.04.2011|R|K|3|0|1|0|1|PER|0|0|0|100|DKK|4263|6153|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Pfizer ApS|Epírúbicín||4263||4263|6153| 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998|30.04.2011|R|K|3|0|1|0|1|PER|0|0|0|100|DKK|8193|11825|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Pfizer ApS|Epírúbicín||8193||8193|11825| 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|DKK|2154|3854|lyfalmen|||10|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2154||2154|3854| 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4910|7624|lyfalmen|||51|1|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4910||4910|7624| 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998|30.04.2011|R|K|3|0|1|0|1|PER|0|0|0|100|DKK|14412|19970|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Pfizer ApS|Epírúbicín||14412||14412|19970| 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|83161|106250|lyfsjukr|||AC|2|0|22,4888|Vistor hf|Novo-Nordisk|Sómatrópín||83161||83161|106250| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|62154|79886|lyfsjukr|||AC|2|0|15,0675|Vistor hf|Novo-Nordisk|Sómatrópín||62154||62154|79886| 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|38619|50349|lyfsjukr|||AC|2|0|7,4213|Vistor hf|Novo-Nordisk|Sómatrópín||38619||38619|50349| 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|675|1831|lyfalmen|||20|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||675||675|1831| 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|308|1329|lyfalmen|||00|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||308||308|1329| 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|475|1557|lyfalmen|||00|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||475||475|1557| 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK||112248|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||87941||87941|112248| 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3287|5404|lyfalmen|||51|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3287||3287|5404| 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|2288|4037|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2288||2288|4037| 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0,0000|Vistor hf|Recip AB|Pýrvín|||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|18460|12576|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||8530||8530|12576| 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|3137|4527|lyfsjukr|||0|2|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||3137||3137|4527| 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|6373|9198|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira UK Ltd|Írinótekan||6373||6373|9198| 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|A||0|1|0|0|ELI|0|0|0|100|XEU|18572|25667|lyfalmen|||00|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18572||18572|25667| 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|886|2119|lyfalmen|||41|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||886||886|2119| 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|2601|3754|lyfsjukr|||0|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||2601||2601|3754| 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|HOP|0|0|0|100|XEU|1524|2200|lyfsjukr|||0|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Cýtarabín||1524||1524|2200| 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|116575|148661|lyfalmen|||00|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||116575||116575|148661| 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|881|2113|lyfalmen|||00|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||881||881|2113| 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|6463|9328|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||6463||6463|9328| 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|HOP|0|0|0|100|SEK|13548|18885|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Hospira Nordic AB|Vínkristín||13548||13548|18885| 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HOS|0|0|0|100|SEK|28983|38256|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28983||28983|38256| 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A||0|0|B|0|DAC|0|0|0|100|NOK|12843|18037|lyfalmen|||00|120|0|120,0000|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||12492||12492|18037|30.04.2011 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3754|7381|vetalmen|||27|25|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||3754||3754|7381| 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|SEK|2156|3857|lyfalmen|||00|75|1|18,7500|Distica|Distica - óskráð lyf|Pímózíð||2156||2156|3857| 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|K||0|0|*|0|POF|0|0|0|100|DKK|2247|2909|lyfalmen|V1989|2379|06|2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1463||1463|2909| 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|DKK|16293|22807|lyfalmen|||10|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16293||16293|22807| 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|54187|69887|lyfsjukr|||00|2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||54187|69887| 150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|3915|6263|lyfalmen|||00|28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiður-Nikótínsýra í blöndum||||3915|6263| 150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|þpakki|1000+20 mg|C10AD52|01.12.2009||R|A||0|0|0|0|MSD|0|0|0|100|DKK|6493|9789|lyfalmen|||00|56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiður-Nikótínsýra í blöndum||||6493|9789| 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3561|5779|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Meningókokka polysakkaríð mótefnavakar||||3561|5779| 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|6692|10062|lyfalmen|||02|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6692||6692|10062| 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1194|2541|lyfalmen|||05|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1194||1194|2541| 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|16481|23043|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||16481|23043| 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|50888|63178|lyfalmen|||00|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||48461||48461|63178| 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|5490|4951|lyfalmen|V0437|4925|00|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2956||2956|4951| 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|1628|3134|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1628||1628|3134| 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|2076|2996|lyfsjukr|||02|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2076||2076|2996| 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|A||0|0|0|0|DAC|0|0|0|100|IKR|2938|4530|lyfalmen|V0343|4526|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2648||2648|4530| 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||23|25|0|0,0000|Icepharma hf|Pfizer ApS|Píroxíkam|||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|4004|6385|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4004||4004|6385| 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5852|8913|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5852||5852|8913| 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10737|15595|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||10737||10737|15595| 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|19496|16663|lyfalmen|V2030|16663|00|100|0|28,0000|Lyfis ehf|Lyfis ehf|Pramipexól||11518||11518|16663| 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1279|2657|lyfalmen|||10|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1279||1279|2657| 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1832|3413|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||1832||1832|3413| 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||| 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|41153|53530|lyfsjukr|||00|1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||41153|53530| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2314|4073|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2314||2314|4073| 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1618|3121|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||1618||1618|3121| 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2346|4117|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2346||2346|4117| 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|236806|299074|lyfsjukr|||00|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||236806||236806|299074| 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|4417|6950|lyfalmen|||10|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4417||4417|6950| 153575|M01AH0104|Celebrex (D.A.C.)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2009||R|A||0|0|E|0|DAC|0|0|1|100|DKK|13523|19331|lyfalmen|||00|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Celekoxíb||13523||13523|19331|31.03.2011 153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|K|2|0|0|E|0|HEX|0|0|1|100|DKK|1625|3130|lyfalmen|||02|1|0|50,0000|Vistor hf|Hexal A/S|Hýdroxókóbalamín||1625||1625|3130| 154464|D05AX5203|Xamiol|hlaup|||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|4696|7331|lyfalmen|||00|30|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4696||4696|7331| 154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|8379|12369|lyfalmen|||00|60|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8379||8379|12369| 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3331|5464|lyfalmen|||00|30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||3331||3331|5464| 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|1094|2404|lyfalmen|||10|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1094||1094|2404| 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|3923|6274|lyfalmen|V2130|6274|10|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3923||3923|6274| 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|1579|3067|lyfalmen|V0954|3067|00|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1579||1579|3067| 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|7475|11133|lyfalmen|V0438|7851|00|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7475||7475|11133| 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|4490|6283|lyfalmen|V0955|6157|00|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3930||3930|6283| 154750|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|2474|4292|lyfalmen|V0957|4292|00|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||2474||2474|4292| 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|7206|6283|lyfalmen|V0956|6157|00|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3930||3930|6283| 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|XEU|1630|3137|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1630||1630|3137| 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|2295|4047|lyfalmen|V0709|4047|00|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2295||2295|4047| 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|3868|6199|lyfalmen|V0710|6199|00|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3868||3868|6199| 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|A||0|0|E|0|POF|0|0|0|100|XEU|6955|10421|lyfalmen|V0711|10421|00|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6955||6955|10421| 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1550|3028|lyfalmen|||00|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1550||1550|3028| 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|539|1645|lyfalmen|||00|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||539||539|1645| 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|6896|10341|lyfalmen|||00|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6896||6896|10341| 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6547|9863|lyfalmen|||00|42|0|14,0000|Icepharma hf|Roche|Orlístat||6547||6547|9863| 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|6077|9220|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||6077||6077|9220| 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|K||0|0|*|0|ELD|0|0|0|100|XEU|6128|9290|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6128||6128|9290| 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|A||0|0|0|0|REP|0|0|1|100|SEK|444|1515|lyfalmen|||00|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||444||444|1515| 156563|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|1861|2686|lyfsjukr|||00|15|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||1861||1861|2686| 156574|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|1040|1501|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||1040||1040|1501| 156585|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|3518|5077|lyfsjukr|||00|45|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||3518||3518|5077| 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|8722|12839|lyfalmen|||00|84|0|28,0000|Icepharma hf|Roche|Orlístat||8722||8722|12839| 156597|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|HOP|0|0|0|100|SEK|5581|8055|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Hospira Nordic AB|Karbóplatín||5581||5581|8055| 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|891|2126|lyfalmen|||00|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||891||891|2126| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14,0000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr||QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7549|13169|vetorma|||16|260|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||7549||7549|13169| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|DKK|514|1610|lyfalmen|||07|4|1|0,0000|Distica|Distica - óskráð lyf|||514||514|1610| 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|A||0|0|E|0|NOH|0|0|0|100|DKK|1578|3066|lyfalmen|||00|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1578||1578|3066| 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|984|2253|lyfalmen|||00|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||984||984|2253| 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|107099|136292|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||107099|136292| 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|214199|270702|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||214199|270702| 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|607355|764113|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||607355|764113| 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|54810|70669|lyfsjukr|||0|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||54810|70669| 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|78189|100010|lyfsjukr|||0|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||78189||78189|100010| 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|DES|0|0|0|100|DKK|849|2069|lyfalmen|||23|5|0|13,3333|Swedish Orphan A/S|Defiante Farmaceutica S.A.|Oxýtócín||849||849|2069| 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|1055|2351|lyfalmen|V0608|2351|10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1055|2351| 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2472|2958|lyfalmen|||00|98|0|31,0300|D.A.C. ehf|D.A.C. ehf|Metóprólól||1409||1499|2958|30.04.2011 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3498|5692|lyfalmen|V1050|5692|00|5|0|20,8333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3498||3498|5692| 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|6022|9145|lyfalmen|V1051|9145|00|5|0|41,6667|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||6022||6022|9145| 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7811|11592|lyfalmen|V1052|11592|00|5|0|62,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7811||7811|11592| 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|9102|13358|lyfalmen|V1053|13358|00|5|0|83,3333|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||9102||9102|13358| 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|5370|4728|lyfalmen|V0925|3340|00|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2793||2793|4728| 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|21022|28742|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||21022||21022|28742| 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|13770|12688|lyfalmen|||00|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8612||8612|12688| 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|1947|2631|lyfalmen|V0921|1969|00|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1260||1260|2631| 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|3371|3727|lyfalmen|V0923|1850|00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2061||2061|3727| 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|6946|4980|lyfalmen|V0927|2092|00|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2977||2977|4980| 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|477|1560|lyfalmen|||72|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||477||477|1560| 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|A||0|0|E|0|MYL|0|0|1|100|SEK|1640|3151|lyfalmen|||72|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1640||1640|3151| 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|APC|0|0|0|100|DKK|104398|132902|lyfsjukr|||00|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||104398||104398|132902| 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|2223|3948|lyfalmen|V2181|3948|00|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2223||2223|3948| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2354|3397|lyfsjukr|||02|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2354||2354|3397| 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|36847|48125|lyfsjukr|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||36847||36847|48125| 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|53650|69213|lyfsjukr|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||53650||53650|69213| 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1011|2290|lyfalmen|||00|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1011||1011|2290| 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2452|4262|lyfalmen|||42|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2452||2452|4262| 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|71572|91705|lyfsjukr|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||71572||71572|91705| 160739|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|399|1453|lyfalmen|||10|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||399|1453| 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|A||0|0|E|0|BOI|0|0|1|100|DKK|1246|2612|lyfalmen|||24|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1246||1246|2612| 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|394|1446|lyfalmen|||14|20|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||394||394|1446| 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|77167|98727|lyfsjukr|||0|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||77167||77167|98727| 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PER|0|0|1|100|DKK|616|1750|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||616||616|1750| 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|955|1378|lyfsjukr|||03|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||955||955|1378| 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|867|1251|lyfsjukr|||03|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||867||867|1251| 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|629|1768|lyfalmen|||03|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||629||629|1768| 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5136|7933|lyfalmen|||23|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5136||5136|7933| 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|62520|80822|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||62520||62520|80822| 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|2973|4291|lyfsjukr|||00|2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2973||2973|4291| 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120,0000|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|5138|7415|lyfsjukr|||00|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||5138||5138|7415| 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|15076|20803|lyfsjukr|||00|18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||15076||15076|20803| 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PER|0|0|0|100|DKK|1990|3630|lyfalmen|||00|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1990||1990|3630| 162929|G04CA0205|Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|4935|5472|lyfalmen|V0437|5472|00|100|0|100,0000|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||3337||3337|5472| 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2196|3911|lyfalmen|||24|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2196||2196|3911| 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1188|2532|lyfalmen|||00|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1188||1188|2532| 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1704|3238|lyfalmen|||41|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1704||1704|3238| 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|210|1195|lyfalmen|||0|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíð||||210|1195| 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2926|4724|lyfalmen|||24|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2790||2790|4724| 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|12042|lyfalmen|||00|454|1|10,0800|Distica|Distica - óskráð lyf|Pólýstýren súlfónat||8140||8140|12042| 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|XEU|3592|5821|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||3592||3592|5821| 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1,5|0|0|E|0|MYL|0|0|0|100|SEK|3078|5118|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3078|5118| 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|A||0|0|E|0|MYL|0|0|0|100|SEK|10149|14791|lyfalmen|||00|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||10149||10149|14791| 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|1062|2360|lyfalmen|||00|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1062||1062|2360| 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MYL|0|1|0|100|SEK|980|2248|lyfalmen|V0908|2248|00|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||980|2248| 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|7520|11194|lyfalmen|V0299|11163|98|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7520||7520|11194| 165001|C05AA0102|Proctosedyl|eþ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7185|13969|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||7185||7185|13969| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4612|7216|lyfalmen|||43|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4612||4612|7216| 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5209|8033|lyfalmen|V0324|3996|43|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5209||5209|8033| 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3362|5506|lyfalmen|V0316|2851|43|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3362||3362|5506| 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|A||0|1|0|1|EMA|0|0|0|100|SEK|273758|345449|lyfsjukr|||00|8|0|3,7500|Icepharma hf|E. Merck AB|Sómatrópín||273758||273758|345449| 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992|31.05.2011|R|A|2|0|1|E|0|PER|0|0|0|100|DKK|14786|20916|lyfalmen|||23|4|0|15,0000|Icepharma hf|Pfizer ApS|Nafarelín||14786||14786|20916| 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|36847|48125|lyfsjukr|||00|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||36847||36847|48125| 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|53650|69213|lyfsjukr|||00|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||53650||53650|69213| 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|721|1894|lyfalmen|||00|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||721||721|1894| 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|209|1193|lyfalmen|||00|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||209||209|1193| 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||| 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|71572|91705|lyfsjukr|||00|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||71572||71572|91705| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|242619|306369|lyfsjukr|||00|500|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||242619||242619|306369| 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|0||3|g|20|spr||QJ51RC22|01.02.2010||R|A||0|0|0|0|INI|0|0|0|100|DKK|4859|9503|vetalmen|||16|60|0||Icepharma hf|Intervet International B.V.|||||4859|9503| 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|1100|2412|lyfalmen|||00|10|0|1,0000|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||1100||1100|2412| 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|1923|3538|lyfalmen|||00|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1923||1923|3538| 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PER|0|0|0|100|DKK|15778|22161|lyfalmen|||23|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15778||15778|22161| 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2281|4028|lyfalmen|||10|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2281||2281|4028| 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|4319|6816|lyfalmen|||10|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4319||4319|6816| 166709|G04CA0103|Alfuzosin Ranbaxy|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|5076|7851|lyfalmen|V0438|7851|00|90|0|120,0000|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||5076||5076|7851| 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|A||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||00|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||| 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|A||0|0|0|0|AGP|0|0|0|100|XEU|467|1546|lyfalmen|V0953|1546|00|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||467||467|1546| 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|611|1743|lyfalmen|||00|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||611|1743| 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|A||0|0|E|0|AGP|0|0|0|100|IKR|4762|6926|lyfalmen|||00|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||4400||4400|6926| 168739|C07AB0209|Metoprolol Actavis|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.12.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|1069|2370|lyfalmen|V0091|2370|00|100|0|15,8300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||1069||1069|2370| 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3169|5242|lyfalmen|V0789|5241|10|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3169||3169|5242| 168750|C07AB0209|Metoprolol Actavis|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|1773|2914|lyfalmen|V2003|2914|00|98|0|31,0300|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||1467||1467|2914| 168761|C07AB0209|Metoprolol Actavis|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.09.2009||R|A||0|0|B|0|AGP|0|0|0|100|XEU|2783|4368|lyfalmen|V2004|4368|00|98|0|62,0700|Actavis Group hf|Actavis Group PTC ehf|Metóprólól||2530||2530|4368| 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1245|2610|lyfalmen|||10|30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1245||1245|2610| 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5849|8909|lyfalmen|V0713|8909|10|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5849||5849|8909| 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|55462|71487|lyfsjukr|||00|10|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||55462||55462|71487| 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|241138|304511|lyfsjukr|||00|50|0|0,0000|Vistor hf|Pierre Fabre Pharma|Vínorelbín||241138||241138|304511| 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|22532|30160|lyfsjukr|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||22532||22532|30160| 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5232|8064|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5232||5232|8064| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|1407|2755|lyfalmen|V0409|2755|67|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2755| 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|A||0|1|C|0|POF|0|0|0|30|IKR|2450|4125|lyfalmen|V0410|4125|67|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4125| 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2505|lyfalmen|V0526|2505|00|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2505| 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1792|lyfalmen|V0522|1792|00|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1792| 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1780|lyfalmen|V0518|1780|00|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1780| 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1445|lyfalmen|V0514|1445|00|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1445| 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3034|5058|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3034||3034|5058| 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3266|5375|lyfalmen|||02|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3266||3266|5375| 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|25224|33539|lyfsjukr|||00|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||25224|33539| 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|62603|80449|lyfsjukr|||00|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||62603|80449| 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5007|7757|lyfalmen|||00|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5007||5007|7757| 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|118334|150392|lyfsjukr|||00|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||118334||118334|150392| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|4050|6448|lyfalmen|||59|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||4050||4050|6448| 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|7089|10605|lyfalmen|||59|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||7089||7089|10605| 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2483|4304|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||2483||2483|4304| 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|11882|16794|lyfsjukr|||00|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11882||11882|16794| 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|28583|37754|lyfsjukr|||00|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||28583||28583|37754| 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|A||0|0|0|1|BRA|0|0|0|100|XEU|42874|55689|lyfsjukr|||00|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||42874||42874|55689| 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|3489|4909|lyfalmen|V0718|4909|00|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2925||2925|4909| 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|A||0|0|E|0|POF|0|0|0|100|IKR|12363|4326|lyfalmen|V0719|4326|00|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4326| 170997|L01BC0701|Vidaza|irþ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|A||0|1|0|1|CEE|0|0|0|100|XEU|59844|76987|lyfsjukr|||00|4|0|0,0000|Celgene Europe ltd|Celgene Europe ltd|Azasitidín||59844||59844|76987| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3761|6052|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||3761||3761|6052| 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|4052|6450|lyfalmen|||17|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|||4052||4052|6450| 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|NOK|1581|3070|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||1581||1581|3070| 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4592|7189|lyfalmen|V0709|4047|00|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4592||4592|7189| 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|7558|11246|lyfalmen|V0710|6199|00|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7558||7558|11246| 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|43681|56702|lyfsjukr|||02|75|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||43681||43681|56702| 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|29121|38429|lyfsjukr|||02|50|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||29121||29121|38429| 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|13650|19490|lyfalmen|V0711|10421|00|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13650||13650|19490| 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|25617|34509|lyfalmen|||00|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||25617||25617|34509| 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|66979|85941|lyfsjukr|||02|100|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||66979||66979|85941| 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|31193|33677|lyfalmen|V1375|33677|00|112|0|74,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||24954||24954|33677| 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|1|*|0|GSK|0|0|0|100|XEU|3628|5870|lyfalmen|||00|100|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||3628||3628|5870| 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|11951|17256|lyfalmen|||00|98|0|0,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||11951||11951|17256| 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6607|9945|lyfalmen|||10|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6607||6607|9945| 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|12274|17763|lyfalmen|||10|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||12274||12274|17763| 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|21295|29085|lyfalmen|||10|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||21295||21295|29085| 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2381|4164|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2381||2381|4164| 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2381|4164|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2381||2381|4164| 172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|XEU|848|2067|lyfalmen|V0720|2067|00|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||848||848|2067| 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|25141|33911|lyfalmen|||10|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||25141||25141|33911| 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|445|1516|lyfalmen|V0901|1516|00|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||445||445|1516| 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|2962|4959|lyfalmen|||00|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríð||2962||2962|4959| 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3602| 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|6322|9556|lyfalmen|||00|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríð||6322||6322|9556| 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1074|2377|lyfalmen|||00|10|0|10,0000|Vistor hf|Meda AS|Tenoxíkam||1074||1074|2377| 173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|363|1404|lyfalmen|||00|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||363||363|1404| 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|3020|5039|lyfalmen|||00|250|1|13,8889|Distica|Distica - óskráð lyf|Pyridostigmin||3020||3020|5039| 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|SEK|13226|18958|lyfalmen|||00|150|1|50,0000|Distica|Distica - óskráð lyf|Pyridostigmin||13226||13226|18958| 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1429|2062|lyfsjukr|||02|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1429||1429|2062| 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|693|1855|lyfalmen|||00|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||693||693|1855| 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|709|1877|lyfalmen|||00|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||709||709|1877| 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1831|3412|lyfalmen|||00|5|0|25,0000|Vistor hf|Allergan|Brímónidín||1831||1831|3412| 174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|268|1274|lyfalmen|V0886|1264|00|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||268|1274| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5371|8255|lyfalmen|||00|15|0|150,0000|Vistor hf|Allergan|Brímónidín||5371||5371|8255| 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2488|2594|lyfalmen|V0507|2556|00|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||1233||1233|2594| 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|6892|5045|lyfalmen|V0809|4491|00|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3025||3025|5045| 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|3578|5802|lyfalmen|||00|20|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||3578||3578|5802| 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|830|2043|lyfalmen|||43|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||830||830|2043| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|658|1309|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||658||658|1309| 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|610|1742|lyfalmen|||03|1|1|5,3330|Distica|Distica - óskráð lyf|Tríamcínólón||610||610|1742| 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK||219423|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||173339||173339|219423| 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10478|15032|lyfsjukr|||00|60|0|0,0000|Vistor hf|N.V. Organon|Rókúrón, brómíð||10478||10478|15032| 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|A||0|1|0|1|WIL|0|0|0|100|XEU|135281|171660|lyfsjukr|||00|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||135281||135281|171660| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|5820|8869|lyfalmen|||10|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5820||5820|8869| 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|828|2040|lyfalmen|||30|5|0|0,0000|Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||828||828|2040| 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989|30.04.2011|R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|751|1935|lyfalmen|||01|100|0|2,5000|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||751||751|1935| 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAI|0|0|0|100|IKR|||lyflausa|||23|50|0|5,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|7739|15033|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer vet.|||7739||7739|15033| 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|10160|14633|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||10160||10160|14633| 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|38353|50016|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||38353||38353|50016| 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|5069|9906|vetalmen|||16|100|0|0,0000|Vistor hf|Intervet International BV|||5069||5069|9906| 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5603|10931|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||5603||5603|10931| 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1235|2597|lyfalmen|||00|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1235||1235|2597| 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|845|2063|lyfalmen|||41|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||845||845|2063| 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|503|1595|lyfalmen|||08|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||503||503|1595| 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1643|2050|lyfalmen|||08|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2050| 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|638|1780|lyfalmen|||00|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||638||638|1780| 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|5061|7831|lyfalmen|V0300|7505|98|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5061||5061|7831| 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|22580|30697|lyfalmen|||00|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||22580||22580|30697| 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|57387|74380|lyfalmen|V0563|63477|00|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||57387||57387|74380| 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1214|2568|lyfalmen|||00|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1214||1214|2568| 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|5474|8396|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5474||5474|8396| 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5491|8419|lyfalmen|||00|100|1|20,0000|Distica|Distica - óskráð lyf|||5491||5491|8419| 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3048|5077|lyfalmen|||00|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3048||3048|5077| 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|USD|1865|3459|lyfalmen|||00|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||1865||1865|3459| 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7440|10738|lyfsjukr|||00|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7440||7440|10738| 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|2592|4453|lyfalmen|||03|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2592||2592|4453| 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|1067|2367|lyfalmen|||03|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1067||1067|2367| 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PER|0|0|1|100|DKK|516|1613|lyfalmen|||03|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||516||516|1613| 190702|M01AB0101|Confortid|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|655|1803|lyfalmen|||04|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||655||655|1803| 190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|454|1528|lyfalmen|||04|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||454||454|1528| 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4013|5792|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||4013||4013|5792| 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|3824|5519|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3824||3824|5519| 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|3945|5694|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|||3945||3945|5694| 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|4,6875|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A||0|0|E|0|PER|0|0|1|100|DKK|542|1649|lyfalmen|||07|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||542||542|1649| 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1670|3192|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1670||1670|3192| 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|465|1543|lyfalmen|||10|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||465||465|1543| 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|21,6000|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2162| 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|898|2136|lyfalmen|||02|50|0|2,5091|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||898||898|2136| 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|PER|0|0|0|100|DKK|1106|1596|lyfsjukr|||02|2|0|0,0000|Icepharma hf|Pfizer ApS|Metótrexat||1106||1106|1596| 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2136|3829|lyfalmen|||00|100|0|16,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2136||2136|3829| 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1885|3486|lyfalmen|||00|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1885||1885|3486| 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2001|3645|lyfalmen|||03|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2001||2001|3645| 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|694|1857|lyfalmen|||03|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||694||694|1857| 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|A||0|1|0|1|EMA|0|0|0|100|SEK|91253|116405|lyfsjukr|||00|2|0|1,2500|Icepharma hf|E. Merck AB|Sómatrópín||91253||91253|116405| 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|K||0|1|0|1|CEO|0|0|0|100|DKK||219423|lyfsjukr|||00|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||173339||173339|219423| 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|776|1969|lyfalmen|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur||776||776|1969| 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|398|1452|lyfalmen|||10|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||398||398|1452| 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|843|2061|lyfalmen|||10|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||843||843|2061| 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|2409|4203|lyfalmen|||00|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2409||2409|4203| 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1500|2959|lyfalmen|||23|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1500||1500|2959| 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|þpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|27610|36533|lyfsjukr|||00|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||27610|36533| 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2656|5272|vetalmen|||27|10|0|0,0000|Icepharma hf|Intervet International B.V.|||2656||2656|5272| 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|12647|24457|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||12647||12647|24457| 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60,0000|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6199| 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|791|1989|lyfalmen|||06|10|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||791||791|1989| 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|884|2117|lyfalmen|||00|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||884||884|2117| 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|2895|4868|lyfalmen|||00|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2895||2895|4868| 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2229|3957|lyfalmen|||00|100|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2229||2229|3957| 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|XEU|2192|3906|lyfalmen|||00|25|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||2192||2192|3906| 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PER|0|0|0|100|DKK|7410|10694|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Pfizer ApS|Flúóróúracíl||7410||7410|10694| 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|421|608|lyfsjukr|||02|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||421||421|608| 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|37238|49093|lyfalmen|||00|100|0|0,0000|Icepharma hf|Pfizer ApS|Estramústín||37238||37238|49093| 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PER|0|0|1|100|DKK|653|1801|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||653||653|1801| 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|97247|123927|lyfsjukr|||00|1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||97247|123927| 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|4821|7502|lyfalmen|||44|8|0|4,0000|Icepharma hf|Pfizer ApS|Kabególín||4821||4821|7502| 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|58184|74903|lyfsjukr|||00|5|0|0,4000|Icepharma hf|Centocor -|Abciximab||58184||58184|74903| 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|5250|7921|lyfalmen|||00|60|1|12,0000|Distica|Distica - óskráð lyf|||5127||5127|7921| 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|592|854|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||592||592|854| 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989|30.04.2011|R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|21561|28942|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||21561||21561|28942| 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|DKK|606|875|lyfsjukr|||03|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||606||606|875| 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||10111| 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|1801|3371|lyfalmen|||00|30|0|3,7500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||1801||1801|3371| 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|6442|9720|lyfalmen|V0104|9720|00|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||6442||6442|9720| 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3777|6074|lyfalmen|||00|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3777||3777|6074| 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|108162|137626|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||108162||108162|137626| 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|215726|272619|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||215726||215726|272619| 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|556228|699949|lyfsjukr|||00|1|0|0,0000|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||556228||556228|699949| 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2590|4450|lyfalmen|||23|66|0|88,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2590||2590|4450| 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|19379|26680|lyfalmen|V0105|26680|00|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||19379||19379|26680| 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4021|6408|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4021||4021|6408| 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|6642|9993|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6642||6642|9993| 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|0|0|GSK|0|0|0|100|GBP|9169|13450|lyfalmen|||23|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9169||9169|13450| 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1632|3140|lyfalmen|||44|2|0|1,0000|Icepharma hf|Pfizer ApS|Kabególín||1632||1632|3140| 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|SEK|702|1868|lyfalmen|||00|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||702||702|1868| 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|4757|7415|lyfalmen|||00|30|0|30,0000|Vistor hf|Yamanouchi Europe|Tamsúlósín||4757||4757|7415| 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11216|16250|lyfalmen|||00|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11216||11216|16250| 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||00|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992|31.03.2011|R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2827|4775|lyfalmen|||23|15|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||2827||2827|4775| 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|9139|13409|lyfalmen|||00|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9139||9139|13409| 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|10846|15744|lyfalmen|||00|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10846||10846|15744| 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|12672|18263|lyfalmen|||00|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12672||12672|18263| 376246|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|þpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|18952|26144|lyfalmen|||0|100|0||Vistor hf|AstraZeneca AB|Ticagrelor||18952||18952|26144| 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|21023|28743|lyfalmen|||00|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||21023||21023|28743| 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A||0|1|*|0|ASP|0|0|0|100|XEU|96329|123252|lyfalmen|||00|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||96329||96329|123252| 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4429|6966|lyfalmen|||63|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4429||4429|6966| 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|10863|10159|lyfalmen|V0508|9967|00|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6763||6763|10159| 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|118777|150948|lyfsjukr|||00|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||118777||118777|150948| 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|167349|211905|lyfsjukr|||00|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||167349||167349|211905| 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|211883|267796|lyfsjukr|||00|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||211883||211883|267796| 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1559|3040|lyfalmen|||00|12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1559||1559|3040| 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1928|3545|lyfalmen|||00|12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1928||1928|3545| 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996|31.03.2011|R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|29586|39013|lyfsjukr|||00|0|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||29586||29586|39013| 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996|31.03.2011|R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|114381|145431|lyfsjukr|||00|2|0|0,0000|Vistor hf|Aventis Pharma SA|Docetaxel||114381||114381|145431| 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001|30.04.2011|R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6078|9222|lyfalmen|||17|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6078||6078|9222| 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5790|8828|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5790||5790|8828| 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|14705|10783|lyfalmen|V0098|10783|00|12|0|12,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||7219||7219|10783| 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7168|10713|lyfalmen|||00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7168||7168|10713| 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|1329|2318|vetorma|||00|2|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||1329|2318| 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8005|13964|vetorma|||00|20|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||8005||8005|13964| 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120,0000|Actavis Group hf|Actavis hf|Ketókónazól|||||| 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|A||0|0|0|0|LYF|0|0|0|100|XEU|6372|7955|lyfalmen|||00|8|0|16,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||5152||5152|7955| 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|AZA|0|0|0|100|SEK|59190|76643|lyfalmen|V0566|52405|00|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||59190||59190|76643| 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|757|1506|vetalmen|||00|100|0|0,0000|Icepharma hf|Icepharma hf|||757||757|1506| 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|CEP|0|0|0|100|DKK|183916|232697|lyfsjukr|||00|200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||183916||183916|232697| 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3408|5569|lyfalmen|V2002|5569|00|25|0|5,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||3408||3408|5569| 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|4295|6783|lyfalmen|||00|30|0|30,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||4295||4295|6783| 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur|||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|8335|12309|lyfalmen|||23|20|0|0,0000|Vistor hf|AstraZeneca A/S DK|Blöndur||8335||8335|12309| 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.06.2011||R|A|2|0|0|E|0|APC|0|0|0|100|IKR|805|2009|lyfalmen|V2182|2009|00|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||805||805|2009| 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4965|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4965| 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2459|4271|lyfalmen|V0388|4271|23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2459||2459|4271| 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2247|3981|lyfalmen|||23|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2247||2247|3981| 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|713|1883|lyfalmen|V0408|1883|00|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||713||713|1883| 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|659|1809|lyfalmen|||00|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||659||659|1809| 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989|30.04.2011|R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|377709|475907|lyfsjukr|||02|4000|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||377709||377709|475907| 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1005|2282|lyfalmen|||00|3|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1005||1005|2282| 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5219|4400|lyfalmen|V0097|4400|00|4|0|4,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2553||2553|4400| 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|5407|4805|lyfalmen|V2020|4805|00|100|0|7,2000|Lyfis ehf|Lyfis ehf|Pramipexól||2849||2849|4805| 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3029|5051|lyfalmen|||01|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||3029||3029|5051| 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|7259|10837|lyfalmen|V2142|10837|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7259||7259|10837| 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|2867|4829|lyfalmen|||00|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2867||2867|4829| 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|13989|19916|lyfalmen|V2140|19914|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13989||13989|19916| 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2744|4661|lyfalmen|||00|50|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín||2744||2744|4661| 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|A||0|0|0|1|GEH|0|0|0|100|NOK|242619|306369|lyfsjukr|||00|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||242619||242619|306369| 392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|flaska||A04AA01|01.08.2009||R|A||0|0|E|0|PCO|0|0|0|100|IKR|12000|17419|lyfalmen|||00|50|1||Distica|Distica - óskráð lyf|Ondansetrón||||12000|17419| 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5206|10169|vetalmen|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5206||5206|10169| 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||| 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|NOK|28923|38658|lyfalmen|V1301|37886|00|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28923||28923|38658| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|174727|221165|lyfsjukr|||02|300|0|0,0000|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||174727||174727|221165| 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|10269|14770|lyfsjukr|||00|60|0|0,0000|Icepharma hf|Roche|Capecitabín||10269||10269|14770| 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|58876|75772|lyfsjukr|||00|120|0|0,0000|Icepharma hf|Roche|Capecitabín||58876||58876|75772| 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|6566|4632|lyfalmen|V1091|4594|00|28|0|28,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||2723||2723|4632| 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3253|lyfalmen|V0703|3253|00|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1715||1715|3253| 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|9360|13711|lyfalmen|||02|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9360||9360|13711| 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|41623|54119|lyfsjukr|||00|2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||41623||41623|54119| 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1517|2983|lyfalmen|||06|8|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1517||1517|2983| 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0,0000|Actavis Group hf|Actavis hf|Blöndur|||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5345|8219|lyfalmen|||10|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5345||5345|8219| 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|232|1225|lyfalmen|||00|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||232||232|1225| 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|421|1483|lyfalmen|||00|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||421||421|1483| 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PER|0|0|1|100|DKK|201|1182|lyfalmen|||00|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||201||201|1182| 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|A||0|0|E|0|AZA|0|0|0|100|SEK|11000|15955|lyfalmen|||0|56|0||Vistor hf|AstraZeneca AB|Ticagrelor||11000||11000|15955| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|787|1984|lyfalmen|||00|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||787||787|1984| 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1259|2630|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1259||1259|2630| 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2612|lyfalmen|||00|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2612| 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3643|lyfalmen|||00|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3643| 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|677|1833|lyfalmen|||51|0|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||677||677|1833| 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1650|3282|vetalmen|||58|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1650||1650|3282| 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|21399|24919|lyfalmen|V2232|24919|00|100|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||17976||17976|24919| 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5330|10407|vetalmen|||27|20|0|0,0000|Vistor hf|Intervet International BV|||5330||5330|10407| 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6087|9234|lyfalmen|||10|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||6087||6087|9234| 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1448|2888|lyfalmen|||06|14|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1448||1448|2888| 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0,0000|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||1818| 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|67551|86659|lyfsjukr|||02|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||67551||67551|86659| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|650|938|lyfsjukr|||02|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||650||650|938| 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1746|3296|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1746||1746|3296| 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|18614|25720|lyfalmen|||00|5|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||18614||18614|25720| 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|18432|25492|lyfalmen|||00|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18432||18432|25492| 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813| 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|21031|28753|lyfalmen|||00|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21031||21031|28753| 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|21388|29201|lyfalmen|||00|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21388||21388|29201| 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|20841|28515|lyfalmen|||00|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20841||20841|28515| 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||02|500|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901| 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|62838|81221|lyfalmen|||00|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||62838||62838|81221| 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|70635|91006|lyfalmen|||00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||70635||70635|91006| 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|76146|97923|lyfalmen|||00|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||76146||76146|97923| 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|6381|9636|lyfalmen|||00|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6381||6381|9636| 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2245|3978|lyfalmen|||00|100|0|50,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2245||2245|3978| 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|1|100|DKK|174|1145|lyfalmen|||00|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||174||174|1145| 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PER|0|0|0|100|DKK|378|1424|lyfalmen|||00|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||378||378|1424| 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2978|4981|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2978||2978|4981| 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2335|4102|lyfalmen|||20|100|0|100,0000|Vistor hf|Schering-Plough|Betametasón||2335||2335|4102| 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PER|0|0|1|100|DKK|4431|6969|lyfalmen|||08|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4431||4431|6969| 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3854|6179|lyfalmen|||00|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3854||3854|6179| 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4351|6859|lyfalmen|||23|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4351||4351|6859| 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|12905|18555|lyfalmen|||00|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12905||12905|18555| 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|3078|5118|lyfalmen|||00|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3078||3078|5118| 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|10982|21260|vetalmen|||27|120|0|0,0000|Vistor hf|Pharmaxim Sweden AB|||10982||10982|21260| 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1694|lyfalmen|||00|100|0|33,3333|Actavis Group hf|Actavis hf|Atenólól||477||575|1694|30.04.2011 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|0|0|BII|0|0|0|100|DKK|10457|15212|lyfalmen|||00|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10457||10457|15212| 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1167|2504|lyfalmen|||00|20|0|10,0000|Vistor hf|Recip AB|Klórókín||1167||1167|2504| 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|797|1998|lyfalmen|||23|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Tretínóín||797||797|1998| 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MYL|0|0|1|100|SEK|698|1862|lyfalmen|||00|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||698||698|1862| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|4297|6202|lyfsjukr|||02|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4297||4297|6202| 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|24741|32932|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||24741||24741|32932| 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1604|3102|lyfalmen|||67|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1604||1604|3102| 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7532|11211|lyfalmen|||98|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7532||7532|11211| 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|AZA|0|0|0|100|SEK|23319|31625|lyfalmen|V0564|31622|00|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||23319||23319|31625| 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3805|5492|lyfsjukr|||00|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3805||3805|5492| 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10383|20109|vetalmen|||02|100|0|0,0000|Vistor hf|Merial|||10383||10383|20109| 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MYL|0|0|0|100|SEK|3504|5701|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3504||3504|5701| 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|A||0|0|*|0|MYL|0|0|0|100|SEK|4305|6796|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4305||4305|6796| 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|29540|39432|lyfalmen|V0376|38098|00|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||29540||29540|39432| 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|DKK|2222|3947|lyfalmen|||00|2|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2222||2222|3947| 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|3949|6309|lyfalmen|||00|90|0|54,0000|Icepharma hf|Servier|Indapamíð||3949||3949|6309| 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1370|2781|lyfalmen|||00|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1370||1370|2781| 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14787|20851|lyfalmen|V0011|20229|00|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||14734||14734|20851| 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|1969|3601|lyfalmen|||05|15|0|15,0000|Vistor hf|Novo-Nordisk|Estradíól||1969||1969|3601| 416222|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|3036|5060|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||3036||3036|5060| 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|9846|9789|lyfalmen|V2219|4851|00|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||6493||6493|9789| 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|PCO|0|0|0|100|GBP|4957|7688|lyfalmen|||00|300|1|15,0000|Distica|Distica - óskráð lyf|Ranitidín||4957||4957|7688| 416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.03.2011||R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|5084|7337|lyfsjukr|||00|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||5084||5084|7337| 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3002|5014|lyfalmen|||23|10|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||3002||3002|5014| 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|25241|34037|lyfalmen|||23|150|0|0,0000|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||25241||25241|34037| 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1264|2636|lyfalmen|||00|30|0|30,0000|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1264||1264|2636| 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|VII|0|0|0|100|GBP|40495|52704|lyfsjukr|||00|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||40495||40495|52704| 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4921|7639|lyfalmen|||10|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4921||4921|7639| 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1660|3178|lyfalmen|||20|50|0|50,0000|Vistor hf|Schering-Plough|Betametasón||1660||1660|3178| 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|7497|11163|lyfalmen|V0299|11163|00|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7497||7497|11163| 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2020|4018|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2020||2020|4018| 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2623|5209|vetalmen|||13|200|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||2623||2623|5209| 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|3450|5627|lyfalmen|||10|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3450||3450|5627| 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7378|11000|lyfalmen|||10|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7378||7378|11000| 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|DKK|54169|69865|lyfsjukr|||00|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||54169||54169|69865| 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|41105|53469|lyfsjukr|||00|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||41105||41105|53469| 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|818|2026|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||818||818|2026| 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PER|0|0|1|100|DKK|12506|18054|lyfalmen|||02|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12506||12506|18054| 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1547|3024|lyfalmen|V0144|3022|70|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1547||1547|3024| 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1554|3033|lyfalmen|V2005|2304|00|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1554||1554|3033| 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3552|5433|lyfalmen|V2004|4368|43|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3308||3308|5433| 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6121|9281|lyfalmen|||43|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6121||6121|9281| 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|4911|7625|lyfalmen|||49|100|0|50,0000|Vistor hf|Meda AS|Brómókriptín||4911||4911|7625| 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|1682|2934|vetorma|||16|24|0|0,0000|Icepharma hf|Intervet International B.V.|||||1682|2934| 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MYL|0|0|0|100|SEK|828|2040|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||828||828|2040| 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|19309|26592|lyfalmen|||52|100|0|25,0000|Vistor hf|Meda AS|Brómókriptín||19309||19309|26592| 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|2|0|0,5000|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|3037|5062|lyfalmen|V0555|1678|10|2|0|1,5000|Icepharma hf|Pfizer ApS|Flúkónazól||3037||3037|5062| 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|693|1855|lyfalmen|||00|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||693||693|1855| 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|905|2145|lyfalmen|||00|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||905||905|2145| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2667| 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|892|2128|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||892||892|2128| 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1024|2308|lyfalmen|||20|30|0|30,0000|Vistor hf|Schering-Plough|Mómetasón||1024||1024|2308| 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|K||0|1|0|1|SAR|0|0|0|100|SEK|50819|65660|lyfsjukr|||00|2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50819||50819|65660| 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992|31.05.2011|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|515|1612|lyfalmen|||23|14|0|1,7500|Vistor hf|Astellas Pharma A/S|Amoxicillín||515||515|1612| 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992|31.05.2011|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|786|1983|lyfalmen|||23|14|0|3,5000|Vistor hf|Astellas Pharma A/S|Amoxicillín||786||786|1983| 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1154|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Atenólól||180||180|1154| 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|28687|28619|lyfalmen|||00|112|0|37,3300|Lyfis ehf|Lyfis ehf|Rívastigmín||20924||20924|28619| 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4385|6906|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4385||4385|6906| 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|43149|56511|lyfalmen|||AC|5|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||43149||43149|56511| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|4237|6703|lyfalmen|||00|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4237||4237|6703| 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1748|2523|lyfsjukr|||02|50|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||1748||1748|2523| 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1496|2159|lyfsjukr|||02|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1496||1496|2159| 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|3969|7794|vetalmen|||27|100|0|0,0000|Vistor hf|Intervet International BV|||3969||3969|7794| 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|A||0|0|0|0|LYF|0|0|0|100|XEU|5597|4766|lyfalmen|V0099|4766|00|4|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2821||2821|4766| 430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2545|4389|lyfalmen|||02|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2545||2545|4389| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|789|1987|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||789||789|1987| 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1196|2543|lyfalmen|||00|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíð dínítrat||1196||1196|2543| 431495|L01CD0201|Taxotere|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|A||0|1|0|1|AVS|0|0|0|100|NOK|237750|300259|lyfsjukr|||00|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||237750||237750|300259| 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|1466|2913|lyfalmen|||00|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1466|2913| 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|A||0|0|E|0|PER|0|0|1|100|DKK|4971|7707|lyfalmen|||00|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4971||4971|7707| 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1180|2522|lyfalmen|||00|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1180||1180|2522| 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11469|16596|lyfalmen|||0|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11469||11469|16596| 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2572|4426|lyfalmen|||00|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2572||2572|4426| 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|5872|8940|lyfalmen|||00|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5872||5872|8940| 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|8963|13168|lyfalmen|||00|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8963||8963|13168| 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|1178|2055|vetorma|||99|10|0|0,0000|Icepharma hf|Intervet International B.V.|||||1178|2055| 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|MCS|0|0|1|100|SEK|921|2167|lyfalmen|||20|50|0|50,0000|Vistor hf|McNeil Sweden AB|Blöndur||921||921|2167| 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|MEB|0|0|1|100|DKK|6016|9137|lyfalmen|||00|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6016||6016|9137| 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|MEB|0|0|1|100|DKK|6016|9137|lyfalmen|||00|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||6016||6016|9137| 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|XEU|10669|15502|lyfalmen|V0915|5833|00|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10669||10669|15502| 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6896|10341|lyfalmen|||00|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6896||6896|10341| 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4785|7453|lyfalmen|||00|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4785||4785|7453| 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|8510|11063|lyfalmen|V0725|9428|00|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7424||7424|11063| 435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|þpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|3481|5669|lyfalmen|||00|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||3481||3481|5669| 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2879|4846|lyfalmen|||00|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíð dínítrat||2879||2879|4846| 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|3668|5925|lyfalmen|||00|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||3668||3668|5925| 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|10179|14832|lyfalmen|V2221|5341|00|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||10179||10179|14832| 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||10|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|768|1958|lyfalmen|||20|15|0|15,0000|Vistor hf|LEO Pharma A/S|Fúsidínsýra||768||768|1958| 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|983|2252|lyfalmen|||00|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||983||983|2252| 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3597|5828|lyfalmen|||00|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3597||3597|5828| 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|21773|14012|lyfalmen|V0090|14012|00|100|0|100,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||9580||9580|14012| 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998|31.03.2011|R|A|3|0|0|0|0|PER|0|1|0|100|DKK|11493|16629|lyfalmen|||00|100|0|75,0000|Icepharma hf|Pfizer ApS|Venlafaxín||11493||11493|16629| 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|6393|9653|lyfalmen|V0957|4292|00|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6393||6393|9653| 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|742|1922|lyfalmen|||00|20|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|||742||742|1922| 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|1147|2476|lyfalmen|||00|10|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1147||1147|2476| 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|3349|5489|lyfalmen|V0954|3067|00|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3349||3349|5489| 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|11516|16661|lyfalmen|V0955|6157|00|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11516||11516|16661| 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|0|0|PER|0|1|0|100|DKK|21864|29799|lyfalmen|V0956|6157|00|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||21864||21864|29799| 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998|31.03.2011|R|A|3|0|0|0|0|PER|0|1|0|100|DKK|19485|26813|lyfalmen|||00|100|0|150,0000|Icepharma hf|Pfizer ApS|Venlafaxín||19485||19485|26813| 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|1951|3576|lyfalmen|||00|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1951||1951|3576| 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6142|9309|lyfalmen|V0984|3204|00|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||6142||6142|9309| 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|170663|216065|lyfsjukr|||00|3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||170663||170663|216065| 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2248|3983|lyfalmen|||66|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2248||2248|3983| 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8792|12934|lyfalmen|||00|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||8792||8792|12934| 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2366|lyfalmen|||00|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2366| 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1536|2217|lyfsjukr|||00|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1536||1536|2217| 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2424|3498|lyfsjukr|||00|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2424||2424|3498| 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PER|0|0|0|100|DKK|960|2221|lyfalmen|V0221|2221|00|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||960||960|2221| 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1292|2675|lyfalmen|||20|30|0|30,0000|Vistor hf|Janssen-Cilag AB|Blöndur||1292||1292|2675| 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0,0000|Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1025|2310|lyfalmen|||00|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1025||1025|2310| 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995|30.04.2011|R|A|5|0|1|0|1|VII|0|0|0|100|GBP|23412|31265|lyfsjukr|||61|40|0|16,6667|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Zídóvúdín||23412||23412|31265| 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3576|5799|lyfalmen|||02|1|0|1,0000|Vistor hf|Novo-Nordisk|Glúkagon||3576||3576|5799| 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|27261|36572|lyfalmen|||10|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||27261||27261|36572| 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998|31.03.2011|R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|45244|58664|lyfsjukr|||00|56|0|21,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||45244||45244|58664| 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998|31.03.2011|R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|45891|59476|lyfsjukr|||00|56|0|28,0000|Vistor hf|Bristol-Myers Squibb|Stavúdín||45891||45891|59476| 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|0|0|ELI|0|1|0|100|DKK|3241|5341|lyfalmen|V0914|3341|00|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3241||3241|5341| 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2264|4004|lyfalmen|||00|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2264||2264|4004| 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|15607|21469|lyfsjukr|||00|2|0|0,3300|Icepharma hf|Roche|Íbandrónsýra||15607||15607|21469| 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1646|3159|lyfalmen|||00|30|0|30,0000|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1646||1646|3159| 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1499|2982|vetalmen|||27|50|0|0,0000|Icepharma hf|Intervet International B.V.|||1499||1499|2982| 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2304|4059|lyfalmen|V0551|2771|10|7|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||2304||2304|4059| 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|10978|15925|lyfalmen|||00|4|0|3,6000|Icepharma hf|Pfizer ApS|Dalteparín||10978||10978|15925| 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|6256|9465|lyfalmen|||00|2|0|2,0000|Icepharma hf|Pfizer ApS|Dalteparín||6256||6256|9465| 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|7744|11501|lyfalmen|||00|2|0|2,5000|Icepharma hf|Pfizer ApS|Dalteparín||7744||7744|11501| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|9215|13513|lyfalmen|||00|3|0|3,0000|Icepharma hf|Pfizer ApS|Dalteparín||9215||9215|13513| 448217|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|0|0|IGB|0|0|0|100|SEK|649|1795|lyfalmen|||04|10|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||649||649|1795| 448233|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1268|2642|lyfalmen|||00|30|0|0,0000|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1268||1268|2642| 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2195|3910|lyfalmen|V0712|3567|00|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2195||2195|3910| 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1433|2868|lyfalmen|||00|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1433||1433|2868| 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5749|8297|lyfsjukr|||00|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5749||5749|8297| 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2311|lyfalmen|V0466|2296|00|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2311| 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|892|1916|lyfalmen|V0902|1805|00|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||737||737|1916| 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3096|5143|lyfalmen|V0903|4277|00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3096||3096|5143| 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|55802|72391|lyfalmen|||00|100|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||55802||55802|72391| 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|83705|107409|lyfalmen|||00|150|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||83705||83705|107409| 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|NOK|111605|142424|lyfalmen|||00|200|0|0,0000|Icepharma hf|GE Healthcare AS|Gadódíamíð||111605||111605|142424| 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|5935|8214|lyfalmen|||00|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5341||5341|8214| 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|0|0|LBK|0|1|0|100|DKK|15675|22032|lyfalmen|||00|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15675||15675|22032| 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1204|2554|lyfalmen|||00|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1204||1204|2554| 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|K||0|0|0|0|LHS|0|0|0|100|XEU|11588|20215|vetorma|||00|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11588||11588|20215| 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|12230|17708|lyfalmen|||00|3000|0|3,0000|Vistor hf|Laboratories 3M Santé|Imikvímóð||12230||12230|17708| 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|2431|4233|lyfalmen|||00|90|0|0,0000|Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2431||2431|4233| 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2464|4278|lyfalmen|||10|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2464||2464|4278| 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7242|10814|lyfalmen|||10|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7242||7242|10814| 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|AEG|0|0|0|100|GBP|2520|4355|lyfalmen|||10|100|0|33,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||2520||2520|4355| 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4757|7415|lyfalmen|||10|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4757||4757|7415| 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|1531|2671|vetorma|||16|6|0|0,0000|Vistor hf|Merial (MSD)|||||1531|2671| 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|14027|19963|lyfalmen|||10|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||14027||14027|19963| 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9104|13361|lyfalmen|||10|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||9104||9104|13361| 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|25566|34445|lyfalmen|||10|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||25566||25566|34445| 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PER|0|1|0|100|DKK|2856|4122|lyfsjukr|||02|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2856||2856|4122| 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2387|4173|lyfalmen|||00|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2387||2387|4173| 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|15910|22326|lyfalmen|||00|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15910||15910|22326| 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|45137|40146|lyfalmen|V0375|35256|00|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||30109||30109|40146| 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|17860|24774|lyfalmen|||00|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17860||17860|24774| 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|49730|44771|lyfalmen|V0376|38098|00|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||33794||33794|44771| 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|SKB|0|0|0|100|GBP|52178|67366|lyfsjukr|||00|1|0|0,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||52178||52178|67366| 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1135|2258|vetalmen|||16|100|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||1135||1135|2258| 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|1046|2338|lyfalmen|||00|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1046||1046|2338| 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BAP|0|0|0|100|SEK|3757|6047|lyfalmen|||00|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3757||3757|6047| 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|22746|30906|lyfalmen|||00|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||22746||22746|30906| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|957|2216|lyfalmen|||00|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||957||957|2216| 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|1082|2387|lyfalmen|||0|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1082||1082|2387| 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|AGT|0|0|1|100|XEU|2244|3977|lyfalmen|||00|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2244||2244|3977| 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5025|7252|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||5025||5025|7252| 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5025|7252|lyfsjukr|||00|12000|0|12,0000|Icepharma hf|Baxter|||5025||5025|7252| 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5264|7597|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5264||5264|7597| 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|5264|7597|lyfsjukr|||00|10000|0|0,0000|Icepharma hf|Baxter|||5264||5264|7597| 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7712|11130|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7712||7712|11130| 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7712|11130|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7712||7712|11130| 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7712|11130|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||7712||7712|11130| 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10281|14785|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||10281||10281|14785| 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10022|14460|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||10022||10022|14460| 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12677|17792|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12677||12677|17792| 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|805|2009|lyfalmen|V2180|2009|00|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||805||805|2009| 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|CHE|0|0|1|100|SEK|1207|2558|lyfalmen|||00|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1207||1207|2558| 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1496|2954|lyfalmen|||43|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1496||1496|2954| 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2174|3881|lyfalmen|||43|30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2174||2174|3881| 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8992|13208|lyfalmen|V0456|13208|00|100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||8992||8992|13208| 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12677|17792|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12677||12677|17792| 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12677|17792|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12677||12677|17792| 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12677|17792|lyfsjukr|||00|10000|0|10,0000|Icepharma hf|Baxter|||12677||12677|17792| 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|25122|33888|lyfalmen|||00|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||25122||25122|33888| 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|889|1283|lyfsjukr|||02|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||889||889|1283| 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|88599|113074|lyfsjukr|||00|10|0|1,6700|Icepharma hf|Roche|Íbandrónsýra||88599||88599|113074| 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PER|0|0|0|100|DKK|1627|2348|lyfsjukr|||02|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1627||1627|2348| 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1493|2950|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1493||1493|2950| 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|1395|2816|lyfalmen|||06|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól||1395||1395|2816| 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|þpakki||N07BA01|01.12.2010||L|A||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||| 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2253|3989|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2253||2253|3989| 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4574|7164|lyfalmen|||00|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4574||4574|7164| 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989|31.05.2011|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|955|2214|lyfalmen|||23|20|0|5,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||955||955|2214| 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4175|6619|lyfalmen|||51|0|0|0,0000|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4175||4175|6619| 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989|31.05.2011|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|251|1251|lyfalmen|||23|20|0|10,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||251||251|1251| 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|585|1708|lyfalmen|||23|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||585||585|1708| 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|MCS|0|0|1|100|SEK|||lyflausa|||23|120|0|120,0000|Vistor hf|McNeil Sweden AB|Ketókónazól|||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|5814|8861|lyfalmen|||51|5|0|0,0000|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||5814||5814|8861| 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1171|lyfalmen|||00|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1171| 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|654|1802|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||654||654|1802| 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|654|1802|lyfalmen|||20|25|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||654||654|1802| 462358|A07EA0601|Entocort|endaþ.dr|20|mcg/ml|7|stk|1|þpakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7825|11612|lyfalmen|V0291|11612|56|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7825||7825|11612| 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|A||0|0|E|0|XEL|0|0|1|100|DKK|12544|18102|lyfalmen|||0|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12544||12544|18102| 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|6955|13527|vetalmen|||02|20|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||6955||6955|13527| 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5548|10826|vetalmen|||00|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5548||5548|10826| 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|LPI|0|1|0|100|DKK|1836|3419|lyfalmen|||00|100|0|8,3333|Swedish Orphan International AB|Lundbeck Pharmaceuticals Ireland Ltd.|Melperón||1836||1836|3419| 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1232|2451|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1232||1232|2451| 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1164|2315|vetalmen|||58|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1164||1164|2315| 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1248|2482|vetalmen|||27|100|0|0,0000|Icepharma hf|Intervet International B.V.|||1248||1248|2482| 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|658|1309|vetalmen|||16|12|0|0,0000|Icepharma hf|Intervet International B.V.|||658||658|1309| 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|692|1854|lyfalmen|||10|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||692||692|1854| 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2142|3838|lyfalmen|||10|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2142||2142|3838| 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1533|3004|lyfalmen|||10|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1533||1533|3004| 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|5993|9105|lyfalmen|||10|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5993||5993|9105| 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|2851|4807|lyfalmen|||10|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2851||2851|4807| 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8213|12142|lyfalmen|||10|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8213||8213|12142| 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|4691|7324|lyfalmen|||10|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4691||4691|7324| 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4669|7294|lyfalmen|||64|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||4669||4669|7294| 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|15842|21764|lyfsjukr|||00|0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15842||15842|21764| 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|24278|32351|lyfsjukr|||00|0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||24278||24278|32351| 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|19175|25947|lyfsjukr|||00|1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||19175||19175|25947| 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|30928|40697|lyfsjukr|||00|1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||30928||30928|40697| 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|DKK|35142|46463|lyfalmen|||00|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||35142||35142|46463| 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|16022|22467|lyfalmen|||10|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16022||16022|22467| 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|57521|74071|lyfsjukr|||00|1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||57521||57521|74071| 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|30506|40644|lyfalmen|||10|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||30506||30506|40644| 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|520|750|lyfsjukr|||00|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||520||520|750| 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6649|6802|lyfalmen|V0922|4605|00|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4309||4309|6802| 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|395|570|lyfsjukr|||02|10|0|0,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||395||395|570| 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|9681|6475|lyfalmen|V0926|4404|00|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4070||4070|6475| 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|0|0|LBK|0|1|0|100|DKK|24460|13149|lyfalmen|V0930|7346|00|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8949||8949|13149| 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|4530|4326|lyfalmen|V0719|4326|00|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2499||2499|4326| 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5845|8903|lyfalmen|||00|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5845||5845|8903| 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1808|3381|lyfalmen|||00|20|0|13,3333|Icepharma hf|Grunenthal|Tramadól||1808||1808|3381| 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6546|9862|lyfalmen|V0738|9862|00|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6546||6546|9862| 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1296|2680|lyfalmen|||00|20|0|10,0000|Icepharma hf|Grunenthal|Tramadól||1296||1296|2680| 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|5323|8189|lyfalmen|V0736|7635|00|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5323||5323|8189| 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|805|2009|lyfalmen|V0733|2009|00|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||805||805|2009| 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3475|5661|lyfalmen|V0734|4966|00|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3475||3475|5661| 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5278|8127|lyfalmen|||24|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5278||5278|8127| 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|7272|10495|lyfsjukr|||02|150|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||7272||7272|10495| 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9707|14010|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9707||9707|14010| 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||02|100|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371| 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|9698|13997|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||9698||9698|13997| 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|13927|19361|lyfsjukr|||02|200|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||13927||13927|19361| 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PER|0|0|0|100|DKK|1264|2636|lyfalmen|||68|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíð||1264||1264|2636| 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|2205|3847|vetorma|||99|20|0|0,0000|Icepharma hf|Intervet International B.V.|||||2205|3847| 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|3422|5588|lyfalmen|||00|100|0|0,0000|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||3422||3422|5588| 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|4939|9656|vetalmen|||27|10|0|0,0000|Vistor hf|Orion Corporation|||4939||4939|9656| 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2183|3788|lyfalmen|V2003|2914|43|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2106||2106|3788| 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2444|4251|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2444||2444|4251| 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|15926|21870|lyfsjukr|||00|400|0|0,4000|Vistor hf|Meda AB|Dextran||15926||15926|21870| 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1050|2344|lyfalmen|||00|30|0|15,0000|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1050||1050|2344| 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0,0000|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|37899|49446|lyfsjukr|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||37899||37899|49446| 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1920|3534|lyfalmen|||00|140|0|35,0000|Vistor hf|Schering-Plough|Mómetasón||1920||1920|3534| 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|A||0|0|E|0|LYF|0|0|0|100|XEU|830|1489|lyfalmen|V2010|1489|00|30|0|1,0600|Lyfis ehf|Lyfis ehf|Pramipexól||425||425|1489| 475327|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1892|lyfalmen|||00|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||720||720|1892| 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3276|5389|lyfalmen|||23|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3276||3276|5389| 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|291|1305|lyfalmen|V0775|1249|00|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||291||291|1305| 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|355|1393|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||355||355|1393| 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|991|2263|lyfalmen|V0780|2216|00|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||991||991|2263| 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|3773|6069|lyfalmen|||00|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3773||3773|6069| 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|4971|7707|lyfalmen|||00|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4971||4971|7707| 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5792|8831|lyfalmen|||00|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5792||5792|8831| 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|4919|7636|lyfalmen|||51|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4919||4919|7636| 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|80370|102747|lyfsjukr|||00|1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||80370|102747| 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1128|2450|lyfalmen|||00|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1128||1128|2450| 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|AZA|0|1|0|100|SEK|7509|11179|lyfalmen|||00|30|0|7,5000|Vistor hf|AstraZeneca AB|Quetíapín||7509||7509|11179| 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4428|6965|lyfalmen|||00|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4428||4428|6965| 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0,0000|Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|10142|14781|lyfalmen|||00|98|0|130,6667|Vistor hf|Meda AS|Benazepríl||10142||10142|14781| 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|0|0|MAS|0|0|0|100|SEK|21194|28958|lyfalmen|||00|98|0|261,3333|Vistor hf|Meda AS|Benazepríl||21194||21194|28958| 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4300|6790|lyfalmen|||00|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4300||4300|6790| 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|A||0|0|E|0|WIH|0|0|0|100|XEU|27194|36488|lyfalmen|V0375|35256|00|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||27194||27194|36488| 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|13020|18700|lyfalmen|||00|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13020||13020|18700| 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|11443|16561|lyfalmen|||00|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||11443||11443|16561| 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|2876|4151|lyfsjukr|||00|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2876||2876|4151| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PER|0|0|0|100|DKK|4964|7164|lyfsjukr|||00|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4964||4964|7164| 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|59321|76330|lyfsjukr|||00|3|0|83,9552|Vistor hf|Ferring|Triptórelín||59321||59321|76330| 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|DKK|6164|9339|lyfalmen|||00|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||6164||6164|9339| 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|K||0|1|0|1|AEU|0|0|0|100|DKK|158768|201136|lyfsjukr|||00|1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||158768||158768|201136| 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1415|2843|lyfalmen|||00|300|0|0,0000|Vistor hf|Meda AB (V)|Benzýdamín||1415||1415|2843| 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||00|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|SAL|0|0|1|100|USD|438|1507|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||438||438|1507| 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|SAL|0|0|1|100|USD|625|1762|lyfalmen|||29|5|0|0,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||625||625|1762| 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|0|0|SEV|0|0|0|100|DKK|3768|6062|lyfalmen|||00|30|0|30,0000|Icepharma hf|Servier|Perindópríl||3768||3768|6062| 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|625|1762|lyfalmen|||00|25|0|6,2500|Vistor hf|Recip AB|Nítrófúrantóín||625||625|1762| 487959|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|978|2245|lyfalmen|||00|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||978||978|2245| 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2720|4628|lyfalmen|||00|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2720||2720|4628| 488114|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1345| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|6517|9822|lyfalmen|||67|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6517||6517|9822| 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|APC|0|0|0|100|DKK|11720|16940|lyfalmen|||67|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11720||11720|16940| 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|107132|136333|lyfsjukr|||00|2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||107132|136333| 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1170|lyfalmen|||67|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1170| 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|882|1546|lyfalmen|V0609|1494|67|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1546| 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2448|4256|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2448||2448|4256| 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2580|4437|lyfalmen|||23|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2580||2580|4437| 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|4103|6520|lyfalmen|||00|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4103||4103|6520| 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|11231|10869|lyfalmen|V2205|2456|00|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7282||7282|10869| 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|5455|8370|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5455||5455|8370| 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|15938|14773|lyfalmen|V2207|3174|00|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10136||10136|14773| 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998|31.05.2011|R|A|3|0|0|0|0|PER|0|0|0|100|DKK|11651|16845|lyfalmen|||00|30|0|60,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11651||11651|16845| 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PER|0|0|0|100|DKK|20271|18411|lyfalmen|V0339|5976|00|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12790||12790|18411| 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|51213|66155|lyfsjukr|||00|3|0|21,0084|Vistor hf|N.V. Organon|BCG bóluefni||51213||51213|66155| 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3405|5565|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3405||3405|5565| 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|A||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12934|18592|lyfalmen|V2206|7629|00|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12934||12934|18592| 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||| 493324|N05AX1202|Abilify (D.A.C)|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.03.2011||R|A||0|0|*|0|DAC|0|1|0|100|XEU|20601|24002|lyfalmen|V1703|24002|00|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Aripiprazól||17245||17245|24002| 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1428|2861|lyfalmen|||00|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1428||1428|2861| 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|2559|4408|lyfalmen|||00|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2559||2559|4408| 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|83840|107102|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||83840||83840|107102| 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|209601|264932|lyfsjukr|||00|50|0|0,0000|Icepharma hf|Roche Registration Limited|Rítúxímab||209601||209601|264932| 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PER|0|0|0|100|DKK|2089|3765|lyfalmen|||00|60|0|60,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2089||2089|3765| 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2343|4112|lyfalmen|V0408|1883|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Estradíól||2343||2343|4112| 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3405|5565|lyfalmen|V0388|4271|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3405||3405|5565| 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1936|3556|lyfalmen|||00|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1936||1936|3556| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|18171|25164|lyfalmen|||00|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||18171||18171|25164| 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7067|8193|lyfalmen|V1088|6505|02|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5326||5326|8193| 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10097|12577|lyfalmen|V1089|10230|02|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8531||8531|12577| 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2773|4701|lyfalmen|||00|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2773||2773|4701| 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|31193|33677|lyfalmen|V1374|33677|00|112|0|56,0000|Lyfis ehf|Lyfis ehf|Rívastigmín||24954||24954|33677| 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4383|8589|vetalmen|||0|10|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||4383|8589| 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4005|6386|lyfalmen|||02|100|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4005||4005|6386| 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1011|2290|lyfalmen|||00|50|0|8,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1011||1011|2290| 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3173|5248|lyfalmen|||00|100|0|33,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3173||3173|5248| 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|486|1572|lyfalmen|||04|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||486||486|1572| 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|878|2108|lyfalmen|||00|20|0|2,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||878||878|2108| 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PER|0|0|0|100|DKK|3348|5487|lyfalmen|||00|100|0|10,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3348||3348|5487| 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2325|lyfalmen|||00|30|0|10,0000|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2325| 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|þpakki||C09AA02|01.07.1990||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|355|1393|lyfalmen|||00|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||355||355|1393| 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|527|1628|lyfalmen|V0167|1527|00|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||527||527|1628| 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1094|2404|lyfalmen|V0169|2195|00|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1094||1094|2404| 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983|31.05.2011|L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Icepharma hf|Bioglan AB|Klórhexidín|||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|618|1753|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||618||618|1753| 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1411|2838|lyfalmen|||03|2|0|35,0000|Vistor hf|Schering-Plough|Betametasón||1411||1411|2838| 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|17586|24430|lyfalmen|||00|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17586||17586|24430| 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|18760|25903|lyfalmen|||00|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18760||18760|25903| 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|23368|31686|lyfalmen|||00|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||23368||23368|31686| 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PER|0|1|0|100|DKK|28231|37789|lyfalmen|V0722|37786|00|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||28231||28231|37789| 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|618|1753|lyfalmen|||20|30|0|30,0000|Icepharma hf|Bioglan AB|Flúócínólón||618||618|1753| 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2860|4820|lyfalmen|||67|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2860||2860|4820| 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3036|5060|lyfalmen|||10|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3036||3036|5060| 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3095|5141|lyfalmen|||00|100|0|25,0000|Vistor hf|Amdipharm Ltd|Maprótilín||3095||3095|5141| 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|31215|41057|lyfsjukr|||00|1|0|27,9851|Vistor hf|Ferring|Triptórelín||31215||31215|41057| 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|A||0|0|E|0|LYF|0|0|0|100|XEU|6878|8019|lyfalmen|V1373|8019|00|28|0|4,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||5199||5199|8019| 504191|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||| 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2117|3803|lyfalmen|||00|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2117||2117|3803| 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1204|2554|lyfalmen|||00|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1204||1204|2554| 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8515|12555|lyfalmen|||00|100|0|75,0000|Vistor hf|Amdipharm Ltd|Maprótilín||8515||8515|12555| 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|1872|2702|lyfsjukr|||02|5|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||1872||1872|2702| 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|3738|5395|lyfsjukr|||02|10|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||3738||3738|5395| 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PER|0|0|0|100|DKK|8529|12309|lyfsjukr|||02|25|0|0,0000|Icepharma hf|Pfizer ApS|Doxórúbicín||8529||8529|12309| 506949|N01AB0601|Forene|innönd.l|||250|ml|1|stauk||N01AB06|01.10.1993|31.05.2011|R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|29678|39128|lyfsjukr|||00|250|0|0,0000|Vistor hf|Abbott Scandinavia AB|Ísóflúran||29678||29678|39128| 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2540|4382|lyfalmen|||10|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2540||2540|4382| 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|415|1475|lyfalmen|||10|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||415||415|1475| 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|683|1191|vetorma|||16|24|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||683|1191| 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2905|5068|vetorma|||16|120|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2905|5068| 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|16676|29090|vetorma|||13|1000|0|0,0000|Icepharma hf|Intervet International B.V.|||16676||16676|29090| 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2607|5178|vetalmen|||27|50|0|0,0000|Vistor hf|Intervet International BV|||2607||2607|5178| 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2652|4535|lyfalmen|||10|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2652||2652|4535| 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5299|10347|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||||5299|10347| 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4250|8333|vetalmen|||0|50|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||4250||4250|8333| 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|13149|25421|vetalmen|||0|100|0|0,0000|Icepharma hf|Bayer Animal Health GmbH|||13149||13149|25421| 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|9284|13607|lyfalmen|||02|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9284||9284|13607| 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2817| 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|VII|0|0|0|100|GBP|46997|60864|lyfsjukr|||00|60|0|0,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||46997||46997|60864| 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|17256|23539|lyfsjukr|||00|2|0|12,0000|Icepharma hf|Roche|Epóetín||17256||17256|23539| 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|25830|34299|lyfsjukr|||00|2|0|18,0000|Icepharma hf|Roche|Epóetín||25830||25830|34299| 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|42369|55056|lyfsjukr|||00|2|0|30,0000|Icepharma hf|Roche|Epóetín||42369||42369|55056| 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|83788|107036|lyfsjukr|||00|4|0|60,0000|Icepharma hf|Roche|Epóetín||83788||83788|107036| 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|194544|246035|lyfsjukr|||00|1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||194544|246035| 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4326|5628|lyfalmen|V0004|5628|00|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||3451||3451|5628| 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|0|0|BII|0|0|0|100|DKK|2810|4751|lyfalmen|||00|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2810||2810|4751| 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2792|4727|lyfalmen|V0385|4523|23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2792||2792|4727| 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|23958|31950|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||23958||23958|31950| 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14987|20691|lyfsjukr|||00|6000|0|6,0000|Vistor hf|Meda AB|Dextran||14987||14987|20691| 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5449|7864|lyfsjukr|||00|100|0|0,1000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||5449||5449|7864| 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0,0000|Vistor hf|AstraZeneca A/S DK|Lídókaín|||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2099|3779|lyfalmen|||23|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2099||2099|3779| 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PER|0|1|0|100|DKK|1750|1501|lyfalmen|||00|20|0|10,0000|Icepharma hf|Pfizer ApS|Reboxetin||434||434|1501| 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PER|0|1|0|100|DKK|4579|4361|lyfalmen|||00|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2525||2525|4361| 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|10,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2556| 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|100|0|20,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||| 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|2069|3738|lyfalmen|||00|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||2069||2069|3738| 517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.06.2011||R|A||0|0|E|0|APC|0|0|0|100|IKR|5469|8389|lyfalmen|V2188|8389|00|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||5469||5469|8389| 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3063|5097|lyfalmen|||00|90|0|11,2500|Vistor hf|Novo-Nordisk|Repaglíníð||3063||3063|5097| 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3335|5469|lyfalmen|||00|90|0|22,5000|Vistor hf|Novo-Nordisk|Repaglíníð||3335||3335|5469| 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|3587|5814|lyfalmen|||00|90|0|45,0000|Vistor hf|Novo-Nordisk|Repaglíníð||3587||3587|5814| 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|951|2208|lyfalmen|||00|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||951||951|2208| 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3506|5703|lyfalmen|||00|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3506||3506|5703| 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2161|3864|lyfalmen|||23|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2161||2161|3864| 518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|þpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|13101|18801|lyfalmen|||00|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||13101||13101|18801| 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1135|2460|lyfalmen|||08|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1135||1135|2460| 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|7529|11207|lyfalmen|||02|2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||7529||7529|11207| 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|4991|7735|lyfalmen|V0096|7598|00|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4991||4991|7735| 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|5637|8618|lyfalmen|V0097|4400|00|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5637||5637|8618| 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|15882|22291|lyfalmen|V0098|10783|00|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15882||15882|22291| 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|6045|9177|lyfalmen|V0099|4766|00|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||6045||6045|9177| 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PER|0|0|0|100|DKK|16726|23351|lyfalmen|V0100|12930|00|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16726||16726|23351| 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1355|2532|lyfalmen|V0308|2532|00|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||1188||1188|2532| 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2163|3480|lyfalmen|V0310|3480|00|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||1881||1881|3480| 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|366|1408|lyfalmen|||00|30|0|8,7500|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||366||366|1408| 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1669| 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|A||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen|||22|25|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1680| 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|33246|44083|lyfalmen|V2030|16663|00|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||33246||33246|44083| 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|11102|15816|lyfsjukr|||00|100|1|0,0000|Distica|Distica - óskráð lyf|Hýdroxýkarbamíð||11102||11102|15816| 522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8284|16079|vetalmen|||16|320|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||8284||8284|16079| 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2372|4152|lyfalmen|||AC|0|0|0,0000|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||2372||2372|4152| 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|192843|243900|lyfsjukr|||00|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||192843||192843|243900| 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|342|1375|lyfalmen|V0730|1207|00|20|0|3,3300|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||342||342|1375| 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|405|1461|lyfalmen|V0731|1461|00|100|0|16,6700|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||405||405|1461| 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|2871|4835|lyfalmen|||00|250|0|208,3333|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||2871||2871|4835| 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|409|1467|lyfalmen|V0732|1467|02|10|0|1,6667|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||409||409|1467| 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7448|11096|lyfalmen|||00|120|0|0,0000|Vistor hf|LEO Pharma A/S|Kalcípótríól||7448||7448|11096| 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|453|1527|lyfalmen|||00|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||453||453|1527| 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1323| 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1281|2660|lyfalmen|||00|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1281||1281|2660| 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|457|1533|lyfalmen|||43|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||457||457|1533| 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2880|4847|lyfalmen|||43|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2880||2880|4847| 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|A||0|0|E|0|EIS|0|0|0|100|IKR|8619|7381|lyfalmen|||00|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||4732||4732|7381| 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1206| 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6,0000|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1185| 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1970|3919|vetalmen|||00|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1970||1970|3919| 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|898|2136|lyfalmen|||00|100|0|29,2000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||898||898|2136| 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|802|2004|lyfalmen|||00|15|0|0,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||802||802|2004| 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|3003|lyfalmen|||10|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|3003| 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7891|lyfalmen|||10|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7891| 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|10490|15257|lyfalmen|||00|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10490||10490|15257| 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5628|8123|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Kalíumklóríð||5628||5628|8123| 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|A||0|0|0|1|BRA|0|0|0|100|XEU|5124|7395|lyfsjukr|||00|1000|0|1,0000|Actavis Group hf|Braun|Natríumklóríð||5124||5124|7395| 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0,0000|Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|4620|7227|lyfalmen|||00|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4620||4620|7227| 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4308|6800|lyfalmen|||10|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4308||4308|6800| 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|6909|13439|vetalmen|||16|188|0|0,0000|Vistor hf|Intervet International BV|||6909||6909|13439| 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3685|5948|lyfalmen|||10|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3685||3685|5948| 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|15490|21322|lyfsjukr|||00|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15490||15490|21322| 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1158|2491|lyfalmen|||00|5|0|0,0000|K.Pétursson hf|Alcon|Emedastín||1158||1158|2491| 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|A||0|0|0|0|LVR|0|0|0|100|NOK|9640|14094|lyfalmen|V1300|13815|00|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9640||9640|14094| 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999|31.03.2011|R|A|1|1|0|0|1|RBP|0|0|0|100|DKK|1922|2774|lyfsjukr|||00|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1276||1922|2774| 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1,5|0|0|0|0|PAL|0|0|0|100|DKK|4433|8685|vetalmen|||16|72|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||4433||4433|8685| 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3819|7506|vetalmen|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||3819||3819|7506| 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PER|0|0|0|100|DKK|71061|91064|lyfsjukr|||00|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||71061||71061|91064| 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3214|5304|lyfalmen|||23|84|0|84,0000|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3214||3214|5304| 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3051|5081|lyfalmen|||43|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3051||3051|5081| 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|8495|12260|lyfsjukr|||00|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8495||8495|12260| 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|þpakki||L04AA06|01.03.2011||R|A||0|1|*|0|LYF|0|0|0|100|XEU|20986|22565|lyfalmen|V2231|22565|00|50|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||16100||16100|22565| 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|675|1831|lyfalmen|||01|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||675||675|1831| 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|356|1394|lyfalmen|||00|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||356||356|1394| 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1035|2323|lyfalmen|||00|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1035||1035|2323| 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|286|1299|lyfalmen|||00|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||286||286|1299| 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|A||0|0|0|0|MEB|0|0|1|100|SEK|1824|3403|lyfalmen|||00|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1824||1824|3403| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2068|3736|lyfalmen|||43|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2068||2068|3736| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6631|9978|lyfalmen|||00|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6631||6631|9978| 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|408|1465|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||408||408|1465| 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|SAL|0|0|0|100|USD|521|1620|lyfalmen|||06|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||521||521|1620| 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|9863|14399|lyfalmen|||52|100|0|12,5000|Vistor hf|Meda AS|Brómókriptín||9863||9863|14399| 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|611|1066|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||611|1066| 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2390| 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|MSE|0|0|0|100|SEK|138510|175713|lyfsjukr|||00|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||138510||138510|175713| 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10629|15447|lyfalmen|||00|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10629||10629|15447| 539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.06.2011||R|A||0|0|*|0|LVR|0|1|0|100|SEK|8224|12157|lyfalmen|||00|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||8224||8224|12157| 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|182|1156|lyfalmen|||00|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||182||182|1156| 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|395|1448|lyfalmen|||00|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||395||395|1448| 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15,0000|Vistor hf|Janssen-Cilag AB|Blöndur|||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|1861|3453|lyfalmen|||23|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1861||1861|3453| 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2889|4859|lyfalmen|||00|250|0|250,0000|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2889||2889|4859| 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|DKK|6096|9246|lyfalmen|||06|15|0|0,0000|Vistor hf|M.S.D.|Tímólól í blöndum||6096||6096|9246| 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2059|3724|lyfalmen|||23|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2059||2059|3724| 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|9856|14390|lyfalmen|||10|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9856||9856|14390| 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|15964|22394|lyfalmen|||10|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15964||15964|22394| 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1551|3029|lyfalmen|||10|28|0|28,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1551||1551|3029| 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4756|7413|lyfalmen|||00|100|1|100,0000|Parlogis hf|Parlogis - óskráð lyf|Dapsón||4756||4756|7413| 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|3013|5029|lyfalmen|||00|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||3013||3013|5029| 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|9,3750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|A|3|0|1|*|0|ASP|0|0|0|100|XEU|13491|19291|lyfalmen|||00|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13491||13491|19291| 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|719|1891|lyfalmen|||00|15|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||719||719|1891| 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|938|2191|lyfalmen|||00|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||938||938|2191| 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|2276|4021|lyfalmen|||00|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2276||2276|4021| 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|31327|41675|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||31327||31327|41675| 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|25257|34057|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|trjáfrjó||25257||25257|34057| 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|31511|41906|lyfalmen|||02|20|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||31511||31511|41906| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|26770|35956|lyfalmen|||02|5|0|0,0000|Vistor hf|ALK-Abello A/S|grasfrjó||26770||26770|35956| 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|XEU|931|2088|lyfalmen|||10|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||863||863|2088| 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|8561|12618|lyfalmen|||00|56|1|37,3333|Parlogis hf|Parlogis - óskráð lyf|||8561||8561|12618| 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||23|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4720| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10036|14478|lyfsjukr|||00|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||10036||10036|14478| 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3307|4773|lyfsjukr|||00|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3307||3307|4773| 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|8083|11965|lyfalmen|||63|0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||8083||8083|11965| 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4057|6457|lyfalmen|||63|0|0|0,6667|Vistor hf|N.V. Organon|Follitrópín beta||4057||4057|6457| 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|5418|8319|lyfalmen|||00|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5418||5418|8319| 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|15594|21930|lyfalmen|||00|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15594||15594|21930| 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|97994|124865|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||97994||97994|124865| 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|9744|14237|lyfalmen|||02|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9744||9744|14237| 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|145109|183994|lyfsjukr|||17|1|0|0,0000|Vistor hf|Abbott Laboratories Ltd|Palivisumab||145109||145109|183994| 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2095|3773|lyfalmen|||00|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefnavakar||2095||2095|3773| 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|24|0|4,0000|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||1520| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0,4800|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0,4167|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól|||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|AZA|0|0|0|100|SEK|10995|15948|lyfalmen|||00|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10995||10995|15948| 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1878|3476|lyfalmen|||03|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1878||1878|3476| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|4007|6389|lyfalmen|||00|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4007||4007|6389| 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|738|1917|lyfalmen|||00|20|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||738||738|1917| 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2157|2130|lyfalmen|V2182|2009|00|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||894||894|2130| 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|4230|lyfalmen|V2185|3928|00|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||2429||2429|4230| 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|1483|2936|lyfalmen|||00|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1483||1483|2936| 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3631|2009|lyfalmen|V2180|2009|00|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||805||805|2009| 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7648|3948|lyfalmen|V2181|3948|00|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||2223||2223|3948| 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BAP|0|0|0|100|SEK|3663|5918|lyfalmen|||63|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3663||3663|5918| 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|5168|7977|lyfalmen|||00|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5168||5168|7977| 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3410|5572|lyfalmen|||00|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3410||3410|5572| 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3213|5303|lyfalmen|||00|50|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3213||3213|5303| 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|A||0|0|E|0|PER|0|0|0|100|DKK|12440|17972|lyfalmen|||00|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12440|17972| 553313|N02CC0601|Relpax|filmhtfl|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|2469|4285|lyfalmen|||00|3|0|3,0000|Icepharma hf|Pfizer ApS|Eletriptan||2469||2469|4285| 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PER|0|0|0|100|DKK|4254|6727|lyfalmen|||00|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4254||4254|6727| 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7510|14593|vetalmen|||27|500|0|0,0000|Vistor hf|Boehringer Ingelheim Danmark|||7510||7510|14593| 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3828|5525|lyfsjukr|||00|6000|0|6,0000|Icepharma hf|Fresenius Kabi|Kolvetni||3828||3828|5525| 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|A||0|1|0|1|EMA|0|0|0|100|SEK|27398|36267|lyfsjukr|||00|1|0|0,5200|Icepharma hf|E. Merck AB|Sómatrópín||27398||27398|36267| 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5053|7820|lyfalmen|||00|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5053||5053|7820| 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6872|10308|lyfalmen|||00|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6872||6872|10308| 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|9851|14383|lyfalmen|||00|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9851||9851|14383| 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1657|3174|lyfalmen|||38|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1657||1657|3174| 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992|30.04.2011|R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|186060|235388|lyfsjukr|||02|200|0|0,0000|Icepharma hf|Schering AG|Gadópentetat||186060||186060|235388| 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|878|2108|lyfalmen|||10|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||878||878|2108| 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2014|3662|lyfalmen|||10|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2014||2014|3662| 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|219|1207|lyfalmen|V0730|1207|10|20|0|3,3333|Icepharma hf|Grunenthal|Tramadól||219||219|1207| 559104|N02AX0201|Nobligan|eþ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|684|1843|lyfalmen|||04|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||684||684|1843| 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|672|1827|lyfalmen|V0732|1467|02|10|0|1,6667|Icepharma hf|Grunenthal|Tramadól||672||672|1827| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1621|3125|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1621||1621|3125| 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0,0000|Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PER|0|0|0|100|DKK|5933|9023|lyfalmen|||23|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5933||5933|9023| 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2854|4811|lyfalmen|||23|30|0|30,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2854||2854|4811| 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3588|5816|lyfalmen|||23|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3588||3588|5816| 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|SEK|13593|18942|lyfsjukr|||00|240|0|0,0000|Icepharma hf|Baxter|Desflúran||13593||13593|18942| 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0,0000|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1367| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|2990|4998|lyfalmen|||00|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||2990||2990|4998| 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2,0000|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír|||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1705|3240|lyfalmen|||07|4|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1705||1705|3240| 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5698|8702|lyfalmen|||00|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5698||5698|8702| 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6179|9360|lyfalmen|||00|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6179||6179|9360| 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|103878|132249|lyfsjukr|||00|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||103878||103878|132249| 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ORC|0|0|0|100|DKK|480402|559881|lyfsjukr|||00|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||444620||444620|559881| 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|1780|3342|lyfalmen|||06|5|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1780||1780|3342| 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|A||0|0|B|0|APC|0|0|0|100|XEU|2591|4452|lyfalmen|||00|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||2591||2591|4452| 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|21931|29883|lyfalmen|||02|6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||21931||21931|29883| 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|37001|48796|lyfalmen|||02|10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||37001||37001|48796| 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|665|1817|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||665||665|1817| 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A||0|0|B|0|GSK|0|0|1|100|GBP|665|1817|lyfalmen|||20|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||665||665|1817| 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PER|0|0|0|100|DKK|1432|2866|lyfalmen|||10|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1432||1432|2866| 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|213329|270087|lyfalmen|||02|60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||213329||213329|270087| 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3715|5989|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3715||3715|5989| 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|3851|6175|lyfalmen|||00|15|0|0,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3851||3851|6175| 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|84853|108373|lyfsjukr|||00|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||84853||84853|108373| 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|5358|8237|lyfalmen|||00|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|||5358||5358|8237| 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||01|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|8041|11907|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||8041||8041|11907| 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|DKK|1422|2853|lyfalmen|||00|28|1|4,6667|Parlogis hf|Parlogis - óskráð lyf|||1422||1422|2853| 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|11970|17282|lyfalmen|||00|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11970||11970|17282| 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1293|2676|lyfalmen|||06|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíð||1293||1293|2676| 566661|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|DKK|76498|97887|lyfsjukr|||00|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||76498||76498|97887| 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|2280|4026|lyfalmen|||00|100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2280||2280|4026| 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|3446|5621|lyfalmen|V0791|3569|00|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3446||3446|5621| 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6975|10449|lyfalmen|V0793|5494|00|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6975||6975|10449| 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|10194|14852|lyfalmen|V0794|8107|00|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10194||10194|14852| 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13388|19161|lyfalmen|V0795|10395|00|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13388||13388|19161| 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||24|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||| 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|9030|lyfalmen|V2188|8389|00|120|0|120,0000|Vistor hf|Eisai Ltd|Rabeprazól||5938||5938|9030| 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1069|2370|lyfalmen|||00|3|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1069||1069|2370| 568790|N02AA5902|Parkodin forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993|30.04.2011|R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1576|lyfalmen|||04|10|0|3,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1576| 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2909|lyfalmen|V0316|2909|10|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2909| 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|4078|lyfalmen|V0324|4078|10|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2318||2318|4078| 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|17814|24239|lyfsjukr|||02|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17814||17814|24239| 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|20484|27590|lyfsjukr|||02|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||20484||20484|27590| 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2381|4164|lyfalmen|||51|0|0|0,0000|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2381||2381|4164| 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|152939|193821|lyfsjukr|||00|5|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||152939||152939|193821| 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|194695|246225|lyfsjukr|||00|10|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||194695||194695|246225| 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|376604|474521|lyfsjukr|||00|20|0|0,0000|Icepharma hf|Baxter|Fíbrínógen manna||376604||376604|474521| 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|A||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||00|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||| 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|5300|8158|lyfalmen|V0705|8158|00|98|0|49,0000|Actavis Group hf|Actavis hf|Lamótrigín||5300||5300|8158| 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3324|5454|lyfalmen|||23|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3324||3324|5454| 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|100143|127562|lyfsjukr|||00|1|0|0,0000|Icepharma hf|Roche|Trastuzumab||100143||100143|127562| 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|24569|32717|lyfsjukr|||00|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||24569||24569|32717| 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|AZA|0|0|0|100|SEK|41601|54092|lyfsjukr|||00|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||41601||41601|54092| 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2587|lyfalmen|V0610|2531|67|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2587| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|2564|2077|lyfalmen|V0931|1977|00|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||855||855|2077| 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|7987|7084|lyfalmen|V0933|4175|00|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4515||4515|7084| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|4728|2077|lyfalmen|V0935|1977|00|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||855||855|2077| 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PER|0|1|0|100|DKK|14155|7084|lyfalmen|V0937|6605|00|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4515||4515|7084| 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0,0000|Icepharma hf|Norpharma |Malatíón|||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|6989|10087|lyfsjukr|||00|12|0|0,0000|Vistor hf|Sanofi - Aventis|Adenósín||6989||6989|10087| 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000|31.05.2011|R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|86879|110916|lyfsjukr|||00|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||86879||86879|110916| 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|A||0|0|E|0|ACA|0|0|0|100|IKR|1150|2481|lyfalmen|V0704|2481|00|42|0|5,2500|Actavis Group hf|Actavis hf|Lamótrigín||1150||1150|2481| 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1324|2719|lyfalmen|||02|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1324||1324|2719| 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|PER|0|0|0|100|DKK|732|1909|lyfalmen|||00|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||732||732|1909| 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|A||0|0|0|0|ANI|1|0|0|100|XEU|14931|28842|vetalmen|||27|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14931||14931|28842| 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|29172|38493|lyfsjukr|||02|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||29172||29172|38493| 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|56299|72538|lyfsjukr|||02|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||56299||56299|72538| 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|112596|143190|lyfsjukr|||02|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||112596||112596|143190| 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|GCO|0|0|1|100|IKR|||lyflausa|||23|8|0|1,8750|Vistor hf|GlaxoSmithKline CH AB|Oxýmetazólín|||||| 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|A||0|0|0|1|GEH|0|0|0|100|NOK|66942|85895|lyfsjukr|||02|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||66942||66942|85895| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5147|8979|vetorma|||16|50|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||5147||5147|8979| 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|19396|33835|vetorma|||16|200|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||19396||19396|33835| 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|45013|58374|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||45013||45013|58374| 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|102407|130403|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jóhexól||102407||102407|130403| 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|838|2054|lyfalmen|||00|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||838||838|2054| 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|49621|64157|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||49621||49621|64157| 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|A||0|1|0|1|EMA|0|0|0|100|SEK|54752|70596|lyfsjukr|||00|2|0|0,7500|Icepharma hf|E. Merck AB|Sómatrópín||54752||54752|70596| 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|98677|125722|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||98677||98677|125722| 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MYL|0|0|0|100|SEK|1128|2450|lyfalmen|||00|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1128||1128|2450| 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|117780|149696|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||117780||117780|149696| 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|53781|69378|lyfsjukr|||02|1000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||53781||53781|69378| 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|110786|140919|lyfsjukr|||02|2000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||110786||110786|140919| 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|NOK|121103|153867|lyfsjukr|||02|3000|0|0,0000|Icepharma hf|GE Healthcare AS|Jódixanól||121103||121103|153867| 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3940|5686|lyfsjukr|||00|5000|0|5,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||3940||3940|5686| 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2231|3220|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2231||2231|3220| 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2387|3445|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Kolvetni||2387||2387|3445| 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2301|3321|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar||2301||2301|3321| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|1898|3504|lyfalmen|||64|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíð||1898||1898|3504| 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10303|14813|lyfsjukr|||02|20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10303||10303|14813| 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3753|5417|lyfsjukr|||02|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3753||3753|5417| 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|DKK|36921|48218|lyfsjukr|||00|12|0|3,0000|Vistor hf|M.S.D.|Imipenem og ensímhemill||36921||36921|48218| 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3548|5761|lyfalmen|||02|1|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3548||3548|5761| 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|33670|44615|lyfalmen|||00|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||33670||33670|44615| 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1798|3367|lyfalmen|||20|100|0|100,0000|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1798||1798|3367| 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2294|3311|lyfsjukr|||00|9000|0|9,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2294||2294|3311| 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1141|2468|lyfalmen|||06|5|0|0,0000|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1141||1141|2468| 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2261|4000|lyfalmen|V0426|3680|43|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2261||2261|4000| 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|9712|14193|lyfalmen|||00|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9712||9712|14193| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9069|13313|lyfalmen|||23|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9069||9069|13313| 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6296|10983|vetorma|||16|3|0|0,0000|Icepharma hf|Pfizer Animal Health|||6296||6296|10983| 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2440|4256|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||2440||2440|4256| 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6075|10598|vetorma|||16|6|0|0,0000|Icepharma hf|Pfizer Animal Health|||6075||6075|10598| 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3281|5724|vetorma|||16|1|0|0,0000|Icepharma hf|Pfizer Animal Health|||3281||3281|5724| 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3408|5945|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||3408||3408|5945| 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2640|4605|vetorma|||16|2|0|0,0000|Icepharma hf|Pfizer Animal Health|||2640||2640|4605| 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|USD|5726|8740|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|Lyf við vörtum og líkþornum||5726||5726|8740| 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|USD|7274|10858|lyfalmen|||00|8|1|7,5000|Parlogis hf|Parlogis - óskráð lyf|Lyf við vörtum og líkþornum||7274||7274|10858| 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996|31.03.2011|R|A|3|0|1|0|1|GZE|0|0|0|100|SEK|165632|209751|lyfsjukr|||00|250|0|0,0000|Vistor hf|Genzyme Europe B.V.|Flúdarabín||133046||165632|209751| 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|71067|91072|lyfsjukr|||00|336|0|28,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||71067||71067|91072| 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAI|0|0|1|100|IKR|||lyflausa|||00|20|0|20,0000|Icepharma hf|Bayer A/S|Klótrímazól|||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|XEU|2100|3780|lyfalmen|V0139|3780|10|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||2100||2100|3780| 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|23210|31488|lyfalmen|||02|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||23210||23210|31488| 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|186040|235363|lyfsjukr|||00|1|0|1,2500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||186040||186040|235363| 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3360|4849|lyfsjukr|||02|12|0|0,0000|Icepharma hf|Hospira Enterprises B.V. (I)|Tíópentalnatríum||3360||3360|4849| 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|1,6000|Actavis Group hf|Actavis hf|Paracetamól|||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|534|1638|lyfalmen|||00|50|0|3,1250|Icepharma hf|Roche|Klónazepam||534||534|1638| 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|927|2175|lyfalmen|||00|150|0|9,3750|Icepharma hf|Roche|Klónazepam||927||927|2175| 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1380|2795|lyfalmen|||00|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1380||1380|2795| 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|21318|29113|lyfalmen|||03|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21318||21318|29113| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|349|609|vetorma|||16|10|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||349|609| 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|2905|5068|vetorma|||16|100|0|0,0000|Icepharma hf|Pfizer Oy Animal Health|||||2905|5068| 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2823|4074|lyfsjukr|||02|9000|0|0,0000|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2823||2823|4074| 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|6166|8899|lyfsjukr|||02|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||6166||6166|8899| 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|605|1735|lyfalmen|||02|0|0|0,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||605||605|1735| 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250,0000|Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||| 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|67068|86053|lyfsjukr|||00|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||67068|86053| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PER|0|0|1|100|DKK|2416|4212|lyfalmen|||43|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2416||2416|4212| 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||00|30|0|30,0000|Vistor hf|McNeil Sweden AB|Ekónazól|||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|459|1535|lyfalmen|||00|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||459||459|1535| 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|LDR|0|0|0|100|DKK|1376|2790|lyfalmen|||00|20|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||1376||1376|2790| 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|SEK|5201|8022|lyfalmen|||00|50|1|25,0000|Distica|Distica - óskráð lyf|Flunarizín||5201||5201|8022| 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|SEK|2835|4786|lyfalmen|||00|100|1|33,3333|Distica|Distica - óskráð lyf|Dómíperídón||2835||2835|4786| 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|10|lykjur||N05BA06|01.11.2005|31.03.2011|R|A||0|0|0|1|PCO|0|0|0|100|DKK|2785|4019|lyfsjukr|||00|10|1|0,0000|Distica|Distica - óskráð lyf|Lórazepam||2785||2785|4019| 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1564|lyfalmen|||00|4|1|0,0000|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||480||480|1564| 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|12095|17539|lyfalmen|||00|20|1|200,0000|Distica|Distica - óskráð lyf|||12095||12095|17539| 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|11317|16388|lyfalmen|||00|100|1|160,0000|Parlogis hf|Parlogis - óskráð lyf|||11317||11317|16388| 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|5086|7865|lyfalmen|||00|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Kolkisín||5086||5086|7865| 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|50663|65941|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Pentósan pólýsúlfat natríum||50663||50663|65941| 938665|A12CX0001|K-Phos Neutral|töflur|||100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6476|lyfalmen|||00|100|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Málmlyf ýmisleg||4071||4071|6476| 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|GBP|17320|24096|lyfalmen|||00|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||17320||17320|24096| 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|GBP|10419|15160|lyfalmen|||00|10|1|100,0000|Distica|Distica - óskráð lyf|||10419||10419|15160| 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|2809|4750|lyfalmen|||00|1|1|83,3300|Distica|Distica - óskráð lyf|Estradíól||2809||2809|4750| 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|5602|8571|lyfalmen|||00|1|1|166,6700|Distica|Distica - óskráð lyf|Estradíól||5602||5602|8571| 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|DKK|9715|14197|lyfalmen|||00|1|1|333,3300|Distica|Distica - óskráð lyf|Estradíól||9715||9715|14197| 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|GBP|2826|4773|lyfalmen|||00|1|1|1,3900|Distica|Distica - óskráð lyf|Testósterón||2826||2826|4773| 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5590|8554|lyfalmen|||00|100|1|13,3300|Distica|Distica - óskráð lyf|Kortisón||5590||5590|8554| 944852|A06AX0102|Glycerol infant|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1375|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1375| 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998|31.03.2011|R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1074|lyfalmen|||00|28|1|2,8000|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1074| 944985|A06AX0103|Glycerol adult|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1375|lyfalmen|||00|12|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||342||342|1375| 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|4044|lyfalmen|||00|10|1|10,0000|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|4044| 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|5033|7792|lyfalmen|||00|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|||5033||5033|7792| 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1800|3370|lyfalmen|||00|100|1|33,3300|Parlogis hf|Parlogis - óskráð lyf|Dexametasón||1800||1800|3370| 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1995|3636|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Prógesterón||1995||1995|3636| 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1182|1706|lyfsjukr|||55|10|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|Dexametasón||1182||1182|1706| 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|838|2054|lyfalmen|||00|21|1|21,0000|Parlogis hf|Parlogis - óskráð lyf|||838||838|2054| 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|PCO|0|0|1|100|DKK|5590|8554|lyfalmen|||00|100|1||Distica|Distica - óskráð lyf|Hýdrókortisón||5590||5590|8554| 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1870|3465|lyfalmen|||00|60|1||Parlogis hf|Parlogis - óskráð lyf|Fúrósemíð||||1870|3465| 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5690|8691|lyfalmen|||00|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||||5690|8691| 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3770|lyfalmen|||00|238|1|0,0000|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3770| 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|DKK|17754|24164|lyfsjukr|||00|30|1|112,0000|Distica|Distica - óskráð lyf|||17754||17754|24164| 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1960|3589|lyfalmen|||00|20|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|Metópímazín||1960||1960|3589| 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|1850|3438|lyfalmen|||00|20|1||Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||1850||1850|3438| 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4320|6817|lyfalmen|||00|25|1|16,7000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||4320||4320|6817| 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3451|5628|lyfalmen|||00|100|1|266,6600|Parlogis hf|Parlogis - óskráð lyf|||||3451|5628| 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|þpakki||R06AB02|01.11.2009||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2360|4136|lyfalmen|||00|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Dexklórfeníramín||2360||2360|4136| 963802|M01AB0107|Indometacin|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.10.2010||R|A||0|0|E|0|PCO|0|0|1|100|GBP|410|1468|lyfalmen|||04|10|1|10,0000|Distica|Distica - óskráð lyf|Indómetacín||410||410|1468| 964371|A03AA0702|Merbentyl|mixtúra|2|mg/ml|120|ml|1|glas|sykursaft|A03AA07|01.12.2010||R|A||0|1|E|0|LDR|0|0|0|100|IKR|657|1806|lyfalmen|||00|120|1|3,0000|Parlogis hf|Parlogis - óskráð lyf|Dícýklóverín||657||657|1806|